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Executive summary 
Introduction  
This report presents the findings of the ORIE economic evaluation on the costs of the WINNN 
programme1. The aim of the work is to assess the costs of delivering the WINNN outputs over the 
programme duration (2011–2017). The level at which the output is focused determines the scope 
and the perspective of the costing. All outputs are costed from a programme perspective, which 
considers the expenditure of the WINNN programme. The infant and young child feeding (IYCF) 
interventions (Output 2) and community-based management of acute malnutrition (CMAM) 
programme (Output 3) are additionally costed from a societal perspective, which includes costs 
incurred by health service providers in providing the intervention and costs incurred by health 
service users, in addition to the expenditure of the WINNN programme.  
The audiences for this full WINNN costing report are DFID, WINNN, the Nigerian government and 
civil society stakeholders. 
Separate reports provide the results of the cost-effectiveness analysis (CEA) of the IYCF 
interventions and CMAM programme interventions (Cost-effectiveness of the WINNN programme, 
2017), and a value for money (VfM) analysis of the overall WINNN programme. These reports will 
complement the costing and cost-efficiency analysis findings in this report and will help provide a 
better answer to the VfM question of whether the best possible outcome was obtained within the 
given budget and considering improvements in equity.  
The WINNN programme 
The WINNN programme is an ambitious £52 million, six-year DFID-funded programme (2011–
2017) to improve maternal, newborn and child nutrition in five states in northern Nigeria: Jigawa, 
Katsina, Kebbi, Yobe and Zamfara. WINNN is implemented by three implementing partners (IPs): 
SCI, Action Against Hunger (ACF), and the UN Children’s Fund (UNICEF).  
WINNN is designed to deliver three nutrition-specific interventions (micronutrient supplementation, 
IYCF interventions and the CMAM programme) that evidence has shown are effective and cost-
effective, while also supporting effective government coordination and planning for nutrition. The 
delivery of these interventions through government is expected to build government systems and 
capacity for implementation, and ultimately to institutionalise them within routine health care 
systems. This is expected to raise the political profile of undernutrition in Nigeria and to encourage 
the government to support nutrition programmes. 
Based on the WINNN logical framework, the outputs of the WINNN programme are as follows: 
Output 1: Integration of micronutrient intervention into routine primary health services. This output 
is concerned with the delivery of micronutrient interventions to pregnant women and children under 
five through their integration in routine primary health services.  
Output 2: Delivery of effective IYCF interventions in selected states and LGAs in northern Nigeria. 
This output is concerned with facility and community-based interventions focused on mothers of 
                                               
1 Suggested citation: Vargas, P., Keen, S. (2017), 'Full costing of the WINNN Programme: Operations Research and 
Impact Evaluation’, Oxford Policy Management, Oxford, UK 
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children under two and pregnant women, to improve IYCF practices through exclusive 
breastfeeding (EBF), weaning and complementary feeding.  
Output 3: Delivery of effective treatment for severe acute malnutrition (SAM) through local health 
systems in selected states and LGAs in northern Nigeria. This output is concerned with the 
provision of treatment for SAM via the CMAM programme through integrated primary health 
services. 
Output 4: Strengthening of nutrition coordination and planning mechanisms at national and state 
levels. This output is related to more effective government planning and coordination in nutrition 
and related sectors at the federal and state levels, as well as building government commitment.  
Output 5: The fifth output, ORIE, is a consortium that is independent of the three IPs, managed by 
Oxford Policy Management (OPM). ORIE is responsible for undertaking operations research and 
assessing the impact and effectiveness of the WINNN programme.  
In the interests of simplicity, throughout the report we refer to the first four WINNN outputs as 
micronutrient supplementation (Output 1), IYCF interventions (Output 2), the CMAM programme 
(Output 3) and government coordination and planning (Output 4).  
Costing methodology 
The costing study was designed to respond to the primary aim of assessing the costs of delivering 
the WINNN outputs over the programme duration, from a programme perspective for all four 
outputs and also from a societal perspective for the IYCF interventions and the CMAM programme. 
The methodology was developed in ORIE’s inception phase and informed by a mapping of the 
intervention cost items and a focused literature review. 
The context of the study is five states in northern Nigeria—Jigawa, Katsina, Kebbi, Yobe and 
Zamfara. WINNN supports the delivery of three nutrition-specific interventions—micronutrient 
supplementation, IYCF interventions and the CMAM programme—through the government primary 
healthcare system and Community Volunteers (CVs). In addition, it supports government planning 
and coordination for nutrition. 
The primary objectives of the costing are: 
 to report WINNN programme expenditure overall and analyse this broken down by WINNN 
output, cost category, state and year; and  
 to estimate the cost-efficiency of the IYCF and CMAM interventions, which is the cost per 
beneficiary from a societal perspective defined as: 
 IYCF: This is the cost per woman reached through WINNN-supported the IYCF 
interventions from September 2012 to August 2016 from a societal perspective;2 
 CMAM: This is the cost per child treated at WINNN-supported CMAM facilities (including 
treatment received at the outpatient therapeutic programme (OTP) facilities and at the 
stabilisation care (SC) facilities) from September 2012 to August 2016 from a societal 
perspective. 
                                               
2 Although the IYCF interventions also target husbands and mothers-in-law through counselling and community 
mobilisation, we necessarily use women for the unit cost calculation because the other beneficiaries are not recorded 
consistently in IYCF beneficiary monitoring statistics for all years and states.  
© ORIE  v
  
The time horizon for the costing is most of the programme duration (September 2011 to August 
2016). The sixth and final year of the programme is not included due to the timing of this report. 
There are some important limitations related to the internal and external validity of our data 
sources for the cost estimates. The four main limitations are as follows:  
1. Sampling for the Health Facility Survey (HFS), Patient Registration Card data and 
interviews with the State Nutrition Officers (SNOs) and Local Nutrition Officers (LNOs) is 
not representative over the time period August 2011–September 2016.  
2. Asking people to estimate the time spent on an activity, even if the recall period is short, is 
notoriously difficult. This issue affects our estimates of WINNN programme expenditure 
through the time spent by WINNN personnel and health workers on WINNN activities, as 
well as the CVs and caregiver opportunity costs of their time spent on WINNN activities. It 
also affects the estimates of state/LGA personnel time spent on the CMAM programme and 
the IYCF interventions supervision and monitoring.  
3. There is a key limitation when interpreting the disaggregation by WINNN outputs. The 
apportioning of staff and other common costs to different WINNN outputs was not done in a 
standardised way in the case of UNICEF, due to the change in the agency’s global financial 
system data capturing coding during the course of the project.  
4. WINNN is not the only nutrition programme in Nigeria. Thus, costing findings for 
micronutrient supplementation and government planning and coordination should be 
interpreted as the DFID contribution to these activities. It is for this reason that cost-
efficiency or cost-effectiveness analyses for these outputs would be problematic. 
Key findings  
The costs of WINNN from a programme perspective 
Overall WINNN expenditure for Years 1–5 of the programme (September 2011 to August 
2016) totalled £33.6 ($52.3) million. The CMAM programme constituted the largest share of total 
expenditure (41%), followed by micronutrient supplementation (32%), the IYCF interventions (15%) 
and support to government coordination and planning (12%). 
The absolute expenditure on each intervention has varied across the years due to the 
gradual expansion of the programme, the varying timing of procurement of some medical 
commodities, and different contributions from states and LGAs to WINNN output across the 
years. Over the years, WINNN has spent increasing amounts on the IYCF interventions and 
government coordination and planning. The 47% increase in expenditure on the IYCF interventions 
from Year 4 to Year 5 can be explained by the expansion of the community IYCF (c-IYCF) 
component of the IYCF interventions to additional wards in the beginning of Year 5. Annual spend 
over the years on the CMAM intervention and micronutrient supplementation has varied a bit more. 
Expenditure on the CMAM intervention in Year 3 was the largest, with the roll-out to the remaining 
states taking place that year. However, this decreased in subsequent years as a result of lower 
set-up costs and bulk procurement of ready-to-use therapeutic food (RUTF) in the first three years 
of the programme (inflating costs in those particular years). Expenditure on micronutrient 
supplementation also varied across the years. This could also reflect the gradual expansion of the 
© ORIE  vi
  
programme to all states3, the possibly lumpy procurement of some medical commodities and the 
varying contributions from states and LGAs to this output across years.  
Human resources constituted the largest expenditure category (33% of total expenditure), 
followed by RUTF and F75/F100 (23%), other medical commodities (13%), and expenditure 
on monitoring and evaluation (M&E) (10%). The majority of the human resources category, 
79%, corresponded to expenses on WINNN staff working at the federal, state and local levels, and 
staff shared with other programmes. The remaining 21% corresponded to expenses on non-staff 
items, such as technical assistance or stipends for health workers. RUTF accounted for 99% of the 
therapeutic commodities expenditure for the CMAM programme. Other micronutrient supplements 
included iron folate, deworming, and oral rehydration solution and zinc for routine primary health 
care (PHC) services and MNCHW events and some other costs (less than 1%) on other medicines 
for the treatment received at the CMAM programme, such as antibiotics. M&E expenses included 
venue hire, M&E materials, per diems, travel, and other costs for supervision and programme 
assessments.  
As anticipated, the main cost drivers for each WINNN output resemble the main 
components of that specific intervention. For instance, RUTF provision is the main cost driver 
of the CMAM programme (55%). WINNN expenditure on micronutrient supplementation is driven 
by the cost of medical commodities (42%) delivered through routine primary health services and 
MNCHW events. The IYCF interventions and government coordination and planning are relatively 
more people-intensive than other WINNN outputs, with human resources constituting the largest 
cost category at 52% and 57%, respectively.  
WINNN is not a capital-intensive programme in the standard sense but it has made 
significant investments in strengthening the government capacity to implement nutrition 
interventions. Only 5% of WINNN programme expenditure has been on traditional capital items, 
such as vehicles, medical equipment and other equipment (e.g. computers). Expenditure on 
human resources, however, has constituted 33% of overall expenditure. This represents the cost of 
WINNN staff (and consultants) at the national, state and local levels supporting the delivery of the 
three key comprehensive nutrition-specific interventions through the public health system and the 
effective planning and coordination of nutrition interventions more generally. 
The government and other development partners work in coordination with WINNN on the 
achievement of micronutrient supplementation and government coordination and planning outputs. 
Thus, the WINNN expenditure on those outputs—£10.8 million on micronutrient 
supplementation and £3.9 million on government coordination and planning—represents 
the DFID-funded contribution to those activities in the focal states and nationally.  
The costs of the IYCF interventions  
The average cost per mother reached for the facility IYCF (f-IYCF) component from a health 
services perspective was £10.0 ($15.6). Of this total, 87% (£8.7) was for WINNN higher-level 
programme costs, and the remaining 13% (£1.3) was for health facility-level costs (health worker 
inputs and facility overheads). CV and caregiver costs were not included in the costing of the f-
IYCF component since the extent of CV involvement in delivering facility-based IYCF services 
could not be estimated (thus we assume health workers only provide this service), and caregivers’ 
                                               
3 WINNN rolled out maternal, newborn and child health weeks (MNCHW events) in Zamfara and Jigawa in Year 1, 
followed by Katsina and Yobe in Year 2. In Kebbi, WINNN supported the platform of the Immunisation Plus Days in Year 
2 and Year 3, up until MNCHW events were first implemented in Year 4. 
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costs are expected to be negligible as they incur costs on the f-IYCF component while they attend 
other facility-based services.  
The average cost per mother reached for the c-IYCF component from a societal perspective 
was £12.3 ($19.2). Of this total, 70% (£8.7) was for WINNN higher-level programme costs, 10% 
(£1.2) was for state and LGA costs, and 20% (£2.5) was for CV costs to establish and facilitate 
mothers’ support groups. Again, the costs to mothers were considered negligible as they attend 
group meetings locally and only once per month. The cost per mother from a health services 
perspective is £9.9 ($15.4). This is very similar to the cost of the facility-based service from 
a health services perspective. 
WINNN higher-level programme costs are the main cost driver of the IYCF interventions. 
From a societal perspective, 87% of the cost per mother reached through the f-IYCF component 
and 70% of the cost per mother reached through the c-IYCF component is expenditure by the 
WINNN programme. WINNN expenditure on the IYCF interventions is primarily spent on human 
resources (52%) to support the delivery of the intervention. Other substantial areas of WINNN 
programme costs on the IYCF interventions include expenditure on materials, allowances and 
meeting expenses (33%), such as for mobilisation of CVs, M&E, and training of health workers, 
state and LGA officers. 
WINNN expenditure on the IYCF interventions is large in proportion to the current 
programme expenditure incurred by state and LGA governments. WINNN programme costs 
per mother reached are 3.5 times larger (£8.68) than the total cost currently incurred by the 
government in health worker inputs, facility overheads, and state-/LGA-level supervision and 
planning of activities (£0.81,  £0.49, and £1.19 respectively).  
Heath worker costs are not a large component of the costs of the f-IYCF component. We 
estimate that health worker costs are £0.81 per mother reached, or 8% of the total cost per mother 
reached through f-IYCF component. This is indicative of the IYCF interventions not being very 
demanding on the health system as it is a service that is easily integrated into other PHC services, 
such as antenatal care (ANC), postnatal care (PNC), or MNCHW events, which does not need a 
bespoke day or independent infrastructure. However, even this may be a stretch for the current 
cadre of health workers, with CVs stepping in to assist in the delivery of the f-IYCF component. 
This cost could even be over-estimated since CVs usually step in to delivery of the f-IYCF 
component as well, but we could not cost their involvement as relevant information is not available.  
Health worker costs in the f-IYCF component model, at £0.8 per mother reached, are less 
costly than CVs costs in the c-IYCF component model, at £2.5 per mother reached. Social 
costs per CV hour are much lower than those for health workers4. Thus, the larger costs of CVs 
can be explained by the fact that c-IYCF component is more of a standalone intervention 
compared to f-IYCF component, which is more integrated into existing PHC services, the costs of 
which are not accounted for as part of our modelling. CVs will spend more time organising and 
facilitating IYCF activities in the community, while health workers will only spend a relatively small 
portion of their time delivering counselling sessions at the facility.  
The costs of the CMAM programme 
The overall cost per child treated with the CMAM programme was £74.8 ($116.7) from a 
health services perspective and £83.7 ($130.7) from a societal perspective. This is based on 
                                               
4 We estimate an hourly salary of $1.85 of an average health worker implementing f-IYCF component, versus an hourly 
opportunity cost of $0.38 of a CV. See Section 4.2.1 and Section 4.2.2 for further details on the assumptions in relation to 
health workers and CVs costs, respectively. 
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the assumption that 15% of SAM cases were treated in SC facilities and then referred back to OTP 
facilities, while the remaining 85% of SAM cases were treated only in an OTP facility.5  
The cost per child treated is found to be higher in SC facilities than in the OTP facilities, at 
£86 versus £62, respectively, from a health services perspective, and at £102 versus £69, 
respectively, from a societal perspective. This is not surprising given the more intensive 
treatment received at SC facilities which is needed to cure SAM children with complications. Both 
levels of care also have very different human resource structures, with SC facilities usually 
operating seven days a week, with relatively more qualified staff, given the level of care required, 
which has implications in terms of costs.  
The main cost drivers of the CMAM programme are RUTF and WINNN higher-level 
programme costs. Our estimates show that they constitute 34% (£28.8) and 33% (£27.2), 
respectively, of the overall cost of the CMAM programme per child treated. In the case of the OTP 
component of the CMAM programme, RUTF and WINNN higher-level programme also constitute 
the largest elements (42% or £28.6 and 35% or £23.7, respectively) of the costs per child of the 
treatment received at the OTP facility. For the cost per child of treatment received at SC facilities, 
the figure is quite different, given that the level of care provided is more intense in terms of human 
resources and infrastructure. In this case, the costs incurred by the government in health worker 
inputs and facility overheads constitute the largest elements, at 56% (£56.9) of the costs per child 
of the treatment received at the SC facility, followed by WINNN higher-level programme costs, at 
23% (£23.7).  
The CMAM programme is not very capital intensive. Our estimates show that 2.6% (£2.2) of 
the overall cost per child treated relates to capital expenditure. However, further investments in 
health facility and supply chain infrastructure would need to be considered more holistically for 
future implementation and sustainability, as evidenced by the current limitations of some facilities 
lacking enough supplies to provide the full set of CMAM services (ORIE Health Facility Survey-final 
report, 2016).  
Introducing the societal costs of CVs and caregivers increases the cost burden of CMAM 
care per child treated, and not by a negligible amount. CVs incur costs per child treated in 
terms of their time and expenses of £1.90, and caregivers £4.73 at an OTP facility and £15.58 at a 
SC facility (£7.1 on average for the CMAM programme overall). These costs combined constitute 
11% (£9.0) of the overall cost of the CMAM programme per child treated from a societal 
perspective. These may be smaller relative to other costs from an overall perspective, but they 
represent a large burden for the CVs and caregivers themselves, and thus a scale-up model 
should evaluate whether some compensation should be offered.  
Discussion 
An investment of £33.6 ($52.3) million over five years in five states in northern Nigeria 
represents a significant contribution to funding three nutrition-specific interventions in those 
states, and moreover in more generally supporting effective government planning and coordination 
for nutrition. However, this level of investment still represents a financial gap when compared to the 
National Strategic Plan of Action for Nutrition (NSPAN) (2014–2019) or, more ambitiously, the 
Scaling Up Nutrition full coverage targets.67 
                                               
5 The assumption is based on evidence from fhi360, 2012.  
6 Federal Republic of Nigeria (2014) National Strategic Plan of Action for Nutrition.  
7 World Bank (2014) Costed Plan for Scaling Up Nutrition: Nigeria. 
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WINNN is a people-intensive programme, with 33% of overall WINNN expenditure being on 
human resources. Also, WINNN higher-level programme costs constitute a significant 
component of the cost per beneficiary of both the IYCF and CMAM interventions, even 
though WINNN has a delivery model which is integrated into existing health systems. 
Although the purpose of this report is not to suggest the cost model for the government taking over 
these interventions, these findings do raise questions as to how government would take over the 
WINNN programme costs. Some of these costs will likely be initial investment, complementary to 
the government expenditure, or just reduced, given the less expensive salary structure of 
government human resources.  
The RUTF cost estimate of £29 ($45) per child treated is not surprising given it is a high cost 
input with a price that is set in the international marketplace, and given that UNICEF is 
playing a significant role in its procurement, both for Nigeria and internationally. There are 
no real economies of scale for this cost item, other than perhaps slight improvements in purchasing 
power for a larger order or in transportation costs. However, future reductions in the unit price of 
RUTF are expected to be crucial to determine sustainability for scaling up and the possibility of the 
government taking over this cost.  
The IYCF interventions come at a much lower cost per beneficiary than the CMAM 
programme. We estimate a cost per child treated through the CMAM programme of £84 ($131) 
from a societal perspective and a cost per mother reached through the f-IYCF component of £10 
($16), and through the c-IYCF component of £12 ($19). This is to be expected, as curative services 
like the CMAM programme are usually more costly than preventative services such as the IYCF 
interventions.  
There is a lack of existing estimates in the global literature, and in particular for Nigeria, of 
the cost per mother reached by other IYCF interventions similar to the IYCF component of 
the WINNN programme, making comparisons difficult. NSPAN (2014–2019) uses a cost for 
community nutrition programmes for behaviour change communication of $5 per child. The source 
of this estimate is not clear, but it appears to be based on a study in 1999 related to a community 
nutrition programme in Asia (Mason et al., 1999). There are many methodological differences in 
the approach used in Mason et al. (1999), compared to ours. One of the most important is that our 
cost estimate of the IYCF interventions is per mother reached, not per child. A conservative 
assumption of two children under two years of age per mother reached would give an estimate of 
$10 per mother reached, which is not too different from our estimates.  
Our estimate of the cost of the CMAM programme per child is broadly similar to another 
recent societal estimate from northern Nigeria, and to other estimates of cost per child in 
similar contexts and settings. Variations in programme costs arise from different costing 
perspective used (health service vs. societal), assumptions regarding the coverage and 
scale of the programme, and the human resource model of service delivery. Frankel, S., 
Roland, M. and M. Makinen (2015) estimated a similar overall societal cost per child treated of 
$123 in the CMAM programme supported by UNICEF with Children’s Investment Fund Foundation 
(CIFF) funding. Bachmann (2009), which is the study used in the DFID Business Case (2011), 
estimates an overall cost per child cured of $203 in Zambia from a health services perspective. 
The five-year (2014–2019) strategic plan for nutrition in Nigeria, NSPAN, estimates a much lower 
cost per child, at $80. The lower cost might be explained by the different methodology used,8 which 
                                               
8 NSPAN 2014–2019 costing employed the ‘program experience’ methodology. This approach generates unit cost data 
that capture all aspects of service delivery, such as costs of commodities, transportation and storage, personnel, training, 
supervision, monitoring and evaluation, relevant overheads, wastage etc., for each intervention from actual programmes 
that are in operation in Nigeria, and considers the context in which they are delivered. Whenever possible, the unit costs 
of the nutrition-specific interventions in NSPAN were estimated using programmatic data that were provided by local IPs, 
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might not accurately reflect actual programmatic experience under WINNN, exclusion of societal 
costs, and different coverage estimates. Interestingly, although there are differences in 
methodologies, the comparison with the cost estimates of other CMAM programmes also 
shows that RUTF and higher-level programme costs remain the largest shares of the overall 
cost, regardless of settings and delivery models.  
 
  
                                               
the Federal Ministry of Health, and state governments, based on programme experience. In cases where the intervention 
was not yet being implemented or local data were not available, global unit cost estimates from the World Bank were 
used (NSPAN, 2014). 
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1 Introduction 
This report presents the findings of the ORIE economic evaluation on the costs of the WINNN 
programme. 
1.1 The WINNN programme 
The WINNN programme is an ambitious £52 million, six-year DFID-funded programme (2011–
2017) to improve maternal, newborn and child nutrition in five states in northern Nigeria: Jigawa, 
Katsina, Kebbi, Yobe and Zamfara. WINNN is implemented by three partners: SCI, ACF, and 
UNICEF.  
WINNN is designed to deliver three nutrition-specific interventions (micronutrient supplementation, 
IYCF interventions and the CMAM programme) that evidence has shown are effective and cost-
effective, while also supporting effective government coordination and planning for nutrition. The 
delivery of these interventions through government is expected to build government systems and 
capacity for implementation, and ultimately to institutionalise them within routine health care 
systems. This is expected to raise the political profile of undernutrition in Nigeria and to encourage 
government to support nutrition programmes. 
Based on the WINNN logical framework, the outputs of the WINNN programme are as follows: 
Output 1: Integration of micronutrient intervention into routine primary health services. This output 
is concerned with the delivery of micronutrient interventions to pregnant women and children under 
five and their integration in routine primary health services.  
Output 2: Delivery of effective IYCF interventions in selected states and LGAs in northern Nigeria. 
This output is concerned with facility and community-based interventions focused on mothers of 
children under two years of age and pregnant women, to improve IYCF practices through EBF, 
weaning and complementary feeding.  
Output 3: Delivery of effective treatment for SAM through local health systems in selected states 
and LGAs in northern Nigeria. This output is concerned with the provision of treatment for SAM via 
the CMAM programme through integrated primary health services. 
Output 4: Strengthening of nutrition coordination and planning mechanisms at national and state 
levels. This output is related to more effective government planning and coordination in nutrition 
and related sectors at the federal and state levels, as well as building government commitment.  
Output 5: The fifth output, ORIE, is a consortium that is independent of the three IPs, managed by 
OPM. ORIE is responsible for undertaking operations research and assessing the impact and 
effectiveness of the WINNN programme.  
In the interests of simplicity, throughout the report we refer to the first four WINNN outputs as 
micronutrient supplementation (Output 1), IYCF interventions (Output 2), the CMAM programme 
(Output 3) and government coordination and planning (Output 4). More detail on each of them is 
presented in Section 3.2 to help put the programme costing results in context.  
The ORIE project consists of the following five workstreams: 
1. operations research; 
2. impact evaluation; 
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3. economic evaluation; 
4. evidence dissemination and uptake; and  
5. supporting national researchers in nutrition. 
This report is a deliverable of the third workstream—the economic evaluation. 
Additionally, note that the IYCF interventions consist of two component parts: one at the facility 
level- the f-IYCF component and one at the community level-the c-IYCF component. Similarly, the 
CMAM programme also consists of two component parts: the treatment received at OTP facilities 
and treatment received at SC facilities. Throughout this report, the narrative refers to both the 
interventions as a whole or to its component parts as appropriate. 
1.2 Aims of the ORIE economic evaluation 
The overall aim of the ORIE economic evaluation is to assess the costs and cost-effectiveness of 
the WINNN programme. This report covers the assessment of the costs of the WINNN 
programme. The CEA has been delivered as a separate report. In addition, although not the 
primary objective of the ORIE Economic Evaluation, a VfM analysis of the WINNN programme will 
also be presented as a separate brief.  
The aim of the work is to assess the costs of delivering the WINNN outputs over the programme 
duration (2011–2017). The WINNN outputs can be divided into two categories: interventions that 
are focused at the level of the LGA —Outputs 2 and 3— and interventions that are focused at the 
level of the state and federal governments—Outputs 1 and 4. The level at which the intervention is 
focused determines the scope of the costing. 
All outputs are costed from a programme perspective (Section 3), which considers the expenditure 
of the WINNN programme. The IYCF interventions (Output 2) and the CMAM programme (Output 
3) are additionally costed from a societal perspective (Section 4 and Section 5, respectively). In 
addition to the expenditure of the WINNN programme, a societal perspective includes costs 
incurred by health service providers in providing the intervention and costs incurred by health 
service users.  
A societal perspective was adopted for the IYCF interventions and the CMAM programme in order 
to determine more fully who incurs the costs of these interventions and also to allow for the cost-
effectiveness analyses of these interventions from a societal perspective. There are, of course, 
societal costs to the other two WINNN outputs (micronutrient supplementation and government 
coordination and planning) but these interventions, focused as they are at the state and federal 
levels, involve many other partners, beyond the government and WINNN, in their delivery, from 
which expenditure data would have been very difficult to obtain. Also, it was agreed that a costing 
of these two outputs beyond the programme perspective would be outside the scope of the ORIE 
economic evaluation.  
The costing is retrospective and is primarily for accountability purposes, though the costing may 
also support the design of future nutrition interventions in Nigeria and elsewhere. The costing of 
the IYCF interventions and the CMAM programme will also be used to assess their cost-
effectiveness.  
© ORIE  3 
1.3 Departures from the inception report  
The inception report, which was produced at the beginning of this evaluation, in consultation with 
various stakeholders, constitutes the key document of reference for this analysis (see Annex A for 
excerpts of Volume I and Volume II of the inception report which relate to the economic 
evaluation). The inception report was written following consultations with DFID, academics, and 
Nigerian counterparts to ensure that the goals of this evaluation reflect the interests of different 
stakeholders.  
There has not been any major departure from the original inception plan. As stated in the inception 
report (Annex A), the costing study aims to estimate (i) direct provider-related costs associated 
with WINNN Outputs 1 (micronutrient supplementation) and 4 (government coordination and 
planning), and (ii) direct and indirect costs and outcomes associated with the implementation of 
WINNN-supported CMAM and IYCF interventions, which this report has done. As explained in 
Section 2.2 and Section 2.3, this report assesses the cost of all outputs from a programme 
perspective, i.e., considering the expenditure of the direct provider, which is the WINNN 
programme. For Outputs 2 (IYCF interventions) and 3 (the CMAM programme), this report 
estimates cost-efficiency indicators from a societal perspective, which considers direct and indirect 
costs. 
The full economic evaluation also aims to evaluate the cost-effectiveness of the CMAM and IYCF 
interventions compared to routine care. This study has been delivered as a separate report. In 
addition, although not the primary objective of the ORIE economic evaluation, a VfM analysis of the 
WINNN programme will also be presented as a separate brief.  
The inception report also outlined the possibility of undertaking full costing studies for WINNN 
Outputs 1 and 4. However, this was not implemented in the end due to limitations in assessing 
WINNN’s contribution to those interventions using a quantitative approach. This is because these 
interventions are delivered state-wide and nationally (there is no WINNN LGA focus, as there is for 
the IYCF and CMAM interventions) and involve many other IPs and donors, from which 
expenditure data would have been very difficult to obtain. Thus, it was agreed that this would be 
outside the scope of the ORIE economic evaluation.  
Finally, this costing analysis has some limitations in terms of the disaggregation of our costing 
estimates. Even though we collected the WINNN expenditure disaggregated by many cost 
categories, we were not able to disaggregate this further by fixed or variable costs – as envisaged 
in the inception report. This was due to lack of availability of programme information at this level of 
disaggregation.  
1.4 Intended audience for this report 
The first audience for this full WINNN costing report is DFID. The report provides DFID with an 
independent assessment of the costs of delivering the WINNN outputs over the programme 
duration. This responds primarily to accountability requirements. However, it should be noted that 
this is not an auditing exercise: we rely on data from the programme that we have not inspected 
from an accounting perspective. In regard to learning, the costing may also support the design of 
future DFID nutrition programmes in Nigeria and elsewhere. 
The second audience for this full WINNN costing report is WINNN. The report provides WINNN 
with an independent analysis of its expenditure over the programme duration, as well as an 
analysis of the costs incurred by those key players involved in delivering the IYCF interventions 
and the CMAM programme—namely the programme itself, the government and CVs—and 
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households, in accessing these interventions. The latter should be useful in understanding the full, 
current costs, as well as potential future costs, of delivering IYCF and CMAM interventions in 
northern Nigeria. 
The third audience is the Nigerian government. This includes key stakeholders at federal, state 
and LGA levels—especially officers responsible for planning nutrition interventions. The fourth 
audience of the report are civil society stakeholders, including the research and professional 
community in Nigeria working in nutrition or nutrition-sensitive areas in northern Nigeria.  
1.5 Organisation of the report 
The report is structured as follows: 
Section 2 describes the costing methodology, focusing on the main elements. Further detail on the 
data and assumptions used in the costing are available in the report’s Annex C and Annex D. 
Section 3 reports on WINNN expenditure for all four outputs (micronutrient supplementation, IYCF 
interventions, CMAM programme, and government coordination and planning) over most of the 
programme duration (September 2011 to August 2016). The sixth and final year of the programme 
is not included due to the timing of this report. The section first reports on overall programme 
expenditure over Years 1–5, and then breaks this total down by WINNN output, and then further by 
different cost categories, states and years. The analysis aims to understand the cost drivers of the 
programme.  
Section 4presents our findings on the costs of the IYCF interventions from a societal perspective. 
It first gives some background on the design and context of the IYCF interventions. It then gives 
our estimates of the cost per mother reached of the various IYCF cost centres, before bringing 
them together to provide an overall cost per mother reached estimate. Finally, it discusses how our 
results compare to IYCF cost estimates from other IYCF programmes. 
Section 5 presents our findings on the costs of the CMAM programme from a societal perspective. 
It first gives some background on the design and context of the CMAM intervention. It then gives 
our estimates of the cost per child treated of the various cost at the centres where the CMAM 
programme is being operated, before bringing them together to provide an overall cost per child 
treated estimate. Finally, it discusses how our results compare to cost estimates from other CMAM 
programmes.  
Section 6 concludes. 
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2 Costing methodology 
This section describes the costing methodology. Our methodology is comprehensive and relies on 
best practice costing principles applied to the study’s aims and context. It goes beyond many 
costing studies by bringing a society perspective to the costing of the IYCF interventions and the 
CMAM programme. Nonetheless, as with all studies, it does have limitations, which are highlighted 
here and further discussed in light of the findings in the discussion in each result section. We focus 
on the main elements here. Further detail on the data and assumptions used in the costing is 
available in the report’s annexes. 
2.1 Study design and context 
The costing study was designed to respond to the primary aim of assessing the costs of delivering 
the WINNN outputs over the programme duration, from a programme perspective for all four 
outputs and also from a societal perspective for the IYCF interventions and the CMAM programme. 
The methodology was developed in ORIE’s inception phase and informed by a mapping of the 
intervention cost items and a focused literature review. 
 We mapped the intervention cost items and contributing stakeholders, using programme 
documentation and discussions with WINNN. This mapping formed the framework for the study 
in terms of how data were collected, analysed and presented. Further detail is available in 
Annex B (for the costing of all WINNN outputs from a programme perspective), Annex C (for 
the costing of the IYCF interventions from a societal perspective) and Annex D (for the costing 
of the CMAM programme from a societal perspective). 
 We identified published economic evaluations of IYCF interventions and CMAM programmes 
through a focused literature search to inform the methods and data sources for the current 
study. We primarily searched for studies published in peer-reviewed academic journals but also 
reviewed relevant ‘grey’ (non-peer-reviewed) literature from Nigeria. Annex A presents 
summary findings from this focused literature review. 
The context of the study is five states in northern Nigeria—Jigawa, Katsina, Kebbi, Yobe and 
Zamfara. WINNN supports the delivery of three nutrition-specific interventions—micronutrient 
supplementation, the IYCF interventions and the CMAM programme—through the government 
PHC system. In addition, it supports government coordination and planning for nutrition. This 
means, for example, that the programme design is for government health workers to directly 
deliver the interventions, with WINNN providing training to state and LGA officials for them in turn 
to provide step-down training to health workers. The programme also relies on CVs to help deliver 
the interventions. These individuals are provided with training, non-financial incentives (e.g. a 
hijab) and stipends to cover travel costs to meetings. They are not remunerated for their time or 
other work-related expenses. 
The context for the WINNN programme has changed over its duration. Extensive further detail is 
available in the ORIE qualitative impact evaluation reports (2017, 2015), which focus on the 
evolving governance context for nutrition and WINNN’s contribution to this federally and through its 
focal states. In summary, there have been both changes that have been influenced by the 
programme and those influenced by external shocks—including the security situation in the five 
northern Nigerian states (particularly Yobe), a presidential election resulting in a transfer of power, 
and a drop in the price of oil, which has negatively affected the country’s economic situation. 
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2.2 Objective 
The primary objectives of the costing are: 
 to report WINNN programme expenditure overall and analyse this broken down by WINNN 
output, cost category, state and year; and 
 to estimate the cost-efficiency of the IYCF and CMAM interventions, which is the cost per 
beneficiary from a societal perspective defined as: 
 IYCF: This is the cost per woman reached through the WINNN-supported IYCF 
interventions from September 2012 to August 2016 from a societal perspective;9 
 CMAM: This is the cost per child treated by the WINNN-supported CMAM programme, 
including OTP and SC components, from September 2012 to August 2016 from a societal 
perspective. 
Assessing the VfM of the WINNN programme and its component interventions is not a primary 
objective of the ORIE economic evaluation. However, the full economic evaluation approach (e.g. a 
CEA) is one standard and popular approach for assessing VfM, particularly in health.10 Using the 
‘3E’ VfM framework, as commonly applied by DFID to assess the VfM of its aid programmes, a 
CEA helps answer the overall VfM question of whether the best possible outcome was obtained 
with a given budget. Figure 1 illustrates this VfM framework, using the CMAM programme as an 
example. 
Figure 1:  VfM for the WINNN programme 
 
Source: Authors 
As also illustrated in Figure 1, the cost per beneficiary indicators are cost-efficiency ones that do 
not necessarily indicate the cost-effectiveness of the interventions. A cost-efficiency indicator tells 
you how much it costs to deliver a unit of output (e.g. treatment received at a CMAM facility for a 
child), it does not tell you what outcome was achieved through this. The forthcoming ORIE CEA 
report will evaluate the impact of the WINNN-supported IYCF and CMAM interventions on both 
costs and outcomes. This type of analysis allows decision-makers to compare interventions in 
                                               
9 Although the IYCF interventions also target husbands and mothers-in-law through counselling and community 
mobilisation, we necessarily use women for the unit cost calculation because the other beneficiaries are not recorded 
consistently in IYCF beneficiary monitoring statistics for all years and states.  
10 OPM (2014) ‘Consultancy for literature review for measuring value for money in health’.  
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terms of their VfM so as to achieve maximum health gains for the population within limited 
resources. Therefore the costing and cost-efficiency analysis in this report provides only a partial 
story of the VfM of the programme at this stage, but this will be complemented with the findings in 
the CEA report (Cost-effectiveness of the WINNN programme, 2017).  
In addition, a more overarching analysis of VfM for the WINNN programme (including all its 
outputs), which also takes into consideration measures of equity, will be presented as a separate 
brief. The inclusion of distributive fairness as another dimension of VfM that ties the ‘3Es’ 
(Economy, Efficiency, and Effectiveness) together is particularly important, as acknowledged by 
DFID (2011): it indicates that VfM of development aid depends not just on cost-efficient delivery 
and cost-effective outcomes, but on delivering improvements in equity as efficiently and cost-
effectively as possible.  
Finally, this report has limited evidence on the domains of economy and efficiency—for example, 
we do not include an analysis to assess whether inputs were of appropriate quality and bought at 
the right price, or a disaggregation of our costing estimates into fixed and variable costs or planned 
and actual expenditure. This is mainly due to availability of programme information at those levels 
of disaggregation, but also because it is outside the scope of this report.  
2.3 The main elements of the costing methodology  
We provide only a short overview of the main elements of the costing methodology here. Further 
detail on the data and assumptions used in the costing is available in the report Annex C and 
Annex D. 
2.3.1 Perspective 
The perspective that is adopted in an economic evaluation is important as regards determining 
who incurs the costs. Two commonly used perspectives in economic evaluations are the health 
services perspective and the societal perspective. The former perspective evaluates the costs 
incurred by health service providers in providing the intervention. The latter perspective also 
includes costs incurred by health service users (i.e. patients and carers) and other members of the 
society who may be directly or indirectly affected by the intervention (or no intervention). 
Figure 2 illustrates these perspectives in the context of the WINNN programme. Health services, 
including micronutrient supplementation, the IYCF interventions and the CMAM programme, are 
provided by state and LGA governments, with support from WINNN. WINNN is the only partner 
supporting the government to provide the IYCF interventions and the CMAM programme in its focal 
LGAs, although other partners support these interventions in other areas of the WINNN states. 
Micronutrient supplementation, which is primarily delivered through routine PHC services at health 
facilities and consolidated by biannual events called MNCHWs is a state-wide intervention that 
involves other partners. The societal perspective is inclusive of these health services providers, but 
also considers health service users, such as CVs, who help deliver the WINNN interventions, and 
households, who access the interventions. A third, narrower perspective, considers the 
expenditure of the WINNN programme.  
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Figure 2:  Perspectives in economic evaluation 
 
Source: Authors 
In the case of developing countries, the perspective adopted in an economic evaluation can be 
crucial. This is because the costs (direct and indirect) incurred by patients and their family 
members can be significant compared to the costs incurred by the health care system.  
We first assess the costs of delivering all WINNN outputs from a programme perspective (Section 
3). We then cost the IYCF interventions and the CMAM programme from a societal perspective 
(Section 4 and Section 5), which allows us to present these results from both a health services 
perspective and societal perspective, keeping in mind that the health services is a subset of the 
societal perspective. Previously published studies of the costs and cost-effectiveness of CMAM 
programmes have used both a health services perspective (e.g. Wilford et al., 2011; Bachmann, 
2009) and a societal perspective (e.g. Ashworth and Khanum, 1997). Our focused literature review 
found very few published studies of IYCF interventions’ costs and cost-effectiveness: the two 
identified studies on promotion of EBF used a health services perspective.  
There are of course wider health service provider and user costs for the other WINNN outputs 
(micronutrient supplementation and government coordination and planning) but it was agreed that 
this was outside the scope of the ORIE economic evaluation. This is because these interventions 
are delivered state-wide and nationally (there is no WINNN LGA focus, as there is for the IYCF 
interventions and the CMAM programme) and involve many other partners, from which expenditure 
data would have been very difficult to obtain.  
2.3.2 Time horizon 
The time horizon for the costing is most of the programme duration (September 2011 to August 
2016). The sixth and final year of the programme is not included due to the timing of this report. 
2.3.3 Unit of analysis 
The WINNN programme expenditure analysis disaggregates data by WINNN output, state, year 
and cost category. The costing of the IYCF interventions and the CMAM programme from a 
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societal perspective constructs indicators at the beneficiary level—i.e. woman reached through 
WINNN-supported IYCF interventions and child treated through WINNN-supported CMAM 
facilities.  
2.3.4 Combination of bottom-up and top-down 
A top-down approach is based on a simple calculation: total expenditure for a given output is 
divided by total units of output (e.g. patients treated). A bottom-up approach identifies all of the 
resources that are used to provide an output and assigns a value to each of those resources. 
These values are summed and linked to a unit of output to derive a total unit cost. 
The WINNN programme expenditure analysis takes a top-down approach. The costing of the IYCF 
interventions and the CMAM programme uses a mix of bottom-up and top-down approaches to 
estimate unit costs. That is, for each cost item it uses the better approach given the availability and 
quality of the data. Our combined approach allows us to make the most of the available data. 
2.3.5 Currency  
The data used in the costing analysis come from various primary and secondary sources with 
different currencies and years. Thus, we convert every cost at every year to United States dollars 
(USD/$) using International Monetary Fund exchange rates for conversion, before bringing all 
costs together in a single calculation. Costs calculations are done in USD given that this is the best 
practice in the international literature of costing and CEA.  
However, final calculations in this report have been converted to GBP/£ using an exchange rate 
USD/GBP of 1.56 (average USD/GBP exchange rate for the period between Year 1 to Year 5 – 
September 2011 to August 201611) to facilitate reporting using DFID’s official currency. In the main 
calculations we still present both GBP and USD figures, in order to facilitate comparison with cost-
efficiency measures from other studies, which are usually presented in USD. 
2.4 Measurement of cost items 
2.4.1 Data sources and collection 
A number of data sources were used in the costing, as follows: 
WINNN expenditure data: Every year WINNN partners submitted their annual programme 
expenditure data to ORIE according to a pre-agreed expenditure tracing template, with data 
disaggregated as much as possible by cost category12, WINNN output and state (see Figure 15 in 
Annex B). Any shared personnel or overhead costs that were not pre-allocated to WINNN outputs 
were allocated by ORIE using an activity-based apportioning methodology. This is a standard 
costing approach for allocating shared costs across outputs. Activity-based costing uses the 
distribution of staff time inputs (in this report we use the time distribution of WINNN staff across 
WINNN outputs, as reported by IPs) as a basis for apportioning staff wage expenditures or other 
non-staff shared costs. Thus, this approach is based on the assumption that staff time usage 
                                               
11 Average of representative rates for the period September 2011 to August 2016 from International Monetary Fund.  
12 The expenditure template for WINNN partners included the following categories: staff personnel; non-staff personnel; 
medical commodities (excluding RUTF and therapeutic foods); RUTF and therapeutic foods; operations and 
maintenance; training (including capacity development); M&E (including supervision and assessments); goods and 
services for CVs and support groups; other goods and services (including programme management meetings and 
stakeholder sensitisation); and capital expenditure, such as vehicles, medical and other equipment.  
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provides a close reflection of how those shared costs inputs are effectively allocated to different 
outputs. Further detail on this approach is available in Annex B.1.  
Health Facility Survey: In August 2015, ORIE conducted a Health Facility Survey (HFS) to collect 
primary data to feed into the work of two of ORIE’s workstreams: the economic evaluation and the 
impact evaluation. For the economic evaluation, the purpose of the HFS was to collect data on 
time use in relation to the CMAM programme for health workers, CVs and caregivers of SAM 
patients. The HFS was representative of WINNN facilities in WINNN LGAs in Jigawa, Katsina, 
Kebbi and Zamfara, at a sample of 24 OTP facilities selected by stratified random sampling (which 
represented 37% of all WINNN-supported OTP facilities in those four states) and 12 SC facilities 
(which is all SC facilities given the small number of SC facilities in which WINNN operates). Data 
collection involved observation of the facilities and the conducting of questionnaires with staff 
members, CVs, and caregivers of patients receiving services at the facilities.  
Patient Registration Cards: As part of the HFS data collection, ORIE also collected a sample of 
CMAM Patient Registration Cards. The purpose of this data collection was to collect data on the 
resource use at the patient level of RUTF, F75/F100 and other routine medicines for the CMAM 
programme. Patient Registration Cards with start dates of June 2014 and May 2015 were collected 
from OTP and SC facilities. At OTP facilities, eight cards (two per quarter) were randomly selected 
for each OTP exit category: recovered, died, defaulted, not recovered and transferred to a SC 
facility. At SC facilities, the same procedure was used for each SC exit category: recovered, died, 
defaulted, and not recovered. The number of cards was chosen to be a representative sample of 
patient cards during June 2014 and May 2015. Results were weighted using the distribution of 
children in each exit category over the data collection period for each LGA, reported in the WINNN 
service data. This was done to avoid bias in our estimates coming from the selection of a fixed 
number of cards per exit category. 
Higher-level data collection. In February 2016, ORIE conducted interviews with SNOs, LNOs 
and WINNN Local Technical Assistants (LTAs) in Jigawa, Katsina, Kebbi and Zamfara. One LGA 
was chosen per state. These interviews aimed to collect information on the state/LGA contribution 
to CMAM and IYCF activities (in terms of time and economic resources) regarding supervision, 
training and monitoring, and information about the programme. Health workers’ salary scales were 
also collected at the state level, which we use to calculate the value of their time spent on CMAM 
and IYCF activities. Information was collected for the three months preceding the interviews: 
November 2015 to January 2016.  
2.4.2 Data analysis 
Analysis of the HFS, Patient Registration Card and endline survey was conducted first in Stata. 
Indicators were then imported into the Excel-based costing models for the comprehensive analysis. 
2.5 Limitations 
There are some important limitations related to the internal and external validity of our data 
sources for the cost estimates. The four main limitations are as follows:  
1. Sampling for the HFS, Patient Registration Card data and interviews with the SNOs and 
LNOs is not representative over the time period August 2011–September 2016. For 
example, this means that the quantity of RUTF administered per child treated is from a 
sample of children treated by the programme in Year 4. In the absence of alternative data 
sources, these estimates are extrapolated from this time period to the programme duration. 
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Moreover, the context in which the interventions are being implemented changed 
throughout the programme duration. This is documented much more fully through the ORIE 
qualitative impact evaluation reports, but key points to note here include the following: 
- the governance context has influenced variations across programme areas in key 
government inputs to the implementation of the WINNN interventions (for example, the 
provision of routine medicines); 
- these have been changes to which WINNN has contributed through its remit to support 
effective government planning and coordination for nutrition (e.g. the establishment of 
CMAM activities monthly meetings at LGA and state levels). This has altered the level 
and mix of inputs of various stakeholders, most notably WINNN and the government, 
over time; and; 
- these have also been external shocks to the system, including the political transition 
following the election of a new president in March 2015, the adverse national economic 
situation following the drop in the oil price and the adverse security situation in northern 
Nigeria. These also altered the level and mix of inputs: for example, the government did 
not pay health workers’ salaries for much of 2015, in all of the WINNN states except for 
Jigawa. 
2. Asking people to estimate the time spent on an activity, even if the recall period is short, is 
notoriously difficult. This issue affects our estimates of WINNN programme expenditure 
through the time spent by WINNN personnel and health workers on WINNN activities, as 
well as the CVs and caregiver opportunity costs of their time spent on WINNN activities. It 
also affects the estimates of state/LGA personnel time on CMAM- and IYCF-related 
supervision and monitoring.  
3. There is a key limitation with regard to interpreting the disaggregation by WINNN outputs. 
The apportioning of staff and other common costs to different WINNN outputs was not done 
in a standardised way in the case of UNICEF, due to the change in the agency’s global 
financial system data capturing coding in the course of the project. In Year 1 a survey was 
undertaken to assess the staff time allocation to WINNN outputs. In Year 6 UNICEF 
estimated the time allocation to WINNN outputs of their current staff by states. These 
shares were applied to Years 2 to 5, assuming that it was a good reflection of the staff time 
distribution over the programme years.  
4. WINNN is not the only nutrition programme in Nigeria. Other donor-funded programmes, 
some also implemented by the WINNN partners, also contribute to the progress on the 
WINNN programme outputs. For example, government planning and coordination activities 
are increasingly being harmonised across partners and donors. This means it is quite hard 
to segregate those costs that are attributable to WINNN alone. Thus, costing findings for 
micronutrient supplementation and government planning and coordination should be 
interpreted as the DFID contribution to these activities. It is for this reason that cost-
efficiency or cost-effectiveness analyses for these outputs would be problematic. 
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3 The costs of WINNN from a programme perspective 
This section reports on WINNN expenditure over most of the programme duration (September 
2011 to August 2016). The sixth and final year of the programme is not included due to the timing 
of this report. The section first reports on overall programme expenditure over Years 1–5, and then 
breaks this total down by WINNN output, cost categories, years and states. The analysis aims to 
understand the cost drivers of the programme.  
3.1 Overall programme costs 
Overall WINNN expenditure for Years 1–5 of the programme (September 2011 to August 2016) 
totalled £33.6 million. Of this, £13.9 million (41%) was spent on the CMAM programme, £10.8 
million (32%) on micronutrient supplementation, £5.0 million (15%) on the IYCF interventions and 
£3.9 million (12%) on government coordination and planning. This is shown in Figure 3. 
Figure 3:  Total programme expenditure by WINNN output, 2011/12 to 2015/16 
 
3.2 WINNN costs by cost categories 
Table 1 further breaks down total programme expenditure by WINNN output by different cost 
categories. We discuss the cost categories overall first and then the expenditure by each WINNN 
output in turn. 
CMAM
41.4%
IYCF
15.0%
Micronutrient 
supplementation
32.0%
Government 
coordination
and planning
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Y1 - Y5:
£33.6 million ($52.3 million)
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Table 1:  Programme expenditure by cost category and WINNN output, 2011/12 to 2015/16 
Cost category 
WINNN output 
 
Total 
 
 
 
Output 1: Micronutrient 
supplementation 
 
Output 2:  
IYCF 
 
Output 3:  
CMAM 
 
Output 4: Government 
coordination and 
planning 
GBP % GBP % GBP % GBP % GBP % 
Capital expenditure 467,189 4% 409,050 8% 507,093 4% 292,212 7% 1,675,544 5% 
Equipment 467,189 4% 409,050 8% 507,093 4% 292,212 7% 1,675,544 5% 
Recurrent expenditure 10,304,008 96% 4,628,925 92% 13,409,669 96% 3,624,420 93% 31,967,021 95% 
RUTF and F75/F100 0 0% 0 0% 7,656,228 55% 0 0% 7,656,228 23% 
Other medical commodities 4,486,353 42% 0 0% 26,073 0% 0 0% 4,512,427 13% 
Human resources 2,774,481 26% 2,607,708 52% 3,445,533 25% 2,239,176 57% 11,066,899 33% 
Operations and maintenance 340,449 3% 383,737 8% 394,907 3% 377,031 10% 1,496,125 4% 
Training expenses 368,820 3% 426,783 8% 423,909 3% 107,196 3% 1,326,709 4% 
M&E expenses 1,770,754 16% 345,069 7% 705,433 5% 438,999 11% 3,260,255 10% 
Goods and services 563,150 5% 865,627 17% 757,584 5% 462,017 12% 2,648,378 8% 
Total 10,771,197 100% 5,037,975 100% 13,916,761 100% 3,916,631 100% 33,642,564 100% 
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3.2.1 WINNN overall 
Out of a total expenditure of £33.6 million, recurrent expenditures constituted approximately £32.0 
million, or 95%. Capital costs accounted for 5% of the total expenditure, including costs of vehicles, 
medical equipment (such as anthropometric scales), and other equipment (such as computers, 
phones, furniture, and generators). In this analysis, we have annualised all capital expenditures 
across years in order to spread the value of lumpy expenditure in initial years across the useful life 
period for the equipment13.  
Among recurrent items, human resources constituted the largest expenditure category, at £11.1 
million, or 33% of total expenditure. The majority of this category (79%) corresponded to expenses 
on WINNN staff working at the federal, state and local levels, and staff shared with other 
programmes (accounting only for the salary attributed to their time spent on WINNN). The 
remaining 21% corresponded to expenses on non-staff items, such as technical assistance or 
stipends for health workers (excluding per diems for training or M&E activities). 
RUTF and F75/F100 constituted the next largest cost category overall, at £7.7 million, or 23% of 
total expenditure. Medical commodities other than RUTF and F75/F100 (which included 
micronutrient supplements, deworming pills, and some routine medicines distributed as part of the 
CMAM programme, and expenditure on M&E, were next, with shares of 13% and 10% of total 
expenditure, respectively. M&E expenses included venue hire, M&E materials, per diems, travel, 
and other costs for supervision and programme assessments. 
The smallest categories of expenditure were goods and services (8%), operations and 
maintenance (4%), and training (4%). Goods and services included costs incurred in relation to 
CVs, support groups, and programme management meetings. Operations and maintenance 
included programme expenses, such as rent, fuel for, and maintenance of, vehicles, utilities and 
communications. Training expenses included venue hire, training materials, per diems, travel, and 
other training costs.  
3.2.2 WINNN Output 1: Micronutrient supplementation 
Output 1 is concerned with the delivery of micronutrient interventions to pregnant women and 
children under the age of five, which is primarily delivered through routine PHC services at health 
facilities and consolidated by MNCHW events. MNCHW events are state-wide biannual events 
provided at specified health facilities. MNCHW events are a multi-donor effort and their 
implementation involves multiple partners, including WINNN. UNICEF has a coordinating role at 
the federal and state levels, and provides support across all LGAs in WINNN’s five focal states.  
WINNN expenditure reflects the following activities carried out under the programme for this 
output: 
 Procurement and delivery of iron folate (for pregnant women), deworming, oral rehydration 
solution and zinc (for under-five children) to the UNICEF zonal stores for routine PHC services 
and MNCHW events. States and LGAs are responsible for collection and distribution to the 
                                               
13 We have carried out this exercise by assuming an annual interest rate of 3% and an average lifespan for each 
aggregated capital expenditure category reported by IPs: 15 years for ‘vehicles’, 10 years for ‘medical equipment’, and 
five years for ‘other equipment’, based on the standard practice in health accounting models (Drummond et al., 2015; 
Formson et al., 2010). For any given financial capital expenditure reported every year, we calculated the annualised 
costs using the assumptions regarding interest rates and asset life-periods described above. Given that the life-period for 
all assets considered is equal or surpasses our analysis timeframe (five years), we assigned the calculated annualised 
cost to the year in which that asset was bought and each subsequent year.  
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health facilities as part of their contribution to the WINNN programme. WINNN also supports 
the distribution of Vitamin A. This constituted the largest cost category for Output 1, at 
£4.5 million, or 42% of WINNN expenditure on micronutrient supplementation.  
 Strengthening capacity, coordination and micro-planning of micronutrient supplementation at 
state and LGA levels, focusing on: planning, logistics, supportive supervision, and monitoring. 
Key activities for the programme were strengthening the capacity of health workers, 
strengthening the monitoring system, and leveraging of government funding for MNCHW 
events. WINNN also engaged in social mobilisation activities for MNCHW events, including 
engaging community influencers and town announcers, media work and disseminating public 
education messages/ merchandising. Strengthening capacity, coordination and micro-
planning of micronutrient supplementation, together with social mobilisation activities, 
constituted a large part of the expenditure on human resources (at £2.8 million, or 26%) 
and M&E expenses (at £1.8 million, or 16%) for this output. 
 The remainder, 16%, of expenditure on this output was on equipment (4.3%), operations and 
maintenance expenses (3.2%), training expenses (3.4%) and goods and services (5.2%). 
It is important to emphasise that WINNN works with government and numerous other development 
partners to plan and implement micronutrient supplementation, at both national level and in the 
focal states. Therefore the expenditure of GBP 10.8 million should be interpreted as WINNN’s 
contribution to MNCHW events in the focal states and at national level, plus the support it provides 
to iron folate supplementation, deworming and medication for diarrhoea treatment through routine 
PHC services. 
3.2.3 WINNN Output 2: IYCF interventions 
Output 2 is concerned with IYCF interventions. This is focused largely on caregivers (female and 
male) who have children under the age of two, or women who are pregnant. The IYCF 
interventions are focused in the communities around the five health facilities per WINNN LGA 
which provide CMAM services, as well as a number of non-CMAM facilities in the focal LGAs. 
WINNN expenditure reflects the following activities by the programme for this output: 
 supporting IYCF training for state and LGA officers, who then provide step-down training to 
health workers and CVs; 
 supporting the establishment of the f-IYCF component, designed to be provided by trained 
health workers. The health workers are tasked with providing IYCF counselling as part of the 
CMAM programme, routine PHC services, such as ANC and PNC care, and health events, 
such as MNCHW events. This includes IYCF-focused counselling to small groups of mothers 
and also one-to-one counselling; 
 supporting the establishment of the c-IYCF component, which is provided by trained CVs. CVs 
are tasked with establishing and facilitating ‘mothers’ support groups’, as well as broader IYCF 
promotion in communities. There was an expansion of the c-IYCF component at the end of 
2015; 
 providing ongoing supportive supervision and monitoring of the IYCF interventions in 
partnership with the state and LGA health teams; and 
 advocacy to promote adequate public funding for IYCF practices, development of the IYCF 
policy agenda and legislation related to IYCF practices. For example, WINNN supported the 
Federal Ministry of Health to develop the ‘National IYCF Strategy and Behaviour Change 
Communication Strategy’. In addition, WINNN has adopted the c-IYCF training package 
developed by the Nigerian Federal Government (adapted from the generic UNICEF c-IYCF 
package), and the f-IYCF training package, also developed by the Nigerian Federal 
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Government (based on manuals developed by UNICEF and the World Health Organization 
(WHO)). 
In line with these activities, which are labour intensive, expenditure on human resources 
constituted the largest cost category for Output 2, at £2.6 million, or 52% of WINNN 
expenditure on the IYCF interventions.  
Goods and services constituted the next largest cost category for Output 2, at £0.9 million, 
or 17% of WINNN expenditure on the IYCF interventions. Costs incurred on CVs and support 
groups, including per diems for CVs for training or meetings, constituted a large component of this 
cost category. The remainder, 31%, of expenditure on this output was on shares of equipment 
(8%), operations and maintenance expenses (8%), training expenses (8%) and M&E (7%). 
3.2.4 WINNN Output 3: CMAM programme 
Output 3 is concerned with the provision of CMAM services. The intended beneficiaries are 
children under five with SAM in the WINNN focal LGAs. WINNN supports OTP facilities in five PHC 
facilities in each of its three focal LGAs, per state. WINNN also supports SC facilities in at least one 
referral centre per focal LGA.  
WINNN support includes:  
 funding of therapeutic commodities provided through the CMAM programme, such as RUTF, 
F75/F100, and ReSoMal. WINNN also supports the government to fill the procurement gap in 
respect of antibiotics (Amoxicillin) and deworming pills (Albendazole). These commodities are 
delivered to the UNICEF zonal stores, and from there states and LGAs are responsible for 
onward transportation to the health facilities. States and LGAs are also responsible for funding 
and procurement of other routine drugs. This constituted the largest cost category for 
Output 3, at £7.7 million, or 55% of WINNN expenditure on the CMAM programme, of 
which 99.2% (£7.6 million, or 54.8% of WINNN expenditure on the CMAM programme) 
corresponded to RUTF expenses only; 
 supporting CMAM training for state and LGA officers, who then provide step-down training to 
health workers and CVs; 
 supporting mobilisation of CVs for SAM detection and community sensitisation;  
 providing ongoing supportive supervision and monitoring of CMAM programme services, in 
partnership with the state and LGA health teams; and 
 advocacy and technical support to promote CMAM systems reform and public funding, 
including support in the development of technical guidelines and to the Federal Ministry of 
Health.  
In line with these last four activities, which are labour intensive, expenditure on human 
resources constituted the next largest cost category for Output 3, at £3.4 million, or 25% of 
WINNN expenditure on the CMAM programme. The remainder, 20%, of expenditure on this 
output was on shares of equipment (4%), operations and maintenance expenses (3%), training 
expenses (3%), M&E (5%), and good and services (5%). 
While WINNN is the only development partner supporting the CMAM programme in its focal LGAs, 
various partners support these interventions in other LGAs in the WINNN focal states and at 
federal level. These include the European Union’s European Civil Protection and Humanitarian Aid 
Operations (ECHO) (implemented by SCI and ACF), and a large CMAM programme funded by 
CIFF, which operates at federal level and across the northern states, including all five WINNN 
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states. Like WINNN, these programmes aim to strengthen nutrition policy, government 
commitment, public funding and civil society engagement. 
3.2.5 WINNN Output 4: Government coordination and planning 
Output 4 is concerned with supporting more effective government planning and coordination of 
nutrition-related interventions (at federal and state levels), and building government commitment. 
This includes support to the following:  
 national-, state- and LGA-level committees on food and nutrition – to promote inter-sectoral 
coordination and attention to nutrition; 
 policy and plans for nutrition work; 
 promotion of public funding and releases for nutrition-specific interventions; and  
 promoting civil society engagement in the planning and monitoring of nutrition work.  
The objectives under Output 4 are closely entwined with the other WINNN outputs, and at its heart 
Output 4 aims to strengthen government commitment to addressing malnutrition and its underlying 
causes. This, again, is a people-intensive activity, and it is not surprising that expenditure 
on human resources constituted the largest cost category for Output 4, at £2.2 million, or 
57% of WINNN expenditure on government coordination and planning.  
Again, various development partners support nutrition sector governance. Most notably, UNICEF’s 
CIFF-funded programme has recently introduced a matched funding mechanism to complement 
WINNN (in the case of WINNN states) to promote state financing for nutrition (particularly the 
CMAM programme), which is being implemented through to 2018. The Gates Advocacy project 
(funded by the Gates Foundation, and implemented by SCI) also works in close partnership with 
WINNN to achieve common advocacy goals, at federal level and in three of the WINNN states. 
3.3 WINNN costs by year 
Figure 4 breaks down total programme expenditure by WINNN output and year—defined as 
running from September to August. WINNN expenditure has generally increased over time, as the 
programme has rolled out all of the interventions to all states. In Year 1 the programme spent £4.4 
million, whereas it was spending between £7.3 million and £8.3 million a year over Years 3–5.  
Over the years, WINNN has spent increasing amounts on the IYCF interventions and government 
coordination and planning, as the programme has expanded its scope both geographically and in 
terms of beneficiaries reached. The 47% increase in expenditure on the IYCF interventions from 
Year 4 (£1.1 million) to Year 5 (£1.6 million) can be explained by the expansion of the c-IYCF 
component to additional wards in the beginning of Year 5. Annual spend on the CMAM programme 
and micronutrient supplementation over the years has varied a bit more. Expenditure on the 
CMAM programme in Year 3 was the largest, with the roll-out to the remaining states (Katsina, 
Kebbi and Yobe) taking place that year (WINNN rolled out the CMAM programme in Zamfara and 
Jigawa in Year 2). The decrease in the expenditure on the CMAM programme in Year 4 and Year 
5 was also a result of lower set-up costs but also ‘lumpy’ procurement of RUTF in the first three 
years of the programme—i.e. bulk procurement of RUTF in one year but use over subsequent 
years: thus, annual procurement expenditure does not necessarily reflect actual use in that year. 
Expenditure on micronutrient supplementation also varied across the years. This could also reflect 
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the gradual expansion of the programme to all states14, the possibly lumpy procurement of some 
medical commodities and the varying contributions from states and LGAs to this output across the 
years.  
Figure 4:  Programme expenditure by WINNN output and year, 2011/12 to 2015/16 
 
Figure 5 shows the percentage distribution of WINNN expenditure by outputs for each year. Over 
Year 1 to Year 4, the CMAM programme constituted the largest expenditure share of WINNN total 
expenditure, ranging from 40% to 56%. This was generally followed by micronutrient 
supplementation—although in Year 5 this output had a larger share than the CMAM programme 
(35% versus 32%, respectively) driven by the decrease in the expenditure on the CMAM 
programme in the last years of the programme—then the IYCF interventions, and finally 
government coordination and planning.  
                                               
14 WINNN rolled out MNCHW events in Zamfara and Jigawa in Year 1, followed by Katsina and Yobe in Year 2. In Kebbi, 
WINNN supported the platform of the Immunisation Plus Days in Year 2 and Year 3, until MNCHW events were first 
implemented in Year 4. 
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Figure 5:  Programme expenditure distribution by WINNN output and year, 2011/12 to 
2015/16 
 
3.4 WINNN costs by state 
Figure 6 and Figure 7 break down total programme expenditure and its distribution by WINNN 
output and state. After central programme spending in Abuja (£8.6), Jigawa and Zamfara were the 
states with the largest programme expenditure, at £6.6 million and £6.4 million, respectively. 
Expenditure across WINNN outputs varied absolutely and relatively by states: Jigawa and Zamfara 
were the states with the largest expenditure on the CMAM programme (£3.6 and £3.4, 
respectively), corresponding to their larger targets of children with SAM admitted into the CMAM 
programme15. Katsina and Kebbi spent proportionally more on micronutrient supplementation (41% 
and 36%) than the other three states (Jigawa (27%), Yobe (25%) and Zamfara (26%)), which spent 
proportionally more on the CMAM programme. One explanatory factor for these differences is the 
various state and LGA-level commitments to support and co-fund some components of the WINNN 
programme.  
 
                                               
15 According to the WINNN logframe, the target by Year 5 for the cumulative number of children admitted in target LGAs 
(Output 3.1) was 40, 800 in Jigawa and Zamfara, and 30, 800 in Katsina, Kebbi and Yobe.  
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Figure 6:  Programme expenditure by WINNN output and state, 2011/12 to 2015/16 
 
Figure 7:  Programme expenditure distribution by WINNN output and state, 2011/12 to 
2015/16 
 
3.5 WINNN costs summary findings 
The largest share of the WINNN programme expenditure was on the CMAM programme 
(41%), with expenditure on RUTF being the main cost driver of this output (54.8% of WINNN 
expenditure on the CMAM programme). The CMAM intervention, a lifesaving intervention which is 
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on the treatment end of the spectrum for malnutrition, compared to the more preventative 
interventions of micronutrient supplementation and the IYCF interventions, has proved to be more 
resource intensive for the WINNN programme, in regard to supporting the government to 
implement this intervention—not only in terms of the medicines required (primarily, RUTF) but also 
in terms of the human resource requirements. However, CMAM programmes save the lives of 
children who otherwise would have died without the interventions. 
As anticipated, the main cost drivers for each WINNN output resemble the main 
components of that specific intervention. For instance, RUTF provision is the largest cost 
category for the CMAM programme (54.8%). WINNN expenditure on micronutrient 
supplementation is driven by the cost of medical commodities (42%) delivered through routine 
primary health services and MNCHW events. While the IYCF interventions and government 
coordination and planning are relatively more people-intensive than other WINNN outputs, with 
human resources constituting the largest cost category, at 52% and 57%, respectively.  
WINNN is not a capital-intensive programme in the standard sense but it has made 
significant investments in strengthening the government capacity to implement nutrition 
interventions. Only 5% of WINNN programme expenditure has been on traditional capital items, 
such as vehicles, medical equipment and other equipment (e.g. computers). Expenditure on 
human resources, however, has constituted 33% of overall expenditure. This represent the cost of 
WINNN staff (and consultants) at the national, state and local levels supporting the delivery of the 
three key comprehensive nutrition-specific interventions through the public health system and the 
effective planning and coordination of nutrition interventions more generally. 
The government and other development partners work in coordination with WINNN on the 
achievement of micronutrient supplementation and government coordination and planning outputs. 
Thus, the WINNN expenditure on those outputs—£10.8 million on micronutrient 
supplementation and £3.9 million on government coordination and planning—represents 
the DFID-funded contribution to those activities in the focal states and nationally. 
Specifically for micronutrient supplementation, DFID funds activities in the focal states and 
contributes to national-level policy activities, which are also complemented by funding from other 
donors. For the advocacy output, a mix of funds at the state and national level are used, depending 
on donors’ priorities. WINNN expenditure on the IYCF interventions and the CMAM programme 
can be allocated more easily to expenditure on specific interventions in WINNN focal states: this is 
one reason why these outputs are costed from a societal perspective in the subsequent sections. 
Compared to the original DFID Business Case (2011), WINNN has spent proportionally more 
on the CMAM programme and less on micronutrient supplementation and the IYCF 
interventions. In the business case, 33% of the WINNN budget was allocated to the CMAM 
programme, whereas in fact 41% of WINNN expenditure has been on the CMAM programme.16 
Some 41% of the budget was allocated to micronutrient supplementation and 19% to the IYCF 
interventions in the business case. In reality, 32% of WINNN expenditure has been on 
micronutrient supplementation and 15% on the IYCF interventions. 
                                               
16 These estimates exclude the cost of ORIE, which was budgeted at £6.5 million of the total £50 million WINNN budget.  
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4 The costs of IYCF interventions from a societal 
perspective 
This section presents our findings on the costs of the IYCF interventions, as supported by WINNN, 
from a societal perspective. It first gives some background on the design and context of the IYCF 
interventions. It then gives our estimates of the cost per woman reached of the various IYCF cost 
centres, before bringing them together to establish an estimate of the overall cost per woman 
reached. Finally, it discusses how our results compare to IYCF cost estimates from other IYCF 
interventions. 
4.1 Background to the WINNN IYCF interventions 
The IYCF interventions are focused on improving the feeding practices of under-two children—i.e. 
promoting adequate maternal nutrition (for pregnant and lactating women), early initiation to 
breastfeeding and EBF during the first six months, continued breastfeeding up to at least two years 
of age and complementary feeding of nutritionally adequate foods for older children. It also 
includes appropriate hygiene behaviours. The IYCF interventions are therefore targeted primarily 
at mothers of under-two children and pregnant women.  
WINNN supports the delivery of the IYCF interventions through its three focal LGAs per state 
within five states in northern Nigeria. More specifically, it supports the establishment of the 
following: 
 f-IYCF counselling as part of routine PHC services – such as ANC services and the CMAM 
programme – as well as at health events such as MNCHW events. The f-IYCF component 
is designed to be provided by trained health workers, although, in practice, CVs also 
support the f-IYCF approach in many facilities due to inadequate human resources for 
health (Qualitative Evaluation of the WINNN Programme, 2017). The f-IYCF component 
includes counselling to groups of mothers and also one-to-one counselling.  
 The c-IYCF component is provided by trained female and male CVs. Female CVs facilitate 
‘mothers’ support groups’, and provide one-to-one counselling. Male CVs reach out to 
fathers, local and religious leaders, while both male and female CVs provide broader IYCF 
sensitisation in communities. WINNN supported the significant expansion of the c-IYCF 
component to additional wards from August 2015 to February 2016.  
As shown in Figure 8, WINNN-supported IYCF interventions started in the beginning of 2013. The 
IYCF interventions work in Kebbi and Katsina started in March 2013, before the CMAM programme 
started in those states. IYCF-related activities started in Zamfara in May 2013, followed by Jigawa 
and Yobe in July 2013. In Zamfara and Jigawa, the IYCF interventions were the last WINNN 
component to be rolled out, while in Yobe the IYCF interventions started a couple of months before 
the CMAM programme’s implementation. Before the expansion, c-IYCF components took place in 
15 health facilities through the provision of ANC services per WINNN LGA. Each health facility had 
three mothers’ support groups attached to it. The expansion at the beginning of Year 5 extended c-
IYCF interventions to 10 wards per LGA, increasing the total number of support groups by more 
than double (WINNN quarterly reports estimate an increase from 669 in Year 2 to 1,558 in Year 5). 
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Figure 8:  WINNN IYCF interventions roll-out, September 2011–August 2017 
State 
Year 1 Year 2 Year 3 Year 4 Year 5 Year 6 
2011/12 2012/13 2013/14 2014/15 2015/16 2016/17 
Zamfara                                                                         
Jigawa                                                                         
Katsina                                                                         
Kebbi                                                                         
Yobe                                                                         
Source: WINNN service data  
WINNN supports the government to integrate f-IYCF services into routine PHC services in target 
facilities in the WINNN focal LGAs. This includes training and ongoing technical support for health 
workers and LGA staff. WINNN also supports capacities of federal and state governments and the 
development and adoption (in WINNN states) of national guidelines and legislation related to the 
IYCF interventions. WINNN is the only programme supporting the IYCF interventions in its focal 
LGAs. However, other development partners support the IYCF intervention in other LGAs in the 
WINNN states.  
In regard to the c-IYCF component, WINNN undertakes community engagement work, and 
supports training and meetings for CVs and ‘IYCF Ward Focal Supervisors’. The CVs receive 
travel allowances for meetings and training, but are not generally remunerated for their time.  
4.2 Findings 
This section gives our estimates of the average cost per mother reached of the various IYCF cost 
centres, before bringing them together to establish an overall average cost per mother reached.  
Our estimates do not include husbands or mothers-in-law reached through counselling or 
community mobilisation since there are no monitoring records across all years and states for those 
beneficiaries reached. There are also some costs to the mother of accessing IYCF services—
mainly in terms of her time and expenses in travelling to a health facility and the opportunity costs 
to her time spent in counselling. These costs are not included in the costing because the proportion 
of these costs attributed to IYCF activities is expected to be negligible given that women receive f-
IYCF counselling integrated into other PHC services (i.e. ANC, PNC, the CMAM programme or 
MNCHW events), and the c-IYCF component does not represent a significant burden in terms of 
time and expenses, since mothers attend support groups in their own or neighbouring 
communities.  
Using the societal perspective as explained in Section 2.3.1, there are three levels at which costs 
are incurred: 
1. health facility; 
2. community; and  
3. higher-level programme.  
Each cost level is explained in turn. Further detail on the IYCF interventions in northern Nigeria, as 
supported by WINNN, is also presented in this section to put the findings in context. 
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4.2.1 Health facility-level costs 
Health facility-level costs are all costs that are directly incurred in delivering an intervention to an 
individual in the health facility—in this case, counselling mothers as part of ANC and PNC services, 
on CMAM days, as well as during health events, such as MNCHW events. These are sometimes 
referred to as treatment costs. Such costs comprise: 1) health worker inputs—the time spent by 
different cadres of health workers on delivering the intervention; and 2) a proportion of overhead 
costs attributable to the IYCF-related services delivered within the health facility. 
Health worker time 
The f-IYCF component’s design is for trained health workers to provide both group and one-to-one 
counselling to pregnant women at routine services such as ANC, mothers of children attending 
CMAM days (including mothers of children who are moderately acutely malnourished, not those 
with SAM, and who are therefore not enrolled in the CMAM programme) and during health events, 
such as MNCHW events. The health worker uses IYCF counselling cards, which pictorially 
demonstrate key IYCF messages relevant to that particular woman—e.g. the importance of iron 
folate supplementation and early initiation to breastfeeding and EBF. 
As the cost of health worker time spent on delivering the f-IYCF component on CMAM days is 
costed as part of that intervention (see Section 5.2.1), here we estimate the cost of the f-IYCF 
component as part of ANC and other points of contact at the facility for other PHC services. We 
necessarily take a partly normative approach to estimating the cost per mother reached through 
the f-IYCF component. A normative approach estimates costs on the basis of what resource 
requirements should be, rather than what they actually are in reality. This is because it is very 
difficult to collect accurate data on the amount of time spent on interventions such as the IYCF 
interventions, which is added on to, or integrated into, another service (i.e. ANC, PNC, the CMAM 
programme or MNCHW events), and it often does not take that much time in reality. This estimate 
therefore represents an upper bound, ideal cost of health worker time per mother reached. 
We estimate an average health worker cost per mother reached of £0.8 across both the group 
and one-to-one f-IYCF approaches. This is estimated using the following data and assumptions: 
 WINNN LTAs report that, ideally, the health workers delivering the f-IYCF component should be 
the Junior Community Health Extension Worker (J-CHEW) cadre. In practice, CVs do also 
provide support delivering f-IYCF-related services; however, we exclude them from our 
analysis since we do not have information on the extent of their support. We assume that J-
CHEWs providing f-IYCF-related services are equally distributed across Grades 5–8. Nigeria 
has a consolidated health salary structure that specifies the range for basic salary at each 
grade and also the various allowances to which a health worker may be entitled. The average 
hourly salary plus relevant allowances of a J-CHEW is £1.18 an hour.  
 WINNN LTAs report that the average length of group counselling is 30 minutes and the 
average length of an individual session is 20 minutes. This means that it costs the government 
£0.59 to employ the average J-CHEW for a 30-minute group session and £0.39 for a 20-minute 
one-to-one session. We assume that group or individual sessions are facilitated by one CHEW.  
 WINNN LTAs report that there are, on average, 32 mothers per f-IYCF group session, and of 
course by design there is one mother at each one-to-one f-IYCF session. This means that the 
health worker cost per mother of a group session is £0.02 ($0.03) and for a one-to-one session 
it is £0.39 ($0.62).  
 Unfortunately, WINNN monitoring data do not track the number of times that mothers attend f-
IYCF activities. We therefore necessarily make the normative assumption, based on the WHO 
recommendation for IYCF counselling during ANC, of two individual sessions per mother. Also, 
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we assume that, in addition to these, mothers also receive one group session at any other 
point of contact at the facility, which can include PNC or MNCHW events. This therefore implies 
a health worker cost per mother of £0.02 ($0.03) for group f-IYCF and £0.79 ($1.23) for one-to-
one f-IYCF activities. This results in an overall estimate for average health worker cost per 
mother reached of £0.81 ($1.26). 
Table 2:  Inputs to f-IYCF cost calculation 
Cost item Source 
Individual 
counselling at 
health facility 
Group counselling 
at health facility 
Average hourly salary of a 
health worker delivering f-IYCF 
activities 
Higher-level data 
collection: salary 
scales 
£1.181/ ($1.85) £1.181/ ($1.85) 
Average length of a session 
Higher-level data 
collection: WINNN 
LTAs interviews 
20 minutes 30 minutes 
Average number of mothers per 
session 
Higher-level data 
collection: WINNN 
LTAs interviews  
1 mother 32 mothers 
Average number of sessions 
per mother 
ORIE assumption 
2 sessions as part of 
ANC based on WHO 
recommendation for 
IYCF counselling 
1 session (at any 
other point of contact 
besides through the 
CMAM programme) 
Cost per mother counselled ORIE calculation  £0.791/ ($1.23) £0.021/ ($0.03) 
Cost per mother reached for f-
IYCF activities overall 
ORIE calculation £0.811/ ($1.26) 
1/ Using an exchange rate of 1.56, calculated as the average of representative rates for the period 
September 2011 to August 2016 (Source: International Monetary Fund (IMF)) 
Facility overheads 
We estimate a proportion of overhead costs attributable to the f-IYCF component of £0.49 
($0.76) per mother reached. For a complete costing it is important to include a share of health 
facility overheads to the direct costs of delivering the f-IYCF component. In the absence of primary 
data from the WINNN programme, we use standard WHO-CHOICE estimates of health facility 
overheads. These are typically used in costing studies.  
This is estimated by taking the WHO-CHOICE estimate of £1.22 ($1.91) in overhead costs per 
outpatient visit to a rural public health facility with no beds in Nigeria and adjusting for the fact that 
WHO-CHOICE estimates already include health worker costs. We have already accounted for 
these, and so we scale the cost to count only infrastructure—building rent and utility costs. We 
then further adjust for the IYCF interventions not taking a full outpatient visit worth of time, given 
that it is additional to, for example, an ANC visit. 
4.2.2 CV costs 
The c-IYCF component’s design is primarily for trained CVs to establish and facilitate mothers’ 
support groups, as well as broader IYCF promotion in communities. The support group approach is 
intended to allow for peer support among pregnant women and mothers of under-two children. 
Female CVs use the IYCF counselling cards also used in the f-IYCF component of the IYCF 
interventions.  
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We estimate CVs costs per mother reached through the support groups of between £1.95 
($3.05) and £2.45 ($3.83) on average across the programme duration (i.e. taking into account the 
expansion of the c-IYCF model in late 2015). We also take a partly normative approach to 
calculating the CV cost per mother reached, given that some of the cost inputs used are difficult to 
estimate accurately with the available information and data sources collected.  
The CV cost per mother reached is estimated using the following data: 
 A recently conducted CV motivation study reports that IYCF-related CVs work on average 
between six and nine hours a week. We apply these lower and upper limits in our 
calculation. An estimate of 8.3 hours worked a week from ORIE’s operations research with 
such CVs in Jigawa fits within this range.  
 Since CVs are not generally remunerated for their working time, we calculate the 
opportunity cost to the CV’s time. On average, according to the ORIE HFS, a CMAM 
programme CV gives up £0.24 of income an hour to work on a CMAM day (ORIE Health 
Facility Survey-final report, 2016). In the absence of data on the opportunity cost of an 
IYCF CV’s time, we use this CMAM programme CV opportunity cost. This hourly 
opportunity cost multiplied by the number of hours an IYCF CV works in a week equates to 
an opportunity cost per CV of between £1.44 and £2.16 a week. 
 There are also expenses that CVs would not otherwise incur which they incur in 
establishing and facilitating IYCF support groups, and for which they are not compensated. 
ORIE’s operations research with IYCF CVs in Jigawa found IYCF CVs incur expenses of 
£1.40 a week, on average, in costs such as transportation, food, water, etc. Any other 
stipends or per diems for volunteers for training or meetings are costed as part of the 
WINNN programme costs (see Section 4.2.4). We assume that an IYCF CV spends both 
time and expenses only during the week in which the monthly support group meetings take 
place, i.e. once a month.  
 The CV motivation study reports that each support group is facilitated by five CVs. Each 
support group should also meet once a month. We were not able to validate if these 
requirements were actually satisfied in a real implementation setting; we therefore used a 
normative approach for these assumptions.  
 WINNN monitoring data show that the number of support groups increased from 669 in 
Year 2 to 1,558 support groups in Year 5. We aggregate the yearly number of support 
groups between Year 2 and Year 5 (since there were no support groups in Year 1), 
resulting in a total of 3,619.  
 We use the inputs above to calculate the total CVs costs across the programme duration, 
which approximate to the costs incurred in terms of CVs’ time and expenses to form and 
facilitate the WINNN support groups over time. These total CVs costs are then divided by 
the first-contact c-IYCF beneficiaries across the programme duration to arrive at CVs costs 
per mother reached for the c-IYCF component. The first-contact c-IYCF beneficiaries’ 
indicator in the WINNN monitoring data capture the number of pregnant women and 
mothers of children less than 24 months reached through community counselling for the 
first time. 
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Table 3:  Inputs to c-IYCF component cost calculation 
 Source 
Group 
counselling in the 
community 
Average number of hours spent by a CV on 
c-IYCF activities a week 
WINNN CV motivation study 6–9 
Average hourly opportunity costs of a CV 
delivering c-IYCF activities 
HFS 
£0.241/ 
($0.38) 
Average weekly expenses of a CV 
delivering c-IYCF activities 
ORIE operations research in 
Jigawa 
£1.401/ 
($2.18) 
Number of CVs per support group session WINNN CV motivation study 5 
Number of support group sessions in a 
year 
ORIE assumption 12 
Number of active support groups across 
the programme duration 
WINNN monitoring data 3,619 
Number of first-contact c-IYCF beneficiaries 
across the programme duration 
WINNN monitoring data 317,293 
CV costs per mother reached for the c-IYCF 
component 
ORIE calculation 
£1.95 to £2.451/ 
($3.05 to $3.83) 
1/ Using an exchange rate of 1.56, calculated as the average of representative rates for the period 
September 2011 to August 2016 (Source: IMF) 
In order to estimate the costs under the expanded c-IYCF model, we also calculate the CV costs 
per mother reached using the number of active support groups and first-contact c-IYCF 
beneficiaries only in Year 5 when the expansion took place. This produces a larger relative 
increase in the number of support groups (part of the numerator) than in the first-contact c-IYCF 
beneficiaries (part of the denominator), resulting in a larger estimate for CVs costs per mother 
reached of between £2.79 ($4.35) and £3.50 ($5.46) under the expanded c-IYCF model.  
4.2.3 Beneficiary costs 
Mothers or caregivers receiving the IYCF interventions also incur costs in accessing IYCF 
services, in terms of time and expenses. However, these costs are very difficult to assess and 
estimate, given that IYCF services are integrated into other services, such as the CMAM 
programme, MNCHW events and other routine PHC services, such as ANC or PNC. The time 
mothers spend on a CMAM day, including the IYCF interventions, is already costed as part of the 
costing of the CMAM programme (see Section 5.2.1). Thus, the only costs for caregivers that are 
excluded from our analysis are those related to the time and expenses spent on the c-IYCF and f-
IYCF components as part of ANC or other facility services, such as PNC or MNCHW events. 
However, as mentioned earlier, we expect this cost to be marginal given the time IYCF services 
take in reality.  
4.2.4 Higher-level programme costs 
Higher-level programme costs are those incurred at a ‘higher level’ than the health facility or 
patient: that is, money that funds activities at the national, state and LGA levels that enable the 
effective implementation of the IYCF interventions. Two broad groups incur these costs: 1) the 
WINNN programme; and 2) state and LGA government. Broad categories of activities include: 
 training; 
 social mobilisation; 
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 M&E; and 
 planning and coordination. 
Table 4 shows how these activities map to different costs incurred by WINNN and the government. 
Table 4:  IYCF interventions activities 
 Training  
Social 
mobilisation 
M&E 
Planning and 
coordination 
Human 
resources1/ 
WINNN: time 
training state 
and LGA 
officers 
 
Government: 
time step-
down training 
health 
workers and 
CVs 
 
WINNN: time 
for 
mobilisation of 
CVs 
 
CVs: non-
reimbursed 
time 
(approximated 
in Section 
4.2.2)  
WINNN: 
time doing 
M&E for 
programme 
reporting 
and 
supervision. 
Payment of 
ward focal 
supervisors 
and 
independent 
monitors 
 
Government: 
time doing 
M&E for 
government 
reporting 
and 
supervision 
WINNN: time for the 
IYCF interventions 
management 
meetings and 
stakeholder 
sensitisation at 
federal, state and 
LGA levels 
 
Government: time for 
the IYCF interventions 
management 
meetings and 
stakeholder 
sensitisation at 
federal, state and 
LGA levels 
 
Materials, 
allowances and 
meeting 
expenses2/ 
WINNN: 
materials, 
per diems, 
travel 
allowances, 
venue hire 
for training of 
health 
workers, 
state and 
LGA officers 
 
WINNN: 
materials, per 
diems for 
trainings or 
meetings, 
travel 
allowances, 
venue hire for 
mobilisation of 
CVs 
WINNN: 
Materials, 
per diems, 
travel 
allowances, 
venue hire 
for 
programme 
reporting 
and 
supervision 
WINNN: Materials, 
per diems, travel 
allowances, venue 
hire for the IYCF 
interventions 
management 
meetings and 
stakeholder 
sensitisation at 
federal, state and 
LGA levels 
Equipment  
WINNN: vehicles and other equipment (computers, phones, furniture, 
generator) 
Operations and 
maintenance 
 
WINNN: rent, transport (fuel, maintenance), utilities (electricity, water), 
communications, and other operating expenses 
 
1/ WINNN expenditure on human resources include payments to staff and non-staff (e.g. 
technical assistance, stipends for health workers excluding stipends for training).  
2/ This category corresponds to the sum of the following WINNN cost categories presented in 
Table 1: Training expenses, M&E expenses, and goods and services.  
WINNN programme 
Table 5 shows WINNN IYCF interventions expenditure over the first five years of the programme. 
This money funded WINNN activities at the national, state and LGA levels that enabled the 
effective implementation of the IYCF interventions. For example, at the state and LGA level, 
WINNN provided supportive supervision and monitoring of IYCF services in partnership with the 
state and LGA health teams. At the national level, WINNN engaged in advocacy to promote 
adequate public funding for the IYCF interventions; development of the IYCF policy agenda; and 
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legislation related to IYCF interventions. Money spent on IYCF interventions at the national level is 
considered a capital investment cost and thus is included in the calculation of the cost of the IYCF 
interventions per mother reached.  
Table 5:  WINNN IYCF interventions expenditure, 2011/12 to 2014/16 
Cost item Source Total (million) % 
Human resources 
WINNN expenditure 
data 
£2.6 ($4.1) 52% 
Materials, allowances and meeting expenses  
WINNN expenditure 
data 
£1.6 ($2.5) 33% 
Equipment 
WINNN expenditure 
data 
£0.4 ($0.6) 8% 
Operations and maintenance 
WINNN expenditure 
data 
£0.4 ($0.6) 8% 
Total WINNN expenditure on IYCF interventions 
WINNN expenditure 
data 
£5.0 ($7.8) 100% 
Number of first-contact c-IYCF and f-IYCF 
beneficiaries  
WINNN monitoring 
data 
575,142 
Average WINNN cost per mother reached ORIE calculation £8.7 ($ 13.6) 
Estimates in GBP were calculated using an exchange rate of 1.56 (average of representative rates 
for the period September 2011 to August 2016, source: IMF) 
Human resources is the largest cost item across all the states, comprising 52% of WINNN IYCF 
interventions expenditure overall. Altogether, £2.6 million worth of WINNN staff and non-staff 
personnel time at central, state and LGA levels was spent across the first five years of the 
programme in designing and implementing the IYCF interventions. Expenditure on materials, 
allowances and meeting expenses (for training, social mobilisation, M&E and planning and 
coordination) is the next largest cost, comprising 33% of WINNN the IYCF interventions 
expenditure overall. Altogether £1.6 million was spent in Years 1–5. In the context of the IYCF 
interventions, equipment costs of £0.4 million and operations and maintenance costs of £0.4 
million represent general WINNN overhead costs allocated to the IYCF part of the WINNN 
programme. 
The WINNN programme expenditure of £8.7 ($13.6) per mother reached is calculated by 
dividing the overall WINNN programme expenditure on the IYCF interventions of £5 million by the 
number of first-contact c-IYCF plus f-IYCF beneficiaries across the first five years of the 
programme (575, 142). First-contact c-IYCF and f-IYCF beneficiaries in the WINNN monitoring 
data are beneficiaries receiving any type of IYCF counselling for the first time. These two indicators 
in the WINNN monitoring data are added up to calculate the total number of unique mothers 
reached by WINNN-supported IYCF services, which is then used to estimate the cost-efficiency of 
WINNN costs on the IYCF interventions as a cost per beneficiary indicator, i.e. cost per mother 
reached. Note that beneficiaries could have attended IYCF services a number of times.  
As explained in Section 3.2.3, WINNN expenditure on the IYCF interventions relates to the 
supporting of IYCF activities at both the facility and the community. However, we are not able to 
estimate WINNN costs per mother reached at the facility and at the community separately, given 
that WINNN IPs’ expenditure data are not available at that level of disaggregation. Hence, we 
assume that WINNN costs per mother reached are £8.7 ($13.6), whether the mother is 
reached by IYCF interventions at the facility or at the community.  
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State and LGA 
Expenditure by WINNN states and LGAs that enable the effective implementation of the IYCF 
interventions includes time spent by SNOs, LNOs, and other state/LGA-paid staff, such as 
assistants, nutrition coordinators and drivers on training, supportive supervision, M&E, programme 
reporting and planning of IYCF activities. State- and LGA-level staff mainly provide this support for 
activities concerned with the c-IYCF component.  
We estimate an average state/LGA human resources cost per mother reached of £1.19 
($1.85) on the c-IYCF component. This is estimated using the following information:  
 We collected information on grade levels and time allocated to WINNN IYCF activities of 
state- and LGA-level staff in Jigawa, Katsina, Kebbi and Zamfara. The average state-level 
staff member spends 20 hours a month on IYCF activities, while the average LGA-level 
staff member spends 31 hours.  
 Nigeria has a consolidated health salary structure that specifies the range for basic salary 
at each grade level, and also the various allowances to which a health worker may be 
entitled. Given that the salaries of state-/LGA-level staff were unavailable, the health salary 
structure collected for each state was used. Based on this and the grade levels of the state-
/LGA-level staff working on the IYCF interventions, we estimate that the hourly salary of an 
average state-level staff member is £3.80 ($5.93) an hour, and that of an average LGA-
level staff member is £2.59 ($4.04) an hour. This means it costs the government £75 a 
month to employ an average state-level staff member for 20 hours of work on IYCF 
activities, and £80 a month to employ an average LGA-level staff member for 31 hours. 
 With an average of three members of staff per state and 4.3 per LGA, the government 
spends a monthly average of £1,242 on personnel costs per WINNN state (assuming three 
LGAs per state).  
 Over the course of the first five years of the programme we estimate, according to the 
WINNN monitoring data, a monthly average of 1,046 first-contact c-IYCF beneficiaries. This 
means the government spent £1.19 ($1.85) worth of state-/LGA-level personnel time per 
mother reached on the c-IYCF component.  
Table 6:  State and LGA human resources expenditure on the c-IYCF component 
Cost item Total 
State and LGA human resources cost per mother reached £1.191/ ($ 1.85) 
Note: OPM calculation based on higher-level data collection in Jigawa, Katsina, Kebbi and 
Zamfara. SNOs and LNOs reported grade levels and time allocation to WINNN activities of their 
state-/LGA-level personnel. Health workers’ salary structures were also collected at each state. 
WINNN monitoring data were used for the number of first-contact c-IYCF beneficiaries.  
1/ Using an exchange rate of 1.56, calculated as the average of representative rates for the period 
September 2011 to August 2016 (Source: IMF) 
4.2.5 Overall 
Table 7 and Figure 9 bring together the estimates of the cost per mother counselled of various 
IYCF cost centres.  
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Table 7:  IYCF costs per mother reached by type of service and cost centre  
  f-IYCF component c-IYCF component 
Cost centre GBP1/ USD % GBP1/ USD % 
Higher-level costs 8.7 13.6 87% 9.9 15.4 80% 
WINNN programme 8.7 13.6 87% 8.7 13.6 70% 
Human resources 4.5 7.1 45% 4.5 7.1 37% 
Materials, allowances and 
meeting expenses  
2.8 4.4 28% 2.8 4.4 23% 
Operations and maintenance 0.7 1.0 7% 0.7 1.0 5% 
Equipment 0.7 1.1 7% 0.7 1.1 6% 
State and LGA - - - 1.2 1.9 10% 
Health facility-level costs 1.3 2.0 13% - - - 
Health workers’ time 0.8 1.3 8% - - - 
Facility overheads 0.5 0.8 5% - - - 
CV costs - - - 2.5 3.8 20% 
Total: Health services perspective 10.0 15.6 100% 9.9 15.4 80% 
Total: Societal perspective 10.0 15.6 100% 12.3 19.2 100% 
1/ Using an exchange rate of 1.56, calculated as the average of representative rates for the period 
September 2011 to August 2016 (Source: IMF) 
Figure 9:  IYCF interventions costs per mother reached by type of service and cost 
centre 
 
4.3 IYCF interventions costs summary findings 
WINNN programme costs are the main cost driver of the IYCF interventions. From a societal 
perspective, 87% of the cost per mother reached through the f-IYCF component and 70% of the 
cost per mother reached through the c-IYCF component is expenditure by the WINNN programme. 
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Overall, WINNN expenditure on the IYCF interventions is primarily spent on human resources 
(52%) to support the delivery of the intervention in three focal LGAs in the five WINNN states, 
including expenditure at the state and national levels for this delivery to be effective. Other 
substantial areas of WINNN programme costs on the IYCF interventions include expenditure on 
materials, allowances and meeting expenses (33%), such as for mobilisation of CVs, M&E, and 
training of health workers, state and LGA officers. The remaining WINNN costs are spent on 
general WINNN overhead costs allocated to the IYCF interventions, such as equipment and 
operations and maintenance (16%). 
WINNN expenditure on the IYCF interventions is large in proportion to the current programme 
expenditure incurred by state and LGA governments. WINNN programme costs per mother 
reached are 3.5 times larger (£8.68) than the total cost per mother reached currently incurred by 
the government in health worker inputs, facility overheads, and state-/LGA-level supervision and 
planning of activities (£0.81, £0.49, and £1.19, respectively).  
Heath worker costs are not a large component of the costs of the f-IYCF component. We estimate 
that health worker costs are £0.81 per mother reached, or 8% of the total cost per mother reached 
through f-IYCF counselling. This is indicative of the IYCF interventions not being very demanding 
on the health system as it is a service that is easily integrated into other PHC services, such as 
ANC, PNC, or MNCHW events, and thus it does not need a bespoke day or independent 
infrastructure. However, even this may be a stretch for the current cadre of health workers, with 
CVs stepping in to deliver the f-IYCF component.  
Health worker costs in the f-IYCF model, at £0.8 ($1.3) per mother reached, are less costly than 
CVs costs in the c-IYCF model, at £2.5 ($3.8) per mother reached. Social costs per hour of CVs 
are much cheaper than those of health workers17. Thus, the larger costs of CVs can be explained 
by the fact that the c-IYCF component is more of a standalone intervention compared to the f-IYCF 
component, which is more integrated into existing PHC services, the costs of which are not 
accounted for as part of our modelling. CVs will spend more time organising and facilitating IYCF 
activities in the community, while health workers will only spend a relatively small portion of their 
time delivering counselling sessions at the facility.  
We estimate a similar cost per mother reached for the c-IYCF component compared to the f-IYCF 
component from a health systems perspective (£9.9 ($15.4) versus £10.0 ($15.6), respectively), 
but a higher cost per mother reached for the c-IYCF component, at £12.3 ($19.2) from a societal 
perspective. This is explained by the inclusion of CVs costs to establish and facilitate mothers’ 
support groups in the c-IYCF model. The additional expenditure on the c-IYCF component might 
be justified as it targets women that the f-IYCF component sometimes cannot reach. For example, 
the Quantitative Impact Evaluation of the WINNN Programme, 2017 found that, at endline, 20% of 
mothers in treatment areas had received f-IYCF and c-IYCF counselling at least once, while 39% 
received either one or the other. 
                                               
17 We estimate an hourly salary of £1.18 ($1.85) of an average health worker implementing f-IYCF component, versus an 
hourly opportunity cost of £0.24 ($0.38) of a CV. See Section 4.2.1 and Section 4.2.2 for further details on the 
assumptions in relation to health workers and CVs costs, respectively. 
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5 The costs of the CMAM programme from a societal 
perspective 
This section presents our findings on the costs of the CMAM programme, as supported by WINNN, 
from a societal perspective. It first gives some background on the design and context of the CMAM 
programme. It then gives our estimates of the cost per child treated at the various CMAM facilities, 
before bringing them together to provide an overall cost per child treated estimate. Finally, it 
discusses how our results compare to the cost estimates from other CMAM programmes. 
5.1 Background to the WINNN CMAM programme 
CMAM is an approach to managing SAM in under-five children that has been designed to address 
the disadvantages—many of them cost-related—of traditional inpatient treatment. It aims to 
maximise access to quality care through a triaging system, community workers and use of RUTF. 
The WINNN CMAM programme has two main components: OTP facilities for SAM cases without 
medical complications, and SC facilities for SAM cases with complications, including lack of 
appetite, or among children under six months of age.  
WINNN supports the delivery of the CMAM model in three focal LGAs per state within five states in 
northern Nigeria. More specifically, it provides support to around five OTP facilities per LGA and 
one SC facility per LGA, as well as the mobilisation of CVs to provide support at CMAM days. As 
shown in Figure 10, WINNN rolled out the CMAM programme gradually across its focal states, 
beginning in Zamfara and Jigawa in September 2012, followed by Yobe in September 2013, then 
Katsina in December 2013, and finally Kebbi in May 2014.  
Figure 10:  WINNN CMAM programme roll-out, September 2011–August 2017 
State 
Year 1 Year 2 Year 3 Year 4 Year 5 Year 6 
2011/12 2012/13 2013/14 2014/15 2015/16 2016/17 
Zamfara                                                                         
Jigawa                                                                         
Katsina                                                                         
Kebbi                                                                         
Yobe                                                                         
Source: WINNN service data  
CMAM services are delivered by the local health system with WINNN support, and they therefore 
depend on different levels of operation and responsibility within health facilities and local, state and 
federal governments. While WINNN is the only programme providing CMAM services in its focal 
LGAs, other CMAM programmes operate in the WINNN focal states and also aim to strengthen 
capacity for CMAM services. 
WINNN also relies on two other key groups to provide inputs to implement CMAM services 
successfully. The first group are CVs, who are recruited, trained and supervised by WINNN to 
support at OTP facilities. CVs receive stipends to cover trainings and meetings but are not 
generally remunerated for their time. The second group are the caregivers of children with SAM, 
who incur costs in accessing CMAM services in terms of their time and expenses spent travelling 
to and from and waiting at the health facilities. 
These four groups – WINNN, government, CVs and caregivers – therefore all contribute important 
inputs to the CMAM programme. This is why we take a societal perspective to the costing. 
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However, we also present results from a health services perspective, given that this is more useful 
for government in terms of understanding the budgetary costs of the programme. 
5.2 Findings 
This section gives our estimates of the cost per child treated at various CMAM programme centres 
before bringing them together to provide an overall cost per child treated estimate. Using the 
societal perspective, as explained in Section 2.3.1, and similarly to IYCF cost centres, there are 
three levels at which costs are incurred: 
1. health facility; 
2. community; and 
3. higher-level programme. 
Each cost level is explained in turn. Further detail on the CMAM programme in northern Nigeria, as 
supported by WINNN, is also included in this section to put the findings in context. 
5.2.1 Health facility-level costs 
Health facility-level costs are all costs that are directly incurred in delivering an intervention to an 
individual in the health facility—in this case, treating under-five children with SAM through OTP and 
SC facilities. These are sometimes referred to as treatment costs. Such costs comprise: 1) 
medicines including RUTF and F75/F100; 2) health worker inputs—the time spent by different 
cadres of health workers on delivering the intervention; and 3) a proportion of overhead costs 
attributable to CMAM programme delivered within the health facility. 
OTP 
SAM cases among children under six months without complications and having good appetite are 
treated at OTP facilities. OTP services are provided at PHC facilities on a weekly basis on CMAM 
days. On these days, new children with SAM are admitted to the programme and follow-up clients 
also attend for an assessment of their recovery status. Patients receive clinical care, nutrition 
counselling, and home-based treatment with RUTF. On non-CMAM days, OTP facilities usually 
provide the existing standard health services, which do not include the standardised CMAM 
services provided on CMAM days. 
There are four cost items associated with the treatment received at OTP facilities: RUTF, other 
routine medicines, health worker costs and health facility overhead costs. Table 8 reports the 
average cost per child treated for every item. 
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Table 8:  OTP health facility-level cost 
Cost item Total 
RUTF cost per treated child1/ £28.555/ ($44.58) 
Other routine medicines cost per treated child2/ £0.545/ ($0.84) 
Health worker cost per treated child3/ £2.815/ ($4.39) 
Health facility overhead cost per treated child4/ £3.145/ ($4.91) 
 
Total 
 
£35.055/ ($54.73) 
All of the above are OPM calculations using the following sources: 
1/ Patient Registration Cards, UNICEF procurement data, LGA-/state-level data collection;  
2/ Patient Registration Cards, UNICEF procurement data, UNICEF procurement data from the One 
Health Tool; 
3/ Patient Registration Cards, HFS, LGA-/state-level data collection; 
4/ WHO-CHOICE estimates; and 
5/ using an exchange rate of 1.56, calculated as the average of representative rates for the period 
September 2011 to August 2016 (Source: IMF) 
RUTF is the most expensive element of the costs of treatment received at OTP facilities, at £28.55 
($44.58) per child treated on average. It is procured by UNICEF and delivered to the UNICEF 
zonal store. States and LGAs then have responsibility for transporting the RUTF from the UNICEF 
zonal store to the state medical stores, and from state medical stores to the health facilities, 
respectively, although ACF and SCI sometimes provide ad hoc support in both cases. UNICEF 
procured RUTF at an average cost of £32.23 ($50.32) a carton (or £0.21 a sachet, as each carton 
contains 150 sachets) over the first five years of the WINNN programme. Storage and 
transportation of RUTF, from the port to the health facility, cost £5.81 ($9.07) a carton (or £0.04 a 
sachet), of which UNICEF spent £2.59 a carton and the state and LGA spent £3.22 a carton. This 
means that of the £0.25 RUTF costs per sachet, 92% (£0.23) is incurred by WINNN (UNICEF) in 
procurement, storage and distribution costs, and 8% (£0.02) is incurred by the government in the 
supply chain expenditure between UNICEF zonal stores and health facilities. 
At each CMAM day children with SAM are prescribed the amount of RUTF that is appropriate to 
their weight for a week, until the next CMAM day. Based on our sample of Patient Registration 
Cards, each SAM case received on average 113 sachets of RUTF through the course of the 
treatment received at OTP facilities. At a unit cost of £0.25, this equates to £28.55 ($44.58) per 
child treated. 
Other routine medicines are given to SAM cases at OTP facilities, at £0.54 ($0.84) per child 
treated on average. In addition to RUTF, there are certain other medicines that are routinely 
prescribed, as appropriate to the child’s age, weight and medical history, during SAM treatment. 
These medicines help prevent and treat childhood illnesses associated with SAM that can 
compromise a child’s nutritional progress. The Nigerian CMAM protocol recommends that children 
be routinely given antibiotics, Vitamin A, anti-malarials, measles vaccination and deworming 
tablets.18 Table 9 shows the schedule for each routine medication (except for measles 
vaccination19), responsibility for procurement and unit cost of the medicine. It also shows the 
                                               
18 Federal Ministry of Health (2011) ‘National Guidelines for Community Management of Acute Malnutrition’.  
19 We do not include measles vaccination, though it is part of the routine protocol for treatment at OTP facilities, because 
this is more an example of how the CMAM programme integrates with other services, rather than a direct part of SAM 
treatment. 
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proportion of SAM cases that receive each routine medicine, and the quantity received through the 
course of treatment, to show how the £0.54 ($0.84) per child treated on average is calculated.  
Table 9:  OTP routine medicines 
 
Medicine 
Further 
information 
Unit Procured by Given to 
% 
receiving 
this 
medicine1/ 
Number of 
units 
received2/ 
Unit 
cost3,4/ 
Amoxicillin Antibiotic Bottle 
WINNN and 
government 
All children at 
admission 
Children 
aged 6–59 
months: 
59% 
1 
£0.56 
($0.88) 
Vitamin A 
Essential to 
support rapid 
growth and 
to help 
combat 
infections 
Tablet Government 
All children at 
admission if no 
oedema and 
not already 
given in past 
one month 
Children 
aged 6–12 
months: 
12% 
 
Children 
aged 13–
59 months: 
16% 
Children 
aged 6–12 
months: 
100,000 IU 
tablet 
 
Children 
age 13–59 
months: 
200,000 IU 
tablet 
100,000 
IU tablet: 
£0.02 
($0.03) 
 
200,000 
IU tablet: 
£0.03 
($0.05) 
Artemether 
and 
Lumefantrine 
Anti-malarial Tablet Government 
All children 6–
59 who test 
positive for 
malaria at 
admission 
Children 
aged 6–59 
months: 
32% 
1 tablet 
twice a day 
for three 
days: 6 
tablets 
£0.10 
($0.16) 
Albendazole Deworming Tablet 
WINNN and 
government 
All children 
12–59 months 
at second visit 
Children 
aged 12–
23 months: 
10% 
 
Children 
aged 24–
59 months: 
5% 
Children 
aged 12–23 
months: 0.5 
400 mg 
tablet 
 
Children 
aged 24–59 
months: 1 
400 mg 
tablet 
400 mg 
tablet: 
£0.01 
($0.02) 
1/ Percentage of children under five who are of the specified age range and received that medicine at OTP 
care. OPM calculation using Patient Registration Cards 
2/ OPM assumptions based on Federal Ministry of Health (2011) ‘National Guidelines for Community 
Management of Acute Malnutrition’ 
3/ Unit costs of Amoxicillin and Albendazole are estimated using UNICEF procurement data. For non-WINNN 
procured commodities (Vitamin A, anti-malarials) estimates from UNICEF procurement data from the One 
Health Tool 
4/ Estimates in GBP were calculated using an exchange rate of 1.56 (average of representative rates for the 
period September 2011 to August 2016, source: IMF) 
The health worker cost is £2.81 ($4.39) per child treated on average. Health workers have 
many duties on CMAM days, from conducting a medical examination and appetite test to indicate if 
the child meets OTP admission criteria, through prescribing and giving RUTF and routine 
medicines, to filling in Patient Registration Cards and other records. The ORIE HFS found that 
health workers spend on average 6.4 hours at the OTP facility working on a CMAM day. This also 
includes the time spent providing IYCF counselling on a CMAM day (ORIE Health Facility Survey-
final report, 2016).  
Some health workers also have CMAM-related duties on non-CMAM days as well, which include 
tasks to prepare for and wrap up a CMAM day. About 54% of health workers reported in the ORIE 
HFS that they spend any time on CMAM-related activities on non-CMAM days—4.1 hours per 
week on average (ORIE Health Facility Survey-final report, 2016). This means that the average 
health worker spends 8.5 hours a week on CMAM activities. 
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Health workers of various grade levels work on the CMAM programme. Nigeria has a consolidated 
health salary structure that specifies the range for the basic salary at each grade and also the 
various allowances to which a health worker may be entitled. Based on the sample of health 
workers working at OTP facilities during the ORIE HFS, the average hourly salary plus relevant 
allowances of a health worker at an OTP facility is £1.42 an hour (ORIE Health Facility Survey-final 
report, 2016). This means that it costs the government £12.10 a week to employ the average 
health worker for 8.5 hours of CMAM activities. 
With an average of 5.5 health workers and 153 patients at each health facility, according to the 
ORIE HFS, this means that each patient receives £0.44 worth of health worker time per visit (ORIE 
Health Facility Survey-final report, 2016). Each child on average makes 6.4 visits per episode of 
SAM, according to our sample of Patient Registration Cards, which means that over the course of 
their treatment they receive £2.81 worth of health worker time. 
Facility overheads 
For a complete costing, it is important to include a share of health facility overheads to the direct 
costs of delivering the OTP in a health facility. In the absence of primary data from the WINNN 
programme, we use standard WHO-CHOICE estimates of health facility overheads. These are 
typically used in costing studies. We estimate that the OTP has overhead costs per child treated 
of £3.14 ($4.91) on average. This is estimated by taking the WHO-CHOICE estimate of £1.22 
($1.91) in overhead costs per outpatient visit to a rural public health facility with no beds in Nigeria 
and adjusting for the fact that the WHO-CHOICE estimates already include health worker costs. 
We have already accounted for these, and so we scale the cost to count only infrastructure—
building rent and utility costs. This is then multiplied by the average number of outpatient visits per 
child with SAM for the treatment received at the CMAM facility (6.4 visits) to arrive at the total 
overhead cost per child treated. 
SC 
SAM cases with complications or among children under six months are referred to SC facilities. 
These centres are usually based within the paediatric services of state hospitals, and in some 
cases at the comprehensive health centre at the LGA level. Given their critical condition, children 
receiving the treatment given at SC facilities are hospitalised in order for them to receive the 
various kinds of clinical treatment and stabilisation with therapeutic milk. Caregivers often stay with 
their child at the facility while the treatment takes place. When the child’s condition improves, the 
child is normally transferred from SC sites to the nearest OTP site, in order to complete their 
rehabilitation.  
There are five cost items associated with service delivery at SC facilities: RUTF, therapeutic milks 
F75 and F100, other routine medicines, health worker time and facility overheads. Table 10 reports 
the average cost per child treated for every item. 
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Table 10:  SC health facility-level cost 
Cost item Total6/ 
RUTF cost per treated child1/ £1.41 ($2.21) 
F75 and F100 cost per treated child2/ £3.12 ($4.87) 
Other routine medicine cost per treated child3/ £0.37 ($0.58) 
Health worker cost per treated child4/  £32.89 ($51.35) 
Facility overheads5/ £24.04 ($37.54) 
Total £61.84 ($96.55) 
All of the above are OPM calculations using the following sources: 
1/ Patient Registration Cards, UNICEF procurement data, higher-level data collection (interviews 
with SNOs and LNOs); 
2/ Patient Registration Cards, UNICEF procurement data; 
3/ Patient Registration Cards, UNICEF procurement data, UNICEF procurement data from the One 
Health Tool; 
4/ Patient Registration Cards, HFS, higher-level data collection; 
5/ WHO-CHOICE estimates; and 
6/ estimates in GBP were calculated using an exchange rate of 1.56 (average of representative 
rates for the period September 2011 to August 2016, source: IMF). 
RUTF costs £1.42 ($2.21) per average child treated at SC facilities. This is much less than at 
an OTP facility (where it is £28.55 ($44.58) per child treated) but this is not surprising, given that 
children over six months only receive RUTF at SC facilities once they have been stabilised—their 
appetite has recovered and medical complications and/or oedema are being resolved. That is, they 
receive RUTF in the transition phase, when they are out of the emergency period and are being 
prepared for discharge to an OTP facility, and at the time of discharge. Children under six months 
do not receive RUTF. Based on our sample of health facility Patient Registration Cards, each SAM 
case received on average 5.6 sachets of RUTF in total, through the course of the treatment at a 
SC facility and at discharge. At a unit cost of £0.25 per sachet (including procurement, distribution 
and transportation costs incurred by WINNN, states, and LGAs), this equates to £1.41 ($2.21) per 
child treated. 
F75 and F100 cost £3.12 ($4.87) per child treated at SC facilities. F75 is a crucial medicine in 
the SC component as it is used for the initial feeding of the child in the stabilisation phase until the 
appetite has recovered and medical complications and/or oedema are resolved. F100 is used in 
the transition phase if RUTF is not available, the child is refusing RUTF or cannot consume the 
required daily ration. The Nigerian protocol for SC facilities20 suggests it is preferable to use RUTF 
in the transition phase, although the two diets (F100 and RUTF) are nutritionally equivalent21. SAM 
children under six months are breastfed and given supplementary diet with F75 if they are 
oedematous, and F100 dilute or generic infant formula if they are not. Similarly to RUTF, these 
therapeutic milks are procured by UNICEF, and the storage and distribution responsibilities are 
shared between UNICEF, the states and LGAs, with ad hoc support from ACF and SCI. However, 
we are only able to capture the storage and distribution costs incurred by UNICEF and not that 
incurred by the states or LGAs.  
Each sachet of F75 costs £0.31 ($0.48) to procure and £0.02 ($0.04) to store and distribute; each 
sachet of F100 costs £0.40 ($0.63) to procure and £0.04 ($0.06) to store and distribute. Based on 
our sample of health facility Patient Registration Cards, each SAM case received on average 8.8 
                                               
20 Federal Ministry of Health (2016) ‘National Guidelines for Inpatient Management of Severe Acute Malnutrition in 
Infants and Young Children in Nigeria’. 
21 RUTF is preferable in the transition phase since children should get habituated to being fed with RUTF so they can 
continue treatment with it as outpatients in their homes. Another advantage is that feeding with RUTF does not require 
surveillance during the night, reducing the need for night staff (Federal Ministry of Health, 2016).  
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sachets of F75 and 0.4 sachets of F100 through the course of the treatment at a SC facility. At unit 
costs of £0.33 and £0.44, respectively, this equates to £3.12 ($4.87) per child treated. 
Other routine medicines are given to SAM cases at SC facilities, at £0.37 ($0.58) per child 
treated on average. The Nigerian protocol for SC facilities22 considers antibiotics, anti-malarials, 
measles vaccine and specific medicines for complications, such as Vitamin A, ReSoMal and anti-
fungal, as routine first-line medicines at SC facilities.  
                                               
22 Federal Ministry of Health (2016) ‘National Guidelines for Inpatient Management of Severe Acute Malnutrition in 
Infants and Young Children in Nigeria’. 
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Table 11 shows the schedule for these medicines (except for measles, anti-malarials and anti-
fungal23), responsibility for procurement and unit cost of the medicine at SC facilities. We also 
include the cost of deworming pills given to children who stay at the inpatient facility for the 
rehabilitation period.  
                                               
23 Similarly to routine medicines for treatment at OTP facilities, we do not include measles vaccination because this is 
more an example of how the CMAM programme integrates with other services, rather than a direct part of SAM 
treatment. Anti-malarials and anti-fungal are not included due to data limitations in the patient cards collected at SC.  
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Table 11:  SC routine medicines 
 
Medicine 
Further information Unit Procured by Given to 
% receiving 
this medicine1/ 
Number of units 
received2/ 
Unit cost3,4 
Amoxicillin Antibiotic Bottle 
WINNN and 
government 
All children 6–59 
months at admission 
All children under 6 
months greater than 2 
kg at admission 
Children 6–59 
months: 63% 
Children < 6 
months: 1% 
1 £0.56 ($0.88) 
Vitamin A 
Essential to support 
rapid growth and to 
help combat 
infections 
Tablet Government 
Children with eye 
signs of Vitamin A 
deficiency or history 
of measles 
Children under 6 
months: 0% 
Children age 6–
12 months: 0% 
Children age 
13–59 months: 
7% 
Children under 6 
months: 50,000 
IU tablet 
Children 6–12 
months: 100,000 
IU tablet 
Children 13–59 
months: 200,000 
IU tablet 
50,000 IU 
tablet: £0.03 
($0.04) 
100,000 IU 
tablet: £0.02 
($0.03) 
200,000 IU 
tablet: £0.03 
($0.05) 
ReSoMal 
Oral rehydration salts 
for children with SAM 
Sachet WINNN 
Children presenting 
dehydration 
Children under 6 
months: 4% 
Children 6–59 
months: 6% 
0.4 of a 42 g 
sachet 
£0.16 ($0.25) 
per sachet 
Albendazole Deworming Tablet 
WINNN and 
government 
All children 12–59 
months 
Children 12–23 
months: 11% 
Children 24–59 
months: 12% 
Children 12–23 
months: 0.5 400 
mg tablet 
Children 24–59 
months: 1 400 
mg tablet 
400 mg 
tablet: £0.01 
($0.02) 
1/ Percentage of children under five who are of the specified age range and received that medicine during treatment at SC facilities. OPM calculation 
using Patient Registration Cards 
2/ OPM assumptions based on Federal Ministry of Health (2016) ‘National Guidelines for Community Management of Acute Malnutrition’ 
3/ Unit costs of Amoxicillin, Albendazole and ReSoMal are estimated using UNICEF procurement data. Unit costs of non-WINNN procured 
commodities, such as Vitamin A, are based on UNICEF procurement data from the One Health Tool 
4/ Estimates in GBP were calculated using an exchange rate of 1.56 (average of representative rates for the period September 2011 to August 2016, 
source: IMF) 
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Health worker cost is £32.89 ($51.35) per average child treated at SC facilities. This is far 
more than at OTP facilities (where it is £2.81 ($4.39) per child treated) but this is not surprising, 
given that the human resources model is very different for the provision of the OTP component 
compared to the provision of the SC component. As SC facilities are based within the paediatric 
services of state hospitals or LGA-level comprehensive health centres, health workers tasks are 
shared among different paediatric services. SC facilities are open all day, seven days a week, 
compared to OTP facilities which only operate on CMAM days and take over the PHC facility on 
that day. The ORIE HFS found that health workers at SC facilities spent on average three hours 
the previous day on SAM care-related activities (ORIE Health Facility Survey-final report, 2016). 
This equated to 39%24 of their total work time (7.6 hours), with significant proportions of the 
remainder being spent on non-SAM patient care (29%), general admin, cleaning, preparation of 
medicines, supplies and equipment (20%), and work outside the SC facility (12%).  
The health worker–patient ratio is very different for the treatment received at SC facilities 
compared to the treatment received at OTP facilities, and, as befitting the level of care being 
provided, health workers at SC facilities have on average a marginally higher grade and are 
therefore slightly better paid. Whereas at OTP facilities the ORIE HFS found a ratio of 28 patients 
to every health worker, at SC facilities it found a ratio of just over one patient to every health 
worker (ORIE Health Facility Survey-final report, 2016). Based on the sample of health workers 
working at SC facilities during the ORIE HFS, the average hourly salary plus relevant allowances 
of a health worker is £1.75 an hour. This means that the government spends £5.25 to employ an 
average health worker for their three-hour work time per day at a SC facility. With 4.6 health 
workers and 5.9 patients on average at each health facility, according to the ORIE HFS, this 
means that each patient receives £4.09 worth of health worker time per day at a SC facility (ORIE 
Health Facility Survey-final report, 2016). Each child on average stays at the SC facility for eight 
days, according to our sample of Patient Registration Cards, which means that over the course of 
their treatment each child treated receives £32.89 ($51.35) worth of health worker time. 
Facility overheads 
For a complete costing, it is important to include a share of health facility overheads to the direct 
costs of delivering the SC component. In the absence of primary data from the WINNN 
programme, we use standard WHO-CHOICE estimates of health facility overheads. These are 
typically used in costing studies. We estimate that provision of the SC component has overhead 
costs per child treated of £24.04 ($37.54) on average. This is estimated by taking the WHO-
CHOICE estimate of £7.49 ($11.69) in overhead costs per inpatient visit to a rural primary-level 
hospital in Nigeria and adjusting for the fact that WHO-CHOICE estimates already include health 
worker costs. We have already accounted for these, and so we scale the cost to count only 
infrastructure—building rent and utility costs. This is then multiplied by the average number of 
inpatient days per SAM child for the SC facility (eight days) to arrive at the total overhead cost per 
child treated. 
5.2.2 CV costs 
CMAM CVs are both men and women who work at health facilities on CMAM days as well as in 
their catchment communities for the rest of the week.  
                                               
24 This includes SAM patient care (28% of their total work time) and a SAM-attributed share of general activities, such as 
admin, cleaning and preparation of medicines, supplies and equipment (11% of their total work time).  
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At OTP facilities 
Some of the CVs’ duties at the health facility on a CMAM day include counselling mothers on 
feeding practices, ensuring caregivers understand how to use RUTF and assisting health workers 
in attending caregivers. In spending time doing so, they incur costs, such as travel expenses. The 
ORIE HFS found that CVs incur expenses of an average of £0.46 on a CMAM day (ORIE Health 
Facility Survey-final report, 2016). With 153 SAM patients and 13 CVs present on the CMAM day, 
this equates to £0.04 per child per visit. Each child on average makes 6.4 visits per episode of 
SAM, according to our sample of Patient Registration Cards, which means that over the course of 
their treatment CVs spend £0.24 to work on CMAM days per child treated. 
There is also an opportunity cost of the CVs’ time spent working on the CMAM day. On average, 
according to the ORIE HFS, a CMAM CV gives up £1.63 of income to work on a CMAM day (ORIE 
Health Facility Survey-final report, 2016). With 153 SAM patients and 13 CVs present on the 
CMAM day, this equates to £0.13 per child per visit, or £0.86 CV costs per child treated, given that 
a child makes on average 6.4 visits per episode. 
On average, CV costs (expenses and opportunity costs) at OTP facilities are £1.11 ($1.73) 
per child treated.  
At the community  
Activities in CVs’ communities mostly include community mobilisation, screening and tracking of 
defaulters. Again, there are costs to doing this, including the CVs’ expenses and the opportunity 
cost of their time. Using a similar approach to that described above, we estimate that CVs spend 
£0.31 on expenses per child treated and have an opportunity cost of £0.48 per child treated for 
their work in the community, outside of CMAM days. 
On average, CV costs (expenses and opportunity costs) in the community are £0.79 ($1.24) 
per child treated. 
Overall, we estimate a total cost of CV work at both OTP facilities and the community of 
£1.90 ($2.97) per child treated. 
5.2.3 Caregiver costs 
Caregivers (the majority of whom are women) of children with SAM incur costs in accessing 
CMAM services, in terms of their time and expenses spent travelling to and from and waiting at the 
health facilities. Caregivers’ expenses can be directly estimated since they refer to explicit cash 
costs. The opportunity cost of caregivers’ time is intrinsically related to the time caregivers spend 
at facilities—longer travel times and more hours spent at the facility mean caregivers have greater 
opportunity costs. We estimate opportunity costs as forgone income: that is, money given up to be 
at the facility by caregivers who do some income-generating activity.  
OTP 
For treatment received at OTP facilities, caregivers must travel back and forth to the health facility 
every week for the child’s course of treatment. They must also spend time at the facility, being 
seen by the health workers and CVs and waiting to see them. All this involves costs that they 
would not otherwise incur. Using data from the ORIE HFS (ORIE Health Facility Survey--final 
report, 2016), we estimate that caregivers spend on average £0.54 in expenses and £0.19 in the 
opportunity cost of their time for each visit to the OTP facility. With each child making on average 
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6.4 visits per episode, this equates to £3.51 in expenses and £1.22 in opportunity costs per 
episode. Thus, caregivers spend £4.73 ($7.39) per child treated at OTP facilities, on average. 
Table 12:  OTP caregiver expenditure 
Cost item Total 
Caregivers’ expenses per child treated  £3.511/ ($5.48) 
Caregivers’ opportunity costs per child treated £1.221/ ($1.91) 
Caregivers’ total costs per child treated £4.731/ ($7.39) 
OPM calculations using the HFS and Patient Registration Cards 
1/ Using an exchange rate of 1.56, calculated as the average of representative rates for the period 
September 2011 to August 2016 (Source: IMF) 
SC 
At SC facilities, caregivers and other adult companions25 (we estimate 1.4 carers per child for each 
day at the SC facility, on average) stay with the child at the inpatient facility for the duration of their 
stay, which is eight days on average. Caregivers must also, of course, travel with the child to the 
SC facility, which is typically farther away from their home than the OTP facility. All this involves 
costs that they would not otherwise incur.  
We estimate that on average caregivers spend £0.85 in expenses and £1.09 in the opportunity 
cost of their time (and of their adult companions) on each day at the SC facility. With each child 
spending on average eight days per episode, this equates to £6.80 in expenses and £8.77 in 
opportunity costs per episode. Thus, caregivers spend £15.58 ($24.33) per child treated 
through SC facility treatment.  
Caregiver costs for the SC component are higher than for the OTP component since the 
associated level of child care for the SC component is more intense than for the OTP one. This 
affects the resources caregivers incur, in terms of time and expenses. For example, average 
expenses and opportunity costs are relatively higher per one day at SC facilities than per visit to 
OTP facilities, since the time spent on an OTP visit (including travel back and forth to the health 
facility) is around five times shorter26 than a full day of stay at the SC facility. In addition, the course 
of treatment is longer in SC facilities than OTP facilities (8 vs 6.4 days), and at SC facilities, 
caregivers stay with other adult companions at the facility (whose expenses and opportunity costs 
are also accounted for) while at OTP facilities, on average, only one caregiver (with no adult 
companions) goes with her child to a CMAM day. 
                                               
25 Adult companions cover people over 15 years of age.  
26 Using data from the ORIE HFS, we estimate that caregivers spend on average 2.9 hours at the health facility on a 
CMAM day and spend approximately 1.6 hours traveling back and forth to the health facility, totalling an average of 4.5 
hours spent per OTP facility visit.  
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Table 13:  SC caregiver expenditure 
Cost item Total 
Caregivers’ expenses per treated child  £6.801/ ($10.62) 
Caregivers’ opportunity costs per child treated £8.771/ ($13.70) 
Caregivers’ total costs per child treated £15.581/ ($24.33) 
OPM calculations using the HFS and Patient Registration Cards 
1/ Using an exchange rate of 1.56, calculated as the average of representative rates for the period 
September 2011 to August 2016 (Source: IMF) 
5.2.4 Higher-level programme costs 
Higher-level programme costs are those incurred at a ‘higher level’ than the health facility or 
patient: that is, money that funds activities at the national, state and LGA levels that enable the 
effective implementation of the CMAM programme. Two broad groups incur these costs: 1) the 
WINNN programme; and 2) state and LGA government. Broad categories of activities include: 
 training; 
 social mobilisation; 
 M&E; and 
 planning and coordination. 
Table 14 shows how these activities map to different costs incurred by WINNN and the 
government. 
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Table 14:  CMAM programme activities 
 Training 
Social 
mobilisation 
M&E Planning and coordination 
Human 
resources1/ 
WINNN: time 
training state and 
LGA officers 
 
Gov’t: time step-
down training 
health workers 
and CVs 
WINNN: time 
for mobilisation 
of CVs 
 
CVs: non-
reimbursed 
time 
(approximated 
in Section 
5.2.2) 
WINNN: time 
doing M&E for 
programme 
reporting and 
supervision. 
Payment of 
ward focal 
supervisors 
and 
independent 
monitors 
 
Gov’t: time 
doing M&E for 
government 
reporting and 
supervision 
WINNN: time for CMAM 
coordination meetings at 
federal, state and LGA levels 
 
Gov’t: time for CMAM 
coordination meetings at 
federal, state and LGA levels 
 
Materials, 
allowances 
and meeting 
expenses2/ 
WINNN: 
Materials, per 
diems, travel 
allowances, 
venue hire for 
training of health 
workers, state 
and LGA officers 
WINNN: 
Materials, per 
diems for 
trainings or 
meetings, 
travel 
allowances, 
venue hire for 
mobilisation of 
CVs 
WINNN: 
Materials, per 
diems, travel 
allowances, 
venue hire for 
programme 
reporting and 
supervision 
WINNN: Materials, per diems, 
travel allowances, venue hire 
for CMAM coordination 
meetings at federal, state and 
LGA levels 
Equipment 
WINNN: vehicles and other equipment (anthropometric scales, computers, phones, 
furniture, generator) 
Operations 
and 
maintenance 
WINNN: rent, transport (fuel, maintenance), utilities (electricity, gas, water), 
communications, other operating expenses 
1/ WINNN expenditure on human resources include payments to staff and non-staff (e.g. technical assistance, 
stipends for health workers excluding stipends for training).  
2/ This category corresponds to the sum of the following WINNN cost categories presented in Table 1: 
training expenses, M&E expenses, and goods and services. 
WINNN programme 
Table 15 shows WINNN CMAM programme expenditure over the first five years of the programme. 
This money funds WINNN activities at the national, state and LGA levels that enable the effective 
implementation of the CMAM programme. Therefore, RUTF and other medicines are excluded 
from this cost centre and included in the health facility level cost centre (Section 5.2.1). Money 
spent on the CMAM programme at the national level is allocated proportionally across the states.  
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Table 15:  WINNN CMAM programme expenditure, 2011/12 to 2014/16 
Cost item Sources Total (million) % 
Human resources 
WINNN expenditure 
data 
£3.4 ($5.3) 55% 
Materials, allowances and meeting 
expenses  
WINNN expenditure 
data 
£1.9 ($2.9) 30% 
Equipment 
WINNN expenditure 
data 
£0.5 ($0.8) 8% 
Operations and maintenance 
WINNN expenditure 
data 
£0.4 ($0.6) 6% 
Total WINNN expenditure on the 
CMAM programme 
WINNN expenditure 
data 
£6.2 ($9.6) 100% 
Number of children treated (unique 
CMAM programme beneficiaries) 
WINNN monitoring data 225,743 
Average WINNN CMAM programme 
cost per child treated 
ORIE calculation £27.2 ($42.5) 
Estimates in GBP were calculated using an exchange rate of 1.56 (average of representative rates 
for the period September 2011 to August 2016, source: IMF) 
 
Human resources is the largest cost item across all the states, comprising 55% of WINNN CMAM 
programme expenditure overall (note that this excludes RUTF and other medicines, which are 
captured in Section 5.2.1). Altogether, £3.4 million worth of WINNN personnel time at central, state 
and LGA levels was spent across the first five years of the programme in designing and 
implementing the CMAM intervention. Expenditure on materials and meeting expenses (for 
training, social mobilisation, M&E and planning and coordination) is the next largest cost, 
comprising 30% of WINNN CMAM programme expenditure overall. Altogether, £1.9 million was 
spent in Years 1–5.  
WINNN is not a very capital-intensive programme. Altogether, 8% (£0.5 million) of WINNN 
programme expenditure was on capital cost items, such as vehicles, medical equipment and other 
equipment. These capital costs have been annualised across the average lifespan for the 
associated category. Operations and maintenance costs of £0.4 million, or 6%, represent general 
WINNN overhead costs allocated to the CMAM programme.  
We calculate a WINNN CMAM programme expenditure cost of £27.23 per child treated, which 
is calculated by dividing WINNN programme expenditure on the CMAM programme of £6.2 million 
by the number of unique CMAM beneficiaries across Year 1 to Year 5: 225,743.  
State and LGA 
Expenditure by the WINNN states and LGAs that enable the effective implementation of the CMAM 
programme includes time spent by SNOs, LNOs and other state-/LGA-paid staff on training, 
supportive supervision, M&E, programme reporting and planning of CMAM activities both at OTP 
and SC facilities. Note that contributions from states and LGAs for the procurement and distribution 
of medicines used in the treatment received at CMAM facilities are accounted for in the cost items 
above (Section 5.2.1). 
We estimate an average state/LGA human resources cost per child treated of £3.11 ($4.86) at 
OTP facilities and £0.62 ($0.97) at SC facilities. These costs are estimated using the following 
information: 
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 We collected information on grade levels and time allocated to WINNN CMAM activities of 
state- and LGA-level staff in Jigawa, Katsina, Kebbi and Zamfara. The average state-level staff 
member spends 44 hours a month on CMAM activities, while the average LGA-level staff 
member spends 61 hours. This is double the time state-/LGA-level staff reported spending on 
WINNN IYCF activities (Section 4.2.4).  
 Nigeria has a consolidated health salary structure that specifies the range for the basic salary 
at each grade and also the various allowances to which a health worker may be entitled. Given 
that the salaries of state-/LGA-level staff were not provided, the health salary structure 
collected for each state was used. Based on this and the grade levels of the state-/LGA-level 
staff working on the CMAM programme, we estimate the hourly salary of an average state-level 
staff member is £3.56 an hour, and that of an average LGA-level staff member is £2.77 an 
hour. This means it costs the government £156 a month to employ an average state-level staff 
member for 44 hours of work on CMAM activities (at both OTP and SC facilities), and £170 a 
month to employ an average LGA-level staff for 61 hours. 
 With an average of 3.3 staff per state and 5 per LGA, the government spends on personnel 
costs a monthly average of £3,047 per WINNN state (assuming three LGAs per state). Using 
the shares of OTP and SC facilities in the four states in which we collected state-/LGA-level 
data27, we estimate monthly personnel costs per WINNN state of £2,552 for activities 
concerning OTP care, and £495 for SC activities. 
 Over the course of the first five years of the programme we estimate, according to the WINNN 
monitoring data, a monthly average of 817 unique CMAM beneficiaries. This means the 
government spent £3.11 ($4.86) worth of state-/LGA-level personnel time per child treated at 
OTP facilities, and £0.62 ($0.97) worth of state/LGA-level personnel time per child treated at 
SC facilities.  
Table 16:  State and LGA human resources expenditure on the CMAM programme  
Cost item Total 
State and LGA human resources cost per child treated at OTP facilities £3.111/ ($4.86) 
State and LGA human resources cost per child treated at SC facilities £0.621/ ($0.97) 
Note: OPM calculation based on higher-level data collection in Jigawa, Katsina, Kebbi and 
Zamfara. SNOs and LNOs reported grade levels and time allocation to WINNN activities of their 
state-/LGA-level personnel. Data on health workers’ salary structures were also collected at each 
state. WINNN monitoring data were used for the number of CMAM programme beneficiaries. 
1/ Using an exchange rate of 1.56, calculated as the average of representative rates for the period 
September 2011 to August 2016 (Source: IMF) 
5.2.5 Overall 
Table 17 and Figure 11 bring together the estimates of the cost per child treated of various CMAM 
cost centres at the OTP and the SC facilities, and also show the cost per child treated through the 
CMAM programme overall. This table also shows the percentage composition of the cost per child 
treated for the various higher-level, health facility, and society cost items. 
The cost per child treated through the CMAM programme overall is calculated as follows: SAM 
cases without complications are treated at OTP facilities only. In the absence of data from the 
WINNN programme, we assume that this applies to 85% of cases. Evidence from other 
programmes suggests that, typically, 15% of SAM cases need inpatient care (i.e. the children have 
complications or are under six months).28 Once stabilised, these cases are then referred back to 
                                               
27 Of all WINNN facilities in Jigawa, Katsina, Kebbi and Zamfara, 16% are SC facilities and 84% are OTP facilities.   
28 fhi360 (2012) CMAM Costing Tool. Version 1.1. 
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OTP facilities to complete their treatment. The cost per child treated overall is therefore calculated 
using the following formula:   
Cost per child treated overall = 85% * cost per child treated at OTP facility + 15% * (cost per 
child treated at SC + cost per child treated at OTP facility) 
Table 17:  CMAM programme cost per child treated by type of service and cost centre 
  OTP SC CMAM programme overall 
Cost centre GBP1/ % GBP1/ % GBP1/ USD % 
Higher-level costs 26.8 39% 24.3 24% 30.4 47.5 36% 
WINNN programme 23.7 35% 23.7 23% 27.2 42.5 33% 
Human resources 13.1 19% 13.1 13% 15.0 23.5 18% 
Materials, allowances and 
meeting expenses  
7.2 11% 7.2 7% 8.3 13.0 10% 
Operations and maintenance 1.5 2% 1.5 1% 1.7 2.7 2% 
Equipment 1.9 3% 1.9 2% 2.2 3.4 3% 
State and LGA 3.1 5% 0.6 1% 3.2 5.0 4% 
Health facility-level costs 35.1 51% 61.8 61% 44.3 69.2 53% 
RUTF and F75/F100 28.6 42% 4.5 4% 29.2 45.6 35% 
RUTF 28.6 42% 1.4 1% 28.8 44.9 34% 
F75/F100 therapeutic milks - 0% 3.1 3% 0.5 0.7 1% 
Other medicines 0.5 1% 0.4 0% 0.6 0.9 1% 
Health worker time 2.8 4% 32.9 32% 7.7 12.1 9% 
Facility overheads 3.1 5% 24.0 24% 6.8 10.5 8% 
CV costs 1.9 3% - - 1.9 3.0 2% 
Expenses 0.6 1% - - 0.6 0.9 1% 
Opportunity cost 1.3 2% - - 1.3 2.1 2% 
Caregiver costs 4.7 7% 15.6 15% 7.1 11.0 8% 
Expenses 3.5 5% 6.8 7% 4.5 7.1 5% 
Opportunity cost 1.2 2% 8.8 9% 2.5 4.0 3% 
Total: Health services perspective 61.8 90% 86.1 85% 74.8 116.7 89% 
Total: Societal perspective 68.5 100% 101.7 100% 83.7 130.7 100% 
1/ Using an exchange rate of 1.56, calculated as the average of representative rates for the period 
September 2011 to August 2016 (Source: IMF) 
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Figure 11:  CMAM programme cost per child treated by type of service and cost centre 
 
5.3 CMAM programme costs – summary findings 
The main cost drivers of the CMAM programme are RUTF and WINNN higher-level 
programme costs. Our estimates show that they constitute 34% and 33%, respectively, of the 
overall the CMAM programme costs per child treated. In the case of the OTP component, RUTF 
and WINNN higher-level programme also constitute the largest elements (42% and 35%, 
respectively) of programme costs per child. For the SC component, the figure is quite different, 
given that the level of care provided is more intense, in terms of human resources and 
infrastructure. In this case, the costs incurred by the government in health worker inputs and facility 
overheads constitute the largest elements, at 56% of the costs of the SC component per child, 
followed by WINNN higher-level programme costs, at 23%.  
The CMAM programme is not very capital-intensive. Our estimates show that 2.6% of the 
overall cost per child treated relates to capital expenditure. However, further investments in health 
facility and supply chain infrastructure would need to be considered more holistically for future 
implementation and sustainability, as evidenced by the current limitations of some facilities lacking 
enough supplies to provide the full set of CMAM services (ORIE Health Facility Survey-final report, 
2016).  
The cost per child treated is found to be higher for the SC component than for the OTP 
component, at £86 ($134), versus £62 ($97), respectively, from a health services 
perspective. Again, this is not surprising, given the original motivation for the introduction of the 
CMAM programme—to treat children with SAM earlier, and to prevent as many of the 
complications (and associated costs) of later treatment in an inpatient facility. Also, the human 
resource model at SC facilities is very different to that at OTP facilities. SC facilities usually operate 
seven days a week, with relatively more qualified staff, given the level of care required, which also 
has implications in terms of costs.  
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Introducing the societal costs of CVs and caregivers increases the cost burden of CMAM 
care per child treated, and not by a negligible amount. The societal perspective also considers 
the costs incurred by health service users, such as caregivers, and other members of the society 
implementing the programme, such as CVs, even if they are not fully financially compensated. We 
estimate that CVs incur costs per child treated, in terms of their time and expenses, of £1.90, and 
caregivers incur costs of £4.73 at the OTP facilities and £15.58 at the SC facilities. These costs 
combined constitute 11% of the overall CMAM programme cost per child treated from a societal 
perspective. These may be smaller relative to other costs from an overall perspective, but they 
represent a large burden for the CVs and caregivers themselves, and thus a scale-up model 
should evaluate whether some compensation should be offered.  
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6 Conclusions and discussion  
An investment of £33.6 ($52.3) million over five years in five states in northern Nigeria 
represents a significant contribution to funding three nutrition-specific interventions in those 
states, and, moreover, to more generally supporting effective government planning and 
coordination for nutrition. However, this level of investment still represents a financial gap when 
compared to the NSPAN (2014–2019) or, more ambitiously, the Scaling Up Nutrition full coverage 
targets.2930 
WINNN is a people-intensive programme. 33% of overall WINNN expenditure is on human 
resources. This is understandable given the objective of the WINNN programme and the nature of 
its activities. However, the scale of expenditure by a donor-funded programme on human 
resources to support the delivery of these nutrition-specific interventions does call into question 
how far government can take over this commitment, even if some of the expenditure is the initial 
investment and/or is complementary to government expenditure. 
The CMAM programme output has the largest expenditure share of the WINNN programme. 
41% of WINNN programme expenditure between Year 1 to Year 5 was on the CMAM programme. 
Moreover, the cost per child estimates from a societal perspective indicate that other actors, 
including the government, CVs and caregivers, are also incurring a significant cost to deliver and 
access the CMAM programme. Of course, the costs are just one side of the story—the Cost-
effectivess of the WINNN programme report, 2017 combines these cost estimates with effect data 
to understand whether this investment is justified, given the improvements in mortality likely to be 
achieved, compared to the alternative of existing health services for children with SAM with no 
CMAM programme. 
WINNN higher-level programme costs constitute a significant component of the cost per 
beneficiary of the IYCF and the CMAM interventions. These costs continue to be large even 
though WINNN has a delivery model which is integrated into existing health systems. There 
are possible programmatic and methodological reasons for these findings. Programmatic reasons 
include the relatively high salaries of WINNN personnel, and capacity building for the CMAM and 
the IYCF interventions being personnel intensive. WINNN has trialled supporting an integrated 
programme, which by design always envisaged some trial and error and parallel systems with 
government. However, as evidenced by the still large WINNN higher-level costs per beneficiary, 
not as much has been handed over to the government during the programme as was originally 
envisaged. Methodological reasons for WINNN’s large costs include our method for allocating 
WINNN personnel and other shared costs to WINNN outputs. Although this is a standard 
approach, this method will be less precise than directly coded costs (i.e. if WINNN staff kept 
timesheets by output). It is also difficult methodologically to draw the line between which WINNN 
support costs are necessary for the successful implementation of the current IYCF and CMAM 
interventions and which are more related to future implementation. Although the purpose of this 
report is not to suggest the cost model for the government taking over these interventions, these 
findings do raise questions as to how government would take over the WINNN programme costs. 
Some of these costs will likely be initial investment, complementary to the government 
expenditure, or will be reduced, given the less expensive salary structure of government human 
resources.  
The RUTF cost estimate of £29 ($45) per child treated is not surprising given it is a high 
cost input with a price that is set in the international marketplace, and UNICEF is playing a 
                                               
29 Federal Republic of Nigeria (2014) ‘National Strategic Plan of Action for Nutrition’.  
30 World Bank (2014) ‘Costed Plan for Scaling Up Nutrition: Nigeria’. 
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significant role in its procurement, both for Nigeria and internationally. There are no real 
economies of scale for this cost item, other than perhaps slight improvements in purchasing power 
for a larger order or in transportation costs. However, future reductions in the unit price of RUTF 
are expected to be crucial to determine sustainability for scaling up and the possibility of the 
government taking over this cost. For example, even over the course of the WINNN programme 
the unit cost of procurement of RUTF (excluding distribution, storage and transportations costs) 
declined from £35 per carton in Year 1 to £30 in Year 4, and £32 in Year 5.  
The IYCF interventions comes at a much lower cost per beneficiary than the CMAM 
programme. We estimate a cost per child treated through the CMAM programme of £84 ($131) 
from a societal perspective and a cost per mother reached through the f-IYCF component of £10 
($16), and through the c-IYCF component of £12 ($19). Again, costs are just one side of the 
story—the cost-effectiveness analyses of these two interventions will be important in order to 
understand more fully how resources should be prioritised for health gain. 
6.1 How our efficiency measurements compare to other studies  
There is a lack of existing estimates in the global literature, and in particular for Nigeria, of 
the cost per mother reached of other IYCF interventions that are similar to the IYCF 
interventions of the WINNN programme, making comparisons difficult. Our focused literature 
search identified two costing studies of breastfeeding promotion programmes piloted in Uganda 
(Chola et al., 2011) and South Africa (Nkonki et al., 2014) using an intense peer support model. 
These interventions were much more expensive, at a cost per mother counselled of $139 in 
Uganda and $228 in South Africa. However, these are not directly comparable to the WINNN-
supported IYCF interventions, which uses a different human resource structure and support model, 
and includes more than just breastfeeding promotion. In addition, NSPAN (2014–2019) uses a cost 
for community nutrition programmes for behaviour change communication of $5 per child. The 
source of this estimate is not clear, but it appears to be based on a study in 1999 related to a 
community nutrition programme in Asia (Mason et al., 1999). There are many methodological 
differences in the approach used in Mason et al. (1999), compared to ours. First, our cost of the 
IYCF interventions estimation is per mother reached, not per child. A conservative assumption of 
two children under two per mother reached would give an estimate of $10 per mother reached, 
which is not too different from our estimates. Second, Mason et al. (1999) consider a support 
structure of one volunteer per 20 families, which is different to the WINNN-supported IYCF 
interventions, which aims to have five CVs per support group, with a maximum of 20 participants31, 
i.e. equivalent to one CV per four participants. Third, although the methodology used in Mason et 
al. (1999) is not very clear it seems to be based on an estimation of the required investment over a 
10-year period to bring about a substantial impact in regard to the prevalence of malnutrition for 
the countries under study32. This is very different to our methodology, which calculates the average 
cost per beneficiary of an intervention implemented over five years. Lastly, the context of Asian 
countries in 1999 considered in that study is very different to the current context in northern 
Nigeria.  
Our estimate of CMAM programme cost per child is broadly similar to another recent 
societal estimate from northern Nigeria, and to other estimates of cost per child in similar 
contexts and settings. Variations in programme costs arise from different costing 
perspective used (health services vs. societal), assumptions regarding the coverage and 
                                               
31 The WINNN IYCF behaviour change communication strategy establishes a maximum of 20 participants at each 
support group session (WINNN, 2015). 
32 Mason et al. (1999) cost calculations were estimated for eight Asian countries: Bangladesh, India, Cambodia, Vietnam, 
Pakistan, Sri Lanka, Philippines, and the People’s Republic of China.   
© ORIE 
 5
4  
scale of the programme, and the human resource model of service delivery. Frankel, S., 
Roland, M. and M. Makinen (2015), in costing the CMAM programme supported by UNICEF 
through CIFF funding, estimate an overall societal cost per child treated of $123, which is slightly 
lower than our overall estimate of $131. Bachmann (2009), which is the study used in the DFID 
Business Case (2011), estimates an overall cost per child cured of $203 in Zambia from a health 
services perspective. The five-year (2014–2019) strategic plan for nutrition in Nigeria, NSPAN, 
estimates a much lower cost per child, at $80. The lower cost might be explained by the different 
methodology used,33 which might not accurately reflect actual programmatic experience under 
WINNN and which does not include the full societal costs incurred by beneficiaries accessing the 
services. Also, that estimate assumes coverage of 35% of the target population (children 6–59 
months of age), which might be different to those reached in WINNN-supported LGAs, given that 
the WINNN-supported CMAM programme was piloted in a limited number of facilities in each focal 
LGA and the supply of RUTF was also limited. Interestingly, despite the differences in 
methodologies, the comparison with other CMAM programme cost estimates also show 
that RUTF and higher-level programme costs comprising the largest shares of the overall 
cost is a consistent finding across studies with different settings and delivery models.  
                                               
33 NSPAN 2014–2019 costing employed the ‘program experience’ methodology. This approach generates unit cost data 
that capture all aspects of service delivery, such as costs of commodities, transportation and storage, personnel, training, 
supervision, M&E, relevant overhead, wastage etc., for each intervention from actual programmes that are in operation in 
Nigeria, and considers the context in which they are delivered. Whenever possible, the unit costs of the nutrition-specific 
interventions in NSPAN were estimated using programmatic data that were provided by local IPs, the Federal Ministry of 
Health, and state governments based on programme experience. In cases where the intervention was not yet being 
implemented or local data were not available, global unit cost estimates from the World Bank were used (NSPAN, 2014). 
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Annex A Inception report 
A.1 Volume I (excerpts) 
A.1.1 Economic evaluation 
A.1.1.1 Rationale and objectives of the economic evaluation workstream 
The World Bank estimates that malnutrition is costing poor countries up to 3% of their yearly GDP. 
Moreover, malnourished children are at risk of losing more than 10% of their lifetime earnings 
potential. In resource-constrained health systems, the prioritisation of resource allocation across 
competing interventions requires evidence not only on effectiveness but also on cost-effectiveness. 
Such analysis is vital to the efficient allocation of resources to maximise health gains.  
The objectives of the economic study include: 
a) To estimate the direct and indirect costs and health-related outcomes associated with 
implementation of CMAM and IYCF interventions in northern Nigeria (WINNN Outputs 1 
and 2); 
b) To evaluate the cost-effectiveness of CMAM and IYCF interventions compared to routine 
care; and 
c) To evaluate the direct provider-related costs associated with WINNN outputs 3 and 4. 
A.1.1.2 Approach and methods 
We propose to conduct separate economic evaluations of each WINNN programme output, 
primarily because the outputs have different objectives, target health conditions, health outcomes 
and population groups. A full economic evaluation of the CMAM programme will be based on the 
cost-utility approach. The cost-utility approach uses a generic outcome, in this case the DALY that 
allows comparison of cost-effectiveness across programmes. Primary studies will be conducted to 
evaluate programme effectiveness, service delivery costs, health service utilisation costs and 
household costs. Based on this, a decision tree model (or an alternative Markov model) will be 
developed to evaluate patient treatment pathways (from identification of malnutrition to treatment 
to health outcomes) using costs and outcomes in CMAM and non-CMAM care to estimate the 
incremental cost per DALY averted. 
The economic evaluation of the IYCF interventions will compare programme delivery costs and 
health services costs against health outcomes that are directly influenced by the IYCF 
interventions. Based on primary data from the impact evaluation survey in intervention and control 
areas, the CEA will estimate the cost per unit of effectiveness outcomes such as the proportion of 
infants aged 0–6 months who are EBF and the proportion of children aged 6–23 months receiving 
foods from four or more groups (and if feasible, cost per DALY averted). Programme-related costs 
will be obtained in a primary costing exercise. 
The economic evaluation of outputs 3 and 4 will be take the form of a programme-based cost 
analysis, as no direct outcome data will be collected/available for these outputs. These costing 
studies are important for understanding the budgetary and economic implications of the 
programmes for health services and the funder.  
A.1.1.3 Key deliverables 
CMAM programme and IYCF interventions:  
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 results of the primary data analysis for costs and outcomes of the CMAM programme;  
 a fully functional economic model and cost per DALY analysis; and 
 a detailed report outlining and explaining findings. 
Outputs 3 and 4:  
 analysis of programme-related costs; and 
 a detailed report outlining and explaining findings. 
A.1.1.4 Key activities by year 
 2012: Key decision-making on primary data collection and the approach to analyses. 
 2013: Planning and organisation of primary data collection activities for all four outputs (first 
half of 2013); data collection initiated during second half of the year. 
 2014: Primary data collection of economic data completed by the end of 2014; report on 
findings. Structure of the economic models completed in 2014. 
 2016: Data from the impact evaluation exercise will be available. Analysis of primary economic 
data for all outputs will be conducted. Economic models and cost analysis will be completed. 
Report writing and dissemination. 
A.2 Volume II (excerpts) 
A.2.1 ORIE economic evaluation 
A.2.1.1 Introduction 
Childhood malnutrition remains an important public health and development problem in low- and 
middle-income countries, especially in sub-Saharan Africa. The World Bank estimates that 
malnutrition is costing poor countries up to 3% of their yearly GDP. Moreover, malnourished 
children are at risk of losing more than 10% of their lifetime earnings potential (Bachmann, 
2009). This can have a devastating economic impact on households. Caulfield et al. (2004) 
conducted a pooled analysis using 10 studies to estimate that 53% of child mortality is attributable 
to being underweight. Causes of death in malnourished children ranged from 44.8% for deaths due 
to measles to 60.7% for deaths attributable to dehydration as a result of diarrhoea. 
Prevalence of malnutrition in Nigeria has been found to be consistently high in most national and 
international studies. The Nigeria demographic and health survey 2008 suggests that 26.7% of 
children under five are moderately or severely underweight; of these, 12.7% were found to be 
severely underweight. More important, compared to previous surveys, the prevalence of 
malnutrition has not improved (27.3% in 1999 and 27.2% in 2003). Therefore, tackling malnutrition 
is one of the public health priorities for Nigeria. 
DFID Nigeria is rolling out an ambitious £50 million, six-year programme to improve maternal, 
newborn and child nutrition which will reach 6.2 million under-fives in five states of northern 
Nigeria. The programme has five outputs that are listed below: 
 Output 1: treatment of SAM via CMAM interventions through integrated services in primary 
health facilities; 
 Output 2: community-based interventions to improve IYCF practices through EBF, weaning 
and complementary feeding; 
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 Output 3: the integration of micronutrient interventions and deworming into routine primary 
health services (Vitamin A supplementation for children, iron and folic acid for pregnant 
women); 
 Output 4: more effective government planning and coordination in nutrition and related sectors 
at the national and state levels, and a stronger health system, through the integration of 
direct nutrition interventions into routine health services funded by the government; 
 Output 5: improved knowledge of what works to tackle child undernutrition in northern Nigeria 
via ORIE, which will be conducted by independent researchers and evaluation experts (output 
5). 
The economic evaluation workstream will concentrate primarily on outputs 1 and 2 for full 
economic evaluation, i.e. the CMAM programme and the IYCF interventions under the WINN 
programme. However, we will also discuss the scope of conducting costing studies (not full 
economic evaluations) for workstreams 3 and 4, i.e. the institutional implementation cost of the 
integration of micronutrient interventions and deworming (workstream 3) and integration of direct 
nutrition interventions into routine health services (workstream 4). 
A.2.1.2 Economic evaluation of CMAM programme/IYCF interventions: rationale and 
approaches 
In resource-constrained health systems across the world, and in particular in developing countries, 
the prioritisation of healthcare resource allocation across competing interventions requires 
evidence not only on effectiveness but also on cost-effectiveness. The CEA involves evaluating the 
impact of interventions on both costs and health outcomes. Such analysis is vital to the efficient 
allocation of resources to maximise health gains. 
There are primarily three potential approaches to full economic evaluation that can be used for the 
evaluation of the CMAM programme and the IYCF interventions (we have ignored cost–benefit 
analysis and cost-minimisation analysis as they are not relevant to the context of evaluation of the 
CMAM programme/IYCF interventions). These are CEA, cost-utility analysis and cost-
consequence analysis. The three approaches differ in terms of how the outcome is measured 
against the costs. All three approaches are described below and their usefulness in the context of 
the current study is discussed. 
A.2.1.3 Approaches to economic evaluation 
Cost-effectiveness approach 
In a CEA, the outcome is programme-specific, such as the reduction in blood pressure (Logan, 
1981), number of positive cases detected (Hull et al., 1981), change in asthma episode days 
(Sculpher et al., 1994) and gain in life years (Mark et al., 1995). In the particular case of the CMAM 
programme, such outcomes may be related to indicators of nutritional status such as 
anthropometric indicators based on body size and composition. In the case of the IYCF 
interventions, the relevant indicators may be the proportion of infants aged 0–6 months who are 
EBF and/or proportion of children aged 6–23 months receiving foods from four or more food 
groups. The CEA will produce estimates of VfM in terms of cost per unit of outcome measure. 
CEA is an incremental analysis, i.e. it evaluates the difference in costs and difference in outcomes 
between the interventions being evaluated. The resulting ICER of the CMAM programme/IYCF 
interventions will reveal the optimal alternative (compared to the control intervention), which may 
be: i) same cost but more effective than the alternative; ii) less expensive and at least as effective 
as the alternative; or iii) more expensive while providing additional benefit that is worth the cost. 
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This last scenario is the most common likely outcome of CEA. The incremental cost per unit of 
outcome is then evaluated against the willingness to pay for gain in one unit of the outcome. 
CEA can be useful when the decision-maker is interested in comparing alternatives within a 
particular field, for instance the CMAM programme against other interventions targeting 
malnutrition. However, the government or international funding organisations (i.e. a decision-maker 
with a broad health sector mandate) with priorities across all health conditions need to use 
outcome measures that are directly comparable across several health conditions to evaluate the 
maximum VfM in terms of health gain. As a result, generic measures of health, such as DALYs or 
quality-adjusted life years (QALYs) are frequently employed.  
On the other hand, CEA’s outcome (such as reduced incidence of malnutrition) can be easier to 
understand and communicate, especially when the focus of health gain is restricted to malnutrition. 
Moreover, the CEA approach is also useful in situations when converting specific outcomes to 
generic outcomes is not straightforward. This is likely to be the case when evaluating interventions 
that aim to promote breastfeeding and weaning (such as the case in the IYCF interventions). 
However, as we will discuss in the literature review section, only a limited number of economic 
studies have achieved this using modelling approaches. 
Cost-utility approach  
The cost-utility analysis is the most common method of economic evaluation in the literature. It 
uses a generic measure of health outcome that can be compared across programmes. The most 
commonly used outcome measure in the economic literature related to developing countries is the 
DALY. An alternative to DALYs is the QALY outcome, which values health outcomes based on 
public preferences. QALYs have been more commonly used in the literature related to developed 
countries, where country-specific value weights (or utility weights) are available for specific 
population groups. Both outcomes combine survival and health-related quality of life. We will 
discuss the DALY in detail below as it relates directly to the evaluation of CMAM programmes in 
the literature. 
The DALY is primarily a measure of disease burden and has been used frequently in economic 
evaluations. DALY incorporates an age-weighting function assigning different weights to life years 
lived at difference ages. The calculation of DALYs is relatively simple as constant disability is often 
assumed. The formula to calculate DALYs averted is (Cairncross et al., 2003): 
DALYs averted= no. of deaths averted * YLL + no. of cases of illness averted * YLD 
YLL = years of life lost due to premature mortality 
YLD = year of life spent with disability 
As discussed above, the advantage of using a generic measure like DALYs is that a decision-
maker with a broad health sector mandate can compare VfM across several health programmes. 
For instance, Wilford et al. (2012) compared the cost per DALY averted of the CMAM programme 
in Malawi against other interventions such as the iron fortification programme in Malawi, with a cost 
per DALY of $66–70/DALY compared to the treatment of SAM with A cost per DALY of $41/DALY. 
Such an analysis puts the value of the intervention into perspective and allows decision-makers to 
prioritise healthcare financing. 
It should be noted that the two terms ‘cost-effectiveness’ and ‘cost-utility’ are often used 
interchangeably in the literature. This is because cost-utility analysis can be understood as a 
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specific type of CEA where the outcome of interest is a generic measure. Cost-
consequence analysis 
While it is common practice in the health economics literature to take the cost-effectiveness or 
cost-utility approach based on short- or long-term outcomes (Briggs et al., 2006; Drummond et al., 
2005), these approaches rely on translating the process or intermediate outcomes into a common 
outcome denominator, such as DALYs or QALYs. However, for interventions that have a diverse 
range of short-term outcome measures, a cost-consequence analysis is also appropriate. This 
approach is defined as an analysis ‘in which costs and effects are calculated but not aggregated 
into quality-adjusted life-years or cost-effectiveness ratios’ (Russell et al., 1996). This method is 
used to display all the key costs and consequences associated with the intervention for the 
purpose of comparison; the consequences are expressed in the most appropriate natural units for 
each outcome measure. This approach is particularly relevant when a wide range of 
multidimensional process outcomes are of interest for a particular intervention (Godber, Robinson 
and Steiner, 1997). The information presented in this format is understandable and usable for non-
health economists (Mauskopf et al., 1998), and it also overcomes the need for complex economic 
modelling to estimate the long-term effects expressed in terms of a single common outcome. This 
approach has been used in many studies in recent years (e.g. Burger, 2010; Ritchie et al., 2005; 
Bergmo, 2009; Barnett et al., 2009). 
However, the primary limitation of this approach is that it does not produce cost-effectiveness 
estimates in terms of cost per unit of outcome. Moreover, there is no generic measure of outcome 
to allow comparison across several conditions. Hence, cost-consequence analysis has limited 
application to situations where a single index cannot be used or is not meaningful. 
Costing study 
A costing study evaluates the costs associated with the delivery of an intervention; hence, a 
costing study should consider all relevant costs, depending on the perspective of the cost analysis 
(perspective is discussed in detail later). A costing study is a form of partial economic evaluation 
because only the costs are examined without reference to outcomes. However, this does not imply 
that a costing study is unimportant, as such studies are crucial for examining the budgetary 
implications of health services (Drummond, 2005) and represent an important stage in our 
understanding of the economic consequences of the workstreams for the health services and the 
funding bodies. Moreover, a costing study represents an important intermediate stage for future 
CEAs. 
Costing studies may use either a top-down or bottom-up data registration approach, and may be 
prospective or retrospective in relation to time. Cost-related data for costing studies may be 
obtained from accounting systems, budgets (allocated or spent), billing histories, accounting and 
statistical reports and other information systems. 
A.2.1.4 Perspective of the economic evaluation 
The perspective of an evaluation is important to the decision-maker, in order to determine to whom 
the costs incur. This matters because an intervention might be cost-effective from one point of view 
(e.g. a societal one) but not from another (e.g. a health care provider view). Hence, stating the 
perspective adopted is therefore an essential task for researchers and is consistently 
recommended in guidelines for economic evaluations. The two commonly used perspectives in 
economic evaluations are the health services perspective and the societal perspective. The former 
evaluates only the costs incurred by health service providers and associated organisations directly 
or indirectly engaged in providing care, such as the IPs in the case of the CMAM programme and 
the IYCF interventions. However, the societal perspective also includes costs incurred by health 
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service users (i.e. patients and carers) and other members of society who may be directly or 
indirectly affected by the intervention (or no intervention). 
In the case of developing countries, the perspective of an economic evaluation can be crucial. This 
is because the costs (direct and indirect) incurred by patients and their family members can be 
significant compared to the actual health-related costs incurred by the health care systems. For 
example, out-of-pocket payments for medication, food, transportation and informal payments can 
amount to significant sums. Moreover, the opportunity cost of visiting health facilities can be huge 
due to wage loss. If such matters are taken into account, these costs can potentially make up a 
significant amount of the total societal cost of interventions. 
There is no consensus on which perspective should be used in an economic evaluation. In 
developing countries, there are no guidelines for such evaluations. Some reimbursement agencies 
in more developed countries, such as England and Wales’ National Institute of Clinical Excellence, 
recommend that cost should be adapted from the National Health Service and Personal Social 
Services perspective. The National Health Service perspective determines the mix of interventions 
that would maximise health outcomes within the limited health care budget. 
The advantage of using the societal perspective in economic evaluation is that it provides an 
estimate of the value of the societal return of health services investments. However, estimating 
societal costs may be time-consuming and resource-intensive and is therefore not always included 
in economic analyses. Moreover, in some cases the decision-maker is not interested in the 
opportunity cost and out-of-pocket expenditures of the beneficiaries of health services.   
Below we present a summary of cost elements that are included or excluded based on the 
perspectives of economic evaluation. 
Table 18: Inclusion and exclusion of costs by perspectives  
Cost elements 
Perspectives 
Societal 
Public 
purchaser 
Private 
purchaser 
Provider 
Health service costs All 
Covered 
expenses 
Covered 
expenses 
Expenses of 
provided 
services 
Productivity costs Included Excluded Excluded None 
Informal carers Included Excluded Excluded Excluded 
Transportation All If any paid If any paid Excluded 
Other non-health service 
costs 
All If any paid If any paid Excluded 
Source: Luce (1996) 
A.2.1.5 Focused review of economic evaluations of nutrition interventions 
We undertook a focused literature review to identify previous economic evaluations in CMAM and 
IYCF programmes to review the evaluation approaches used in the economic analyses, outcomes 
evaluated, data sources used and types of costs considered. The literature search was targeted to 
assist with the current study and was not intended to be a systematic review.  
We identified three relevant studies that reported full economic evaluations of interventions aimed 
at reducing severe malnutrition in children. One of these studies was an evaluation of the CMAM 
programme in Malawi (Wilford et al., 2011). We did not find any economic studies that evaluated 
the cost-effectiveness/cost-utility of any IYCF programmes. However, we found a health 
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technology assessment report that evaluated the economic impact of interventions promoting 
breastfeeding. We will summarise all four studies below. Lessons drawn from these studies have 
been used directly to inform the design methodology proposed in this document. 
Wilford et al. (2011) 
Wilford et al. (2011) evaluated the cost effectiveness of a CMAM programme among children 
under five in Dowa district, Malawi. 
A decision tree model was used to evaluate the cost-effectiveness of CMAM integrated into 
existing health services compared with the status quo (existing health services without CMAM) in 
Dowa district. Hence, the first two branches of the decision tree represented areas where CMAM 
was implemented against non-programme areas. Each malnourished child may be treated by the 
CMAM programme or the alternative programme or may go untreated. Each scenario was further 
divided into additional decision nodes, i.e. children in the CMAM programme exit the OTP facility in 
one of four possible ways: cured, died, non-recovered, or referred to the inpatient therapeutic 
programme due to complications. A child is assumed to be non-recovered after missing two 
consecutive fortnightly visits. These nodes are further divided until a terminal node of alive or death 
is reached. The proportion of malnutrition cases assigned to each node and its respective mortality 
was based on the data collected from the Dowa CMAM programme. 
The study was based on a health services perspective. The outcome (effect) was based on the 
DALY, which was estimated using the decision tree model for each treatment pathway (scenario). 
The incremental cost and effect of the two scenarios was used to estimate the incremental cost per 
DALY averted. This decision tree is an extension to the original Bachmann (2009) study; however, 
this present study includes an option of non-CMAM care alongside CMAM care and no treatment. 
The cost of the CMAM programme was broadly separated between capital cost (cars, motorbikes 
and computers, which amounted to 3% of the total cost of the programme) and recurrent cost 
(97% of the total cost). Recurrent cost included: RUTF (32%), administration (24%), direct staff 
(19%), transport (8%), others (surveys/reviews, HIV and AIDS mainstreaming, upgrading storage – 
5%), clinic staff (5%), training (2%), medical supplies (1%), and inpatient costs for referrals to OTP 
facilities (1%). All costs were converted into 2007 USD for the purpose of analysis. 
The cost-effectiveness results showed that the ICER of implementing CMAM integrated into 
existing health services was $42 per DALY averted (or $1,365 per life saved), which is well within 
the Gross National Income per capita threshold of $250 (World Bank, 2008).  
We identified a few limitations of the Wilford et al. (2011) study. First, the perspective was limited 
to health services. Hence, patient-related resource use (e.g. time taken off work, health-related 
expenses, etc.) was not considered in this study. Second, the capital costs did not include the cost 
of new building work, renovation of office premises and the depreciation cost of existing facilities. 
Moreover, the cost of inpatient stays appears to be very small in comparison to other cost 
elements (i.e. 1% of the total cost), which would need to be further investigated. Further limitations 
are identified in the paper itself. 
Bachmann (2009) 
Bachmann (2009) assessed the cost-effectiveness of community-based therapeutic care (CTC) 
against no treatment for children with SAM in Lusaka, Zambia. This study later served as a 
precursor for the Wilford et al. (2011) study. 
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The CEA was based on a decision tree model and the health services perspective was used for 
cost and effectiveness. Two scenarios were considered: CTC or no treatment. Children receiving 
CTC could have one of four possible outcomes: referred to hospital, defaulted, died, or recovered. 
For the no treatment group, mortality was based on children’s HIV status. This option was not 
considered for the CTC group because the HIV status was not known for most children and also 
some of the symptoms would already be incorporated into CTC outcomes. 
The probability for each option was used in the model to estimate the expected rate of outcome 
(i.e. recovery or death). Relevant costs were also added into the model with the exception of the 
no treatment option. Effectiveness was measured in terms of DALYs. Mortality rates were based 
on a community-based cohort study conducted in Malawi and Uganda.  
The relevant cost components used in the model included: health centre visits, RUTF, hospital 
admissions, community mobilisation, and technical support. All costs were converted to 2008 USD.  
The cost-effectiveness results showed that the cost of CTC was $1,760 per life saved and $53 per 
DALY gained. The cost-effectiveness acceptability curve showed that, at a willingness to pay of at 
least $88 per DALY gained, CTC was more than 80% likely to be cost-effective.  
Ashworth and Khanum (1997) 
Ashworth and Khanum (1997) assessed three alternative cost-effective approaches for treating 
severely malnourished children in Bangladesh. The study was based on a longitudinal, prospective 
controlled trial conducted to evaluate the most cost-effective treatment for severe malnutrition. In 
total, 573 children were sequentially allocated to three treatment groups. The three main treatment 
options evaluated were: inpatient management, day care, and domiciliary care.  
The cost component was categorised into institutional cost and parental cost. Institutional cost 
comprised capital cost, salary cost, utilities, laboratory tests, medical supplies and food costs. 
Parental cost comprised transport costs, wage loss of working mother and child food cost (day 
care). The cost-effectiveness was evaluated as the total cost (institutional and parental cost) to 
achieve 80% weight-for-height. All costs were reported in USD. 
The study showed that the institutional cost of inpatient treatment was 2.6 times more than for day 
care, and 5.3 times higher than domiciliary care. When combined institutional and parental costs 
were considered, domiciliary care was 1.6 times more cost-effective than day care and 4.1 times 
more cost-effective than inpatient care. 
This study is more comprehensive in terms of collection of cost data than the earlier studies. 
However, the study did not use a generic measure of effectiveness that can be compared across 
health programmes. 
Renfrew et al. (2009) 
The objective of this study was to estimate the long-term costs and benefits of enhanced staff 
contact in promoting breastfeeding to mothers whose infants were admitted to neonatal units. 
The rationale of the model structure was that enhanced staff contact increases milk expression; in 
turn, it was assumed that this would lead to increased milk consumption by the infant. Milk 
consumption was then assumed to reduce the incidence of illness episodes, thereby improving 
long-term health outcomes. The health benefits evaluated were in the form of QALYs. 
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Population:  All mothers with infants (<2500g) in neonatal units. Weight-based subgroups were 
developed with the rationale that the incidence of diseases increases greatly as the birth weight 
decreases: 500–999g, 1,000–1,749g, 1,750–2,500g. A health care perspective was used, and 
costs and benefits were discounted at the annual rate of 3.5%. 
Intervention:  In the base case model two interventions were evaluated: enhanced staff contact – 
the addition of specially trained staff, which would be available to advise and support mothers on 
milk expression and breastfeeding – compared with normal staff contact, i.e. no addition of 
specially trained staff. 
Model: The model divides the population into those women who intend to breastfeed and those 
who do not intend to breastfeed prior to their infant’s birth. The model was designed to capture the 
health effects for three different levels of milk consumption: all own mother’s milk, some mother’s 
milk (supplemented by formula in the base case) and formula alone. The literature suggests that 
there are potential cost and benefit differences in the different levels of mother’s milk consumption. 
Clinical outcomes: In hospital clinical outcomes were sepsis and mortality. Sepsis was further 
divided into Gram-negative, Gram-positive and fungal infection. Resource use and utility outcomes 
were captured by these subdivisions of clinical outcomes. 
Long-term outcomes: QALYs were used as a long-term outcome. The outcome was linked to 
disability by mean of neurodevelopment impairment, which is a composite measure that captures 
many elements of disability including visual, hearing and mobility impairments. The 
neurodevelopment impairment scores were divided into four categories: no, mild, moderate, and 
severe disability. The utility values for each of the health states were then used to quality weight 
life expectancy. Life expectancy for infants in each of the four disability states were taken from 
Colbourn et al. (2007). A combination of life expectancy and utilities were used to derive QALYs for 
each of the disability states.  
A.2.1.6 Aim of the economic evaluation 
The aim of this ORIE study is to evaluate the incremental cost-effectiveness (or cost-utility) of the 
CMAM programme (workstream 1) and the IYCF interventions (workstream 2) compared to routine 
care, and to evaluate the costs associated with delivery of the micronutrients and deworming 
programme (workstream 3) and integration of direct nutrition interventions into routine health 
services (workstream 4) in northern Nigeria. 
Specific objectives of the study include: 
a. To estimate the direct and indirect costs associated with implementation of the CMAM and 
IYCF interventions;  
b. To evaluate the health-related outcomes associated with the CMAM and IYCF interventions 
for the purpose of economic evaluation; 
c. To evaluate the cost-effectiveness of the CMAM and IYCF interventions compared to 
routine care in northern Nigeria; and 
d. To evaluate the direct provider-related costs associated with the implementation of 
workstreams 3 and 4. 
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A.2.1.7 Study methodology 
Overall approach of the economic evaluation of the CMAM programme and the IYCF 
interventions 
Separate workstream-specific evaluation or joint evaluation? 
For the purposes of an economic evaluation, it is important that the interventions being compared 
are targeted toward the same condition, such as severe malnutrition. Since the two interventions 
being evaluated in this study (i.e. CMAM programme and IYCF interventions) have different 
objectives and different target health conditions, health outcomes and even population groups, we 
propose that, for the purposes of the economic evaluation, the CMAM programme and the IYCF 
interventions are evaluated and reported on separately. Moreover, the two programmes work or 
can work independently of each other. For instance, the CMAM programme is operational in 
several countries as an independent programme in itself. The programme has been evaluated and 
published as such in the following four countries: Zambia, Ethiopia, Malawi and Bangladesh. We 
strongly believe that, besides the technical reasons outlined above, a separate economic 
evaluation to determine the VfM of each workstream can be crucial for decision-makers. 
However, we acknowledge that DFID as the funding institution may require that the two 
workstreams are evaluated together as one programme. Hence, although we do not recommend 
that the workstreams are evaluated jointly, one such potential joint approach is discussed later on. 
CMAM programme (Workstream 1) 
We propose to conduct a full economic evaluation of the CMAM programme based on a cost-utility 
approach (i.e. cost per DALY method) outlined above. Following Wilford et al. (2011) and 
Bachman et al. (2009), we propose that a decision tree model (or an alternative Markov model 
based on the same principles) is developed for the evaluation of the CMAM programme to 
evaluate the cost per DALY of the intervention compared to non-CMAM care. The decision model 
(discussed below) evaluates patient treatment pathways (from identification of malnutrition to 
treatment to health outcomes) based on the probability of different outcomes along the pathway for 
the alternative interventions being compared. Costs and health outcomes along the pathway are 
evaluated and aggregated. Health outcomes (i.e. malnutrition-related health state) are converted 
into DALYs (as discussed in the cost-utility section above). Costs and outcomes are subsequently 
evaluated together to estimate the incremental cost per DALY for the intervention (i.e. CMAM 
programme) compared to routine care. This approach is summarised in the figure below. The 
detailed decision tree approach will be discussed in the following sections. 
Figure 12: Proposed approach for the economic evaluation of the CMAM programme 
 
 
 
 
Decision tree (or 
Markov) model: 
Patient identification and 
treatment pathway (using 
transition probabilities 
along the pathway) 
Costs and health outcomes 
associated with health states (such 
as malnutrition status) in the 
treatment pathway are recorded. 
Costs are aggregated and health 
outcomes are converted to DALYs. 
Cost per DALY 
analysis is 
conducted 
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IYCF interventions (Workstream 2) 
For our evaluation of the IYCF interventions, we propose two alternative options:  
 A model-based cost-utility analysis where the intermediate outcomes of breastfeeding (and 
possibly weaning and complementary feeding) can be converted into a generic utility-based 
measure of DALY or QALY as presented in the literature review above (see Health Technology 
Assessment report);  
 Cost-consequence analysis (discussed above);  
The cost-consequence analysis is relatively straightforward as it does not require the aggregation 
of multiple outcomes to generate a single outcome. However, for decision-makers intending to 
compare across programmes, such an approach may have limited application. The other 
alternative, i.e. the cost per DALY approach, is similar to the approach proposed for the CMAM 
programme; however, unlike malnutrition, it is not straightforward to derive disability-weighted 
outcome measures for breastfeeding, weaning and complementary feeding outcomes. 
Nevertheless, an indirect approach has been used in the literature. In this approach, indicators of 
feeding practices (such as whether or not a child is breastfed) are obtained from an impact 
evaluation; following this, estimates of the probability of the health-related consequences of 
undesired feeding practices (such as no EBF) are obtained from the literature for the specific 
population or the closest population group. Subsequently, the disability weights are attached to 
health-related consequences based on the estimates available in the literature – this allows us to 
calculate DALYs associated with the intervention. The same is done for the control areas to obtain 
DALY estimates. To estimate cost data, intervention-related costs for the providers are obtained 
using the institutional cost approach (discussed later). Furthermore, the health services costs and 
patient-related costs associated with treating health-related consequences (such as diarrhoea) are 
obtained. All the cost data are aggregated and compared against DALYs to obtain the cost per 
DALY. This approach has been used in several studies (including Renfrew et al. (2009) presented 
above) and is recommended for full economic evaluation. The approach is summarised in the 
figure below. 
 
 
 
 
 
 
 
 
Figure 2: Proposed approach for the economic evaluation of the CMAM programme 
Combined analysis of the CMAM programme and the IYCF interventions 
While we recommend that the economic evaluation of the CMAM programme and the IYCF 
interventions are conducted and reported on separately (i.e. that the costs per DALY are estimated 
Impact evaluation: 
Indicators for feeding 
practices (such as 
exclusive, partial or no 
breastfeeding, or initiation 
of complementary feeding) 
Health outcomes: health-related 
consequences associated with 
undesired feeding practices are 
identified through literature review (such 
as diarrhoea/respiratory infections)  
health-related consequences are 
converted into DALYs Cost per 
DALY analysis 
is conducted 
Costs: a) Health provider costs 
associated with the delivery of IYCF; 
and b) health services and patient-level 
resource use associated with health 
consequences of undesired feeding 
practices (such as diarrhoea) 
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separately for the two interventions), the evaluation of the two workstreams can potentially be 
combined. This may only make sense if the resources used for the two workstreams have a 
significant degree of overlap, such as the use of community health workers. For a combined 
evaluation, the health benefits of the two programmes, expressed in terms of a common currency 
(i.e. DALYs averted), can be combined to estimate the combined effect in terms of DALYs averted; 
this outcome measure is then evaluated against the costs associated with implementing the two 
workstreams.  
However, in this case, it is crucial to avoid double counting costs and outcome benefits. 
Some of the health service resources may be common across the two workstreams, such as 
support/advice provided by community health workers or high-level supervision provided by senior 
management. It is important that such costs and any health benefits that may be common to the 
two workstreams are identified early on through discussions with programme delivery teams and 
that the evaluation process reflects these common costs and outcomes to avoid double counting. 
Micronutrient interventions and deworming (workstream 3) and integration of direct 
nutrition interventions into routine health services (workstream 4) 
While an outcome evaluation of workstreams 3 and 4 is not part of the impact evaluation exercise 
(as no outcome data will be available for them), these workstreams can/will be evaluated as part of 
the economic evaluation. We propose that the economic evaluation of workstreams 3 and 4 takes 
the form of a costing study or cost analysis. 
The costing study will take a health provider or institutional perspective. Further details are 
discussed in the following section. 
Table 19: Proposed approaches for the economic evaluation 
Programme Approaches for the economic evaluation 
CMAM programme (Workstream 1) Cost-utility analysis (cost per DALY) 
 Options 
IYCF interventions (Workstream 2) Cost-utility analysis Cost-consequence analysis 
Micronutrients/deworming (Workstream 3) Costing study 
Integration of direct nutrition interventions 
into routine health services (Workstream 
4) 
Costing study 
A.2.1.8 Framework for the economic evaluation  
It is common practice in economic evaluations to use decision tree models or Markov models, 
especially in situations when the aim is to evaluate the long-term cost-effectiveness of 
interventions. The decision tree represents a sequence of events with different probabilities along 
the pathway with associated costs and health outcomes. The decision tree is then rolled back to 
estimate the expected costs and expected health benefits of interventions and comparators. These 
values can be averaged on the basis of the likelihood, or probability, of each path in the tree.  
CMAM model: the decision tree approach 
The decision tree approach was also used in the Wilford et al. (2011) study, which also evaluated 
the cost-effectiveness of a CMAM programme. Similarly, Bachmann (2009) also used the same 
approach. An alternative approach would be to develop a Markov model, which is a cohort model 
that is commonly used when the decision tree becomes too unwieldy with recurrent events or 
when time is an important consideration in the transition pathway. For relatively simpler cases, the 
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decision tree approach is usually appropriate and sufficient; however, we suggest that the option to 
use a Markov model should be considered if it becomes obvious that more states and/or decision 
nodes are required than can be comfortably handled by the decision tree. 
We propose that the economic analysis is based on a decision modelling approach that uses a 
decision tree or Markov model. The decision tree approach is close to the method used by Wilford 
et al. (2011). However, our interpretation of the Wilford model suggests that it has several 
limitations that can be improved upon in this study:  
 The Wilford et al. (2011) model is primarily a treatment-based model, i.e. it does not explicitly 
model community-based case findings; this is an important and integral part of the CMAM 
programme. We propose that the model in this study starts by introducing probability at the 
start of the decision tree to take into account the case finding of a malnourished child who is 
then referred to outpatient or inpatient therapeutic care. 
 The Wilford et al. (2011) model was based on a health services perspective but we propose 
that a societal perspective is taken to capture the full impact of the WINNN interventions on 
society. 
 The Wilford et al. (2011) study did not collect any data from control or non-CMAM sites, and 
made assumptions around programme effectiveness. This is a serious limitation that we 
propose addressing in the current study. 
 Wilford et al. (2011) assumed that the no treatment arm did not incur any costs. We think this 
assumption needs to be evaluated.  
 Wilford et al. (2011) used several other assumptions when data were not available. The validity 
of some of these assumptions may be contestable. We propose that robust data are collected 
so that fewer assumptions are made. 
 We do not see that the Wilford et al. (2011) model considered the cost of death, i.e. the high 
expenditure associated with healthcare before death. 
Thus, the Wilford et al. (2011) model should be revisited and further areas of improvement should 
be explored. However, we agree with the general approach of using a decision tree for this 
purpose, although as noted above the need for a Markov model should be revisited later on. We 
understand that there may be opportunities to contact the authors directly to better understand the 
model parameters and how our study can improve on them. 
For illustration purposes, we present a modified version of the decision tree presented by Wilford 
et al. (2011). It should be noted that the decision tree is likely to be modified at a later stage. The 
required model parameters will be discussed in the cost and outcomes sections. 
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Figure 13: Decision tree for the CEA of the CMAM programme 
 
Analysis of the IYCF interventions 
As discussed earlier, the analysis of the IYCF interventions will take one of the two forms: a cost-
utility analysis or a cost-consequence analysis. We propose that the cost-utility analysis option 
should be explored first because it would allow decision-makers to compare the VfM of the IYCF 
interventions against other competing interventions. While the outcomes of IYCF interventions 
cannot be directly associated with disability or utility weights, we propose that the immediate 
outcomes from the impact evaluation (e.g. breastfeeding rate) are mapped onto the probability of 
longer-term benefits in terms of health-related consequences averted (such as diarrhoea, 
respiratory infections or possibly other infections), which are then used to estimate DALYs averted. 
We have presented one study in the literature review section (Renfrew et al., 2009) that conducted 
such an analysis for an intervention aimed at promoting breastfeeding.  
Analysis of workstreams 3 and 4: costing study 
Cost studies are usually conducted to provide budgetary estimates or to estimate the costs of a 
programme initiative. The costing study of workstreams 3 and 4 will be conducted from a provider’s 
perspective to capture all programme-related costs. These are discussed in detail later and will 
include programme investment costs and operational costs, including staff salaries, procurement 
and distribution of supplies (such as Vitamin A capsules for children and iron and folic acid for 
pregnant women), supervision costs, training costs and travel costs. 
A.2.1.9 Perspective of the economic evaluation 
As discussed above, it is important to establish the perspective of an economic evaluation. Both 
health services and societal perspectives have been used in economic evaluations of interventions 
targeting severe malnutrition (presented in the literature review section above). Wilford et al. 
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(2011) conducted a cost-per-DALY analysis of the CMAM programme using a health services 
perspective. No patient-related costs were included in the analysis. Similarly, Bachmann (2009) 
used the same approach and focused only on the health services perspective. However, Ashworth 
and Khanum (1997) used a societal perspective to include parent-related costs such as transport 
costs, wage loss for working parents, payments to neighbours for looking after the family in the 
mother’s absence and child’s food cost when at home. However, the costs of out-of-pocket 
expenditure on health services were not considered. 
We propose that, for the full economic evaluations of the CMAM programme and the IYCF 
interventions, the preferred option is to take a societal perspective. The potential cost elements to 
be included are discussed in detail in the following section. There are several reasons for 
proposing a societal perspective for this analysis: 1) a societal perspective in an economic 
evaluation provides an estimate of the return of investment on health services for society; 2) the 
burden of malnutrition and the burden of care seeking have direct cost implications for households; 
and 3) a restricted budget perspective is inconsistent with decisions based on willingness to pay 
for DALYs. However, for pragmatic reasons we propose that due consideration should be given to 
both perspectives. In the following discussion on cost components, we will discuss all relevant 
costs, including societal costs. A decision can be reached later in terms of which perspective 
should be adopted. 
Costing studies generally tend to take a provider’s perspective. This is mainly because the aim of 
the costing study is to provide budgetary estimates or to estimate the costs of a programme 
initiative to the provider. A broad health services or societal perspective is more appropriate when 
a full economic evaluation is planned. For the current scenario, we propose that all costs 
associated with delivering workstreams 3 and 4 are captured during the evaluation using the 
provider’s perspective. 
In the following sections, we discuss the costs and outcomes to be included in the economic 
evaluation. We present specific cost components, line items, potential sources, method of data 
collection and process of cost estimation. We will also discuss a CMAM-specific costing tool that 
has been developed by Food and Nutrition Technical Assistance (FANTA). Following this, the next 
section will discuss the outcome measures required for the economic analysis and their potential 
sources, and will also identify the sources used by previous studies. 
A.2.1.10 Cost components of CMAM programme and the IYCF interventions 
Two broad categories of cost for economic evaluation 
The following cost elements will be collected for the evaluation of all four workstreams: 
1. Programme delivery costs (A): these include capital costs, fixed operating costs and 
variable operating costs, which are outlined in the table below. These cost elements relate 
to programme inputs for service delivery, monitoring, training, supervision, community visits 
to households and provision of curative care. These costs are discussed in detail in the 
following section.  
2. Household costs (B): these costs relate to household expenditures in relation to the 
health condition. As discussed above, the household costs will only be considered in the 
evaluation of workstreams 1 and 2 and will not be part of the costing study of workstreams 
3 and 4. 
For programme delivery costs of all workstreams, the CMAM cost template from USAID’s FANTA-
2 project (summarised later in the document) will be used. This document can be adapted to suit 
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workstreams 2–4 and will ensure that cost elements are captured in a standardised format across 
all workstreams. 
Programme delivery costs (A) 
Programme costs may be incurred by the IPs, i.e. UNICEF, Save the Children, and ACF, and the 
government health provider that provides care. Hence, during the process of evaluation, all 
programme-related costs should be evaluated for all organisations involved in the delivery, 
management, supervision or other directly related activities of the programme.  
The programme components of the CMAM programme can be represented by the diagram below, 
which shows community outreach services, outpatient services, inpatient care and services and 
programmes addressing management of malnutrition. Based on this, the cost components can be 
identified and are listed below. 
Figure 14: Programme-related components of the CMAM programme 
 
Source: UNICEF (2013)  
Activities that will incur costs in the CMAM programme: 
 Treatment (or case management) of children with SAM (on either an inpatient or an outpatient 
basis);  
 Community outreach in support of the management of SAM;  
 Supply logistics (transportation and storage of supplies, especially of RUTF and other 
therapeutic food);  
 Training of health care providers and health managers;  
 Supervision of health care providers and health managers; and  
 Management of the service/programme (e.g. planning, budgeting, monitoring).  
Activities that will incur costs in the IYCF interventions: 
Similarly, the cost components of the IYCF interventions are listed below: 
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 Mothers’ support group training and other training; 
 Information, education and communication materials; 
 Sensitisation and community outreach; 
 Training of health workers; 
 Supervision of health care providers and health managers; 
 Management of the service/programme (e.g. planning, budgeting, monitoring);  
 Festivals (e.g. breastfeeding weeks); and 
 Mass media. 
For the economic evaluation of the IYCF interventions, the last two cost elements may not be 
included in the analysis. 
Activities that will incur costs in workstreams 3 and 4: 
 Supply logistics (procurement, transportation and storage of supplies, especially Vitamin A 
capsules for children and iron and folic acid for pregnant women); 
 Distribution costs; 
 Training costs;  
 Supervision of health care providers and health managers; and 
 Management of the service/programme (e.g. planning, budgeting, monitoring).  
Household costs related to health conditions 
These costs are related to household out-of-pocket expenditure or opportunity costs associated 
with the health condition. For instance, for the evaluation of the CMAM programme, the household 
costs may include the following: 
 Out-of-pocket payments for medication; 
 Informal payments; 
 Expenses on transportation; 
 Expenses on food; 
 Employment status; 
 Daily wage; and 
 Payments to neighbours for looking after the family in the mother’s absence.  
Types of programme-related costs for all workstreams 
For practical purposes of cost analysis, we propose that the above cost components are evaluated 
in three categories: capital costs, fixed operating costs and variable operating costs. These are 
defined with specific examples from the CMAM/IYCF interventions in the table below. In the 
following section, we have identified specific cost line items for each one of these categories, and 
further details are provided. 
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Table 20:  Types of programme-related cost included in the economic evaluation of the 
CMAM programme/IYCF interventions 
Type of cost Description 
Programme-specific costs for the CMAM 
programme and the IYCF interventions 
Programme 
capital costs 
* These are direct costs that can be 
incurred at the start of a programme 
or at later stages.  
* These will include infrastructure-
related costs, equipment and vehicle 
purchase costs and training costs. 
* To avoid losing cost-related 
information, it is best practice to 
collect this cost data early on, and 
also at later time points. 
* Construction or start-up renovation/repair 
of facilities. 
* Depreciation of existing facilities. 
* Cars and other vehicles. 
* Computers and other office equipment. 
Fixed operating 
costs 
* These are fixed direct costs that are 
incurred regularly regardless of 
programme-related variable 
indicators. 
* These may include the salaries of 
staff members (full or part time), 
facility rents and utilities. 
* Salaries of full-time and part-time staff. 
* Rent of facilities/items. 
* Utilities and other bills. 
Variable operating 
costs 
* These are variable direct costs that 
increase with the volume of service, 
and may not have much impact on 
cost per capita 
* These may include medical 
supplies, training materials, 
maintenance costs, supplies and 
variable staff costs. 
* Ready-to-use food supplements. 
* Medication supplies. 
* Laboratory tests. 
* Vehicles (repairs and fuel). 
* Training costs (including training 
materials). 
Capital costs to be evaluated for the economic analysis of all workstreams 
Summaries of the cost data required, estimation methods, sources of data and assumptions are 
presented in the tables below. These include capital costs (i.e. costs related to starting up a 
nutritional programme at a health facility) and operating costs (i.e. the expenditure required to keep 
the facility fully functional). Operating costs are further divided into fixed operating costs, which 
include staff salaries, and variable operating costs, which include RUTF, medical supplies, 
laboratory test, utility bills, training costs and vehicle maintenance and fuel costs. 
These cost elements should be thought of as programme inputs to service delivery, monitoring, 
training, supervision, community visits to households and provision of curative care. All cost 
elements below should be collected with such activities in mind. 
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Table 21: Capital cost elements for CEA of CMAM programme/IYCF interventions  
Capital costs Who will incur the cost? Cost estimation 
Building facilities 
a. Cost of any new building facilities 
developed specifically for the programme (such as 
community-based treatment facilities). 
These costs are likely to be related to 
renovation/redecoration/construction of government 
health facilities.  
However, they may be incurred by the health service 
provider (i.e. the government) or IPs (i.e. Save the 
Children and ACF). 
Costs incurred at the central offices and local and 
community offices will be investigated.  
It is important to ensure that costs are not double 
counted when gathering data from multiple sources. 
Estimation of depreciation cost: Attributable 
depreciation cost of building facilities will be 
estimated based on proportionate service activity 
(i.e. number of patients seen or admissions) 
attributable to the CMAM/IYCF interventions. A 
lifespan of 30–50 years will be assumed, 
discounted at 3% and 5%, and uniform 
depreciation will be used in calculations.  
b. Start-up cost of renovating/restructuring 
existing building facilities used for CMAM/IYCF 
interventions (i.e. outpatient and inpatient treatment 
facilities). Also, depreciation cost of existing 
buildings used for CMAM/IYCF interventions will 
also be considered. 
Equipment and furniture 
a. Purchase of new equipment, such as 
laboratory machines, and furniture for the 
programme (including community-based care, 
outpatient and inpatient facilities). 
These costs can be related to purchases or use of 
existing equipment and furniture based at the offices of 
the IPs or health provider. Estimation of depreciation cost: Attributable 
depreciation cost of equipment will be estimated 
based on proportionate use attributable to the 
programme annualised to 10 years, discounted at 
3% and 5%. 
b. Estimated depreciation cost of existing 
equipment shared with other services (such as 
machines in outpatient and inpatient facilities). Also, 
initial cost of repairs will also be included. 
 
Vehicles 
a. Purchase of new cars, motorbikes and 
other means of transportation for the programme 
and start-up repair costs. 
These costs are likely to be related to IPs. 
Estimation of depreciation cost: For vehicles 
used only for the programme, depreciation costs 
will be calculated over the lifespan of the vehicle 
and attributed completely to the programme. For 
vehicles shared with other programmes, 
depreciation cost will be estimated by keeping a 
b. Depreciation cost of existing vehicles used 
for the programme. 
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log of total kilometres driven for CMAM/IYCF 
interventions purposes. For practical purposes, 
this can be done at representative sites and 
assumed to be constant across sites. 
Computer and office equipment 
a. Purchase of new computer equipment and 
other office supplies specific to the programme. 
b. Use of existing computer equipment for the 
programme. 
As above. 
Estimation of depreciation cost: These costs 
will be annualised over three years to calculate 
the depreciation cost, discounted at 3% and 5%. 
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Operating costs to be evaluated for the economic analysis of all workstreams 
Fixed and variable operating costs will be considered for all four workstreams. Details of these 
costs and how they should be estimated are presented in the table below. 
Activity-based costing approach 
For staff time operating costs (part of the operating costs), we propose to use an activity-based 
costing approach. This approach allocates activity-based staff time to specific programmes based 
on the proportion of the staff time spent on certain activities. Waters (2006) defines activity-based 
costing in the following way: ‘Activity-based costing essentially defines the principal activities of the 
individuals who work within an organization, then traces costs, first, to these activities, and then 
from the activities to products and services. Human and financial resources within a department 
(production centre) are traced to activities, which are in turn traced to products and services. 
Allocation of personnel time among the activities becomes the principal means for assigning 
overhead and other indirect costs’. 
This approach will be used to allocate costs to specific workstreams for staff who share work 
across several programmes or activities. 
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Table 22: Operating cost elements for CEA of CMAM programme/IYCF interventions 
Type of cost Cost details Who/what will incur the cost? Cost estimation 
Fixed operating 
costs 
Staff salaries 
Salaries of staff specific to the CMAM 
programme/IYCF interventions as well as non-
programme-specific staff (shared with other 
programmes). 
Staff members employed by the IPs and the 
government will be included in the analysis 
based on their share of time. The staff 
members may be in: 
 * Management and administrative roles 
 * Community-based roles (although many may 
be volunteers) 
 * Health facility-based (including nurses, 
doctors, medical assistants, district staff, 
district nutritionists, maternal and child health 
coordinators and health management 
information system officers). 
 * Salaries of international staff and consultants 
 * Salaries of staff members shared with other 
programmes. 
A previously published CEA of the 
CMAM programme (Wilford, 2012) 
suggests that programme-specific 
management and administrative costs and 
international staff costs are incurred 
mainly by the IPs. However, the staff 
salaries of health centre staff and district 
staff are incurred by the government. 
Staff cost attributable to the programme will 
be calculated based on whether staff are 
employed solely (full or part time) by the 
programme or shared with other projects. 
Solely employed staff costs will be equal to 
the salary for staff working only for the 
CMAM/IYCF interventions. For staff 
members with shared work activities, 
proportionate time spent on the 
CMAM/IYCF interventions will be estimated 
by interviewing staff at each level about 
their role share with other programmes, and 
subsequently costing based on time share 
using salary data. 
Any rented facilities/items – to be 
investigated with field staff. 
These can be incurred by government or 
IPs. 
Data on rent paid divided by the time period 
will be used to estimate cost over the period 
of the programme. 
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Variable operating 
costs 
RUTF 
* Cost of all RUTF procured and used during 
the study period should be documented. 
A previous evaluation suggests that these 
costs are incurred mainly by IPs. Any 
government facilities used for this purpose 
(such as warehouses) should also be 
evaluated. 
It should include the cost of purchase, 
transport from the producer’s factory and 
warehousing. Distribution mechanisms will 
be explored before they are costed to avoid 
double counting. 
Medication supplies 
* Including cost of medication and other 
supplies used to treat patients at OTP or SC 
facilities. 
Incurred by government facilities or IPs. 
Programme-specific drug costs will be 
estimated based on supplies 
dispensed/used (or, if these data are not 
available, then supplies purchased). 
Laboratory tests. As above. 
All laboratory tests will be documented for 
each patient and their costs will be obtained 
from the Department of Health. If not 
available, their market price may be 
considered. Alternatively, a micro-costing 
approach may be used at selected facilities. 
Vehicles 
* Cost of repairs and cost of fuel (staff costs 
will be covered in the salaries category). 
Incurred primarily by the IPs. 
Running costs of dedicated programme 
vehicles will be based on financial accounts 
and/or receipts. Cost of shared cars will be 
allocated based on logs recording total 
kilometres driven for CMAM programme 
purposes. 
Utility bills (gas, electric, water, others). As above. 
Taken directly from the financial accounts of 
bill history.  
Training costs, including venue and per diems. As above. 
These will be calculated directly from the 
financial accounting records of IPs. 
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Available/recommended template for collection of cost data 
As mentioned earlier, we are aware of the FANTA costing tool developed by USAID specifically for 
costing CMAM programmes in developing countries. This tool can be very useful in ensuring that 
all line items are captured and a standardised costing practice can be used across all CMAM 
programmes. Below we present a summary of the extensive list of staff salaries that are required to 
be captured by this tool. We propose that this tool is used as much as possible for costing 
purposes.  
Table 23: List of line items required to be collected by the CMAM programme costing 
tool developed by USAID 
Health care providers and other staff Provided type and functions 
Central HQ 
Senior Central HQ staff (head/deputy head of department) 
Manage and advocate for CMAM 
programme at national level 
Mid-level Central HQ staff (programme manager) 
Establish, coordinate CMAM programme 
activities 
Group area HQ 
Senior group area HQ staff (graduated nutrition officers – 
more experienced) 
Regional Nutrition Officer – management 
of CMAM programme 
Mid-level group area HQ staff (technical officers) 
Assistant Nutrition Officer – supervision 
and training of area HQ staff 
Junior group area HQ staff (community health nurse or 
officer at regional level) 
Technical Officer – monitoring/data 
collection and analysis and assisting with 
other management tasks 
Area HQ 
Senior area HQ staff (District Nutrition Officer, who 
graduated within 1–3 years) 
Nutrition Officer (graduate/technical officer) 
– Management of CMAM programme 
Mid-level area HQ staff (technical officers) 
Technical officers/National service officers 
– Supervision and training at outpatient 
care sites/inpatient care sites 
Junior area HQ staff (community health nurses or officers at 
district level) 
Technical officers/community health 
nurses – Monitoring/data collection and 
analysis and support to mid-level and 
senior staff 
Outpatient care site – Health care providers 
Senior outpatient care staff (senior nurse, medical assistant 
– health facility in-charges) 
Medical assistant/midwifes/clinical nurses 
– management of SAM cases, establishing 
community outreach, training of COWs, 
data management 
Junior outpatient care staff (community health nurses, 
community health officers, and public health nurses) 
Community health nurses – assisting with 
management of SAM cases, supervision of 
COWs, helping establish community 
outreach, data collection 
Community Outreach Worker 
CMAM programme outreach in the 
community (volunteers)  
Inpatient care site – Health care providers 
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Senior inpatient care staff (clinician, paediatrician, or other 
medical specialist) 
Physician/paediatricians – in-house 
supervision of health care providers, 
managing SAM children with 
complications, data analysis 
Mid-level Inpatient Care staff (clinical nurses, dieticians, 
graduate nutritionist) 
Clinical nurses/graduate dietician/graduate 
nutritionist – day-to-day management of 
SAM in inpatient care, nursing care 
supervision of feeds and preparation, 
monitoring and reporting 
Junior inpatient care staff (health aids, health extension 
workers) 
Health aid/heath extension worker – 
assisting in care of SAM cases with 
complications, preparation of therapeutic 
foods, data collection 
Other workers (all levels) 
Driver 
Driving vehicles carrying supplies or 
people 
Store guard Guarding stores of RUTF 
We propose that patient (carer)-related costs are also captured in this study to reflect the societal 
perspective of the value of the intervention compared to the control. Patient-related costs may 
make up a significant proportion of the total cost of the programme. Below we present a list of 
patient (carer)-related costs that will be captured in the current study. 
Sources of cost data 
Summaries of the sources of the cost data required, as well as some consideration of requirements 
and assumptions, are provided in the tables below.  
Table 24: Sources of cost data, requirements and assumptions 
  Source of data 
Requirements and 
assumptions 
Notes 
Building 
facilities 
Capital cost: Financial 
accounting books and financial 
reports (systems). 
Alternatively, they can be 
estimated according 
to the local market price, using 
current replacement costs. 
 
Service-level activity: Hospital 
and outpatient records 
required to estimate proportion 
of service activity attributable 
to the programme. 
Assumption:  
- Financial accounting 
data exists and is 
accessible. 
- Data on service-level 
activity is available and 
accessible. 
- Technical resources are 
available to carry out 
estimation based on the 
approach described.  
- Qualification: We 
recommend basic 
knowledge of financial 
accounting. 
This type of cost, albeit 
important, is sometimes 
ignored in economic 
evaluations, partly due to 
the difficulty of estimation 
of depreciation costs 
(especially, cost of existing 
facilities). Although this is 
ideal, if it is a challenge to 
collect this cost, the 
approach can be revisited. 
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Equipment 
and furniture 
Same as capital cost sources 
above. 
As above. 
Cost of existing equipment 
and furniture may not be 
available. Hence, 
replacement cost can be 
used and depreciation cost 
applied. 
Vehicles 
As above. In addition, vehicle 
logs will be required. 
Vehicle logs will be 
required. We assume 
that this may be part of 
routine practice or can be 
implemented for 
evaluation purposes, at 
least in selected sites. 
If vehicles logs are not 
available or cannot be 
used, an estimate of the 
proportionate share of use 
of vehicles can be 
obtained by interviewing 
selected programme staff 
and/or drivers at each 
level. 
Computer and 
office 
equipment 
Same as capital cost sources 
above. 
Accounting data will be 
available. 
If not, then data on the 
market price of the used 
models will be available 
or can be estimated. 
Cost of any relevant 
purchases, such as 
software, should be 
included. 
Further sources of cost data were identified through our communication with Dr Kenneth Ojo in 
Nigeria. These are listed below. These sources will be explored with a view to identifying cost-
related data and other inputs for the economic analysis. 
Table 25: Costing studies in Nigeria 
UNFPA/DFID/PATHS2: Report on Costing the Integrated Maternal, Newborn and Child Health Package 
of Interventions 
Harmonized Nigeria Living Standard Survey 2011:  Data collection for poverty analysis using a welfare 
and expenditure approach. 
The Costs and Benefits of a Maternal and Child Health Project in Nigeria, Health Policy Initiative, 
USAID: The Initiative completed interviews with officials from the government, health maintenance 
organisations and development partners, as well as academics and several primary healthcare providers, 
and collected information on the costs of delivering services on NHIS/MDG Maternal and Child Health 
Project and analysed the financial sustainability and incentive structure of the programme design. 
NPHCDA Costing Ward Minimum Health Care Package. It provides an estimate of the cost of providing 
a minimum level of health care package at each PHC and by inference at each ward of Nigeria. 
SMART Nutrition Survey in eight Sahel states of northern Nigeria, 2010/2011; Kano, Jigawa, Katsina, 
Kebbi, Sokoto, Yobe, Zamfara, and Borno. 
Multiple Indicator Cluster Survey 4 (MICS 4) funded by UNICEF Nigeria 2010. The survey collected 
data on maternal and child health care and MDG health indicators. 
Household Baseline Survey by Partnership for Transforming Health Systems 2 (PATHS2) 2010/11, 
2011/12, Collected baseline data for health systems strengthening. 
Baseline Survey on Drug Revolving Fund Programme by PATHS2. 
Core Welfare Indicator Questionnaire Survey. It involves data collection for poverty analysis using a 
welfare approach. 
Outcome measures in the economic evaluation 
The other important aspect of the economic evaluation is the outcome data. These are the model 
parameters that will inform the decision model. These data will be collected through various 
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sources and using different methods. Where possible, we have proposed that data on outcome 
parameters for the economic analysis are collected alongside the impact evaluation. Details of the 
model parameters and their sources are presented below.  
A.2.1.11 Outcome measures for evaluation of the CMAM programme 
Table 26: Model parameters, sources of data and method of data collection 
Model parameters Source Method 
Prevalence of malnutrition 
Prevalence of moderate and 
severe malnutrition in under-
fives in programme evaluation 
areas. 
- The ORIE baseline 
population survey 
(impact evaluation). 
- Random sample of households 
within each LGA. 
- Other sources: 
Demographic and 
Health Survey 
(DHS) of Nigeria 
(report available 
online). 
- Other data sources 
and major reports. 
- Focused literature search for 
published reports/papers based 
on DHS, Nigeria. 
- Further data or reports may be 
available from or through Dr 
Kenneth Ojo’s team at the Centre 
for Health Economics and 
Development, Nigeria (we have 
had direct correspondence 
through Aly Visram). 
Identification and referral to OTP/SC facilities in CMAM programme areas 
Probability of identification and 
referral to OTP facility for 
moderate malnutrition in 
CMAM programme 
implementation areas 
[Pr(OTP)]. 
- The ORIE impact 
evaluation survey. 
- The ORIE impact evaluation 
survey will evaluate the 
malnutrition status of children and 
establish whether or not the 
malnourished patient was 
identified and referred to OTP/SC 
facilities through the CMAM 
programme 
- These data will be used to 
estimate the probability of being 
referred to OTP/SC facilities, 
given moderate malnutrition. 
Probability of referral to SC for 
severe malnutrition in CMAM 
programme implementation 
areas [Pr(SC)]. 
- As above. 
Probability of refusal or default 
without seeking referred care 
in CMAM programme 
implementation areas 
[Pr(RD)]. 
- As above. 
- As above 
- Alternatively, patient records 
available with the CMAM 
community team will be 
evaluated against OTP and SC 
facilities attendance data to 
estimate default and refusal 
rates. 
Probability of not identifying 
malnutrition through CMAM 
programme [Pr(notI)] 
 
[Pr(notI)] = 1 – [Pr(OTP) + Pr(SC) + 
Pr(RD)] 
Probability of seeking non-
CMAM outpatient or inpatient 
care for malnutrition among 
those not identified by CMAM 
- As above. 
- The ORIE impact evaluation 
survey. 
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programme (in CMAM 
programme areas). 
Type of non-CMAM care 
sought for malnutrition. 
- As above. 
- The impact evaluation survey will 
ask about the kind of non-CMAM 
care sought. 
Referral to OTP/SC facilities in non-CMAM programme areas 
Probability of seeking 
outpatient care for malnutrition 
in non-CMAM programme 
areas. 
- Same as for CMAM 
programme areas – 
based on data 
collected from 
control sites. 
- Same as for CMAM programme 
areas. 
Type of outpatient care 
sought. 
- As above. 
- The impact evaluation survey will 
ask about the kind of non-CMAM 
care sought. 
Probability of referral 
(including self-referral) to 
inpatient care for malnutrition 
in non-CMAM programme 
areas. 
- As above. - As above. 
Outcome of OTP facility care in CMAM programme areas 
Probability of being cured 
during treatment at OTP 
facility/community-based 
treatment. 
- CMAM programme 
data. 
- Routine data collection system 
will be put in place to collect 
patient-level data for all children 
seeking care at OTP over a 
period of 12 months (preferably 
once the programme is well 
established).  
- The database should collect the 
following outcome data for each 
patient seeking OTP care: cured, 
referred to SC, died or refusal or 
discontinuation of treatment, 
revisit during the 12-month period 
for malnutrition. 
Probability of death during 
treatment at OTP 
facility/community-based 
treatment. 
- As above. 
Probability of referral to SC 
facility during treatment at 
OTP facility. 
- As above. 
Probability of refusal or 
discontinuation of CMAM 
programme treatment at OTP 
facility. 
- As above. 
Outcome of outpatient care in non-CMAM areas 
Probability of being cured 
during outpatient treatment in 
non-CMAM programme areas. 
- Data from non-
CMAM programme 
facilities. 
- A routine data collection system 
will be established for control 
OTP component area/s and the 
abovementioned data should be 
collected. 
Probability of death during 
outpatient treatment in non-
CMAM programme areas. 
- As above. 
Probability of referral to SC 
during treatment at OTP 
facility. 
- As above. 
Probability of refusal or 
discontinuation of non-CMAM-
outpatient treatment in non-
CMAM programme areas. 
- As above. 
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Outcome of SC care in children directly referred to SC through CMAM programme 
Probability of being cured 
during SC treatment. 
- Hospital routine 
data. 
- A routine data collection system 
will be put in place to collect 
patient-level data for all children 
seeking care at SC over a period 
of 12 months (during the same 
period when data from OTP 
facilities is being collected).  
The database should collect the 
following outcome data for each 
patient seeking SC care: cured, 
referred to OTP facility, died or 
refused or discontinued treatment. 
Probability of death during SC 
treatment. 
- Hospital routine 
data. 
Probability of refusal or 
discontinuation of SC 
treatment. 
- Hospital routine 
data. 
Outcome of SC care for non-CMAM programme patients/areas 
Probability of being cured 
during SC treatment. 
- Hospital routine 
data. 
- As above. 
Probability of death during SC 
treatment. 
- Hospital routine 
data. 
Probability of refusal or 
discontinuation of SC 
treatment. 
- Hospital routine 
data. 
 
Below we summarise the main categories of data that will be required for the economic evaluation 
(as presented in detail above), and the sources/studies proposed in this design document. 
A.2.1.12 Outcome measures for evaluation of the IYCF interventions 
As discussed in the methods section, the outcome measures for the economic evaluation of the 
IYCF interventions are the same as the outcome measures of the impact evaluation, i.e. young 
children and infant feeding related outcomes. These outcomes will be converted into probabilities 
of health consequences (as discussed earlier) and subsequently converted into DALYs. Hence, the 
outcome data for the evaluation of the IYCF interventions will come from the impact evaluation 
exercise. 
Sampling strategy for data collection (cost and outcome data) 
In order to get a representative sample of the population to reflect the costs and outcomes 
associated with the programme, we propose that variation across states and between LGAs within 
states should be considered. With regards to the economic evaluation, the functional 
capacity/performance of the healthcare system, level of disease burden, socioeconomic gradient 
and cultural differences are among the variables of interest.  
For the impact evaluation exercise, stratified random samples of households will be collected from 
four states, i.e. Zamfara, Jigawa, Kebbi and Katsina. Within each state, two or three LGAs will be 
selected and then households will be randomly selected within each LGA. The expected sample 
size for each state is 500 households for the intervention group and 500 for the control group within 
each state. 
We have had a detailed discussion with Dr Kenneth Ojo of the Centre of Health Economics in 
relation to variability across states and between LGAs to achieve a representative sample in terms 
of variability in the factors outlined above. Based on this, we propose the following: 
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1. Cost and outcome data are collected from two states only, Jigawa and Zamfara. Jigawa is 
in the North East while Zamfara is in North West of Nigeria. Jigawa has relatively better 
health indicators compared to other northern states of Nigeria and much better compared to 
Zamfara.  
2. Within each state, we propose that random samples of households are drawn from all three 
LGAs following the same strategy as the impact evaluation. Taking this approach would 
ensure that sufficient variation in health services, socioeconomic gradient and other 
regional variations will be captured. Hence, the household survey will be conducted using 
the same sample as the impact evaluation within the chosen LGAs. Both intervention and 
control households will be included in the sample, in line with the impact evaluation. The 
sample size used within each state for the impact evaluation will be sufficient for the 
economic evaluation. 
3. For facility-based data collection (for programme-related costs and facility-based patient 
outcome data for CMAM; see below), the same strategy will be used as above. Hence, 
three LGAs will be selected from Jigawa and Zamfara. Within each LGA, we recommend 
that two health facilities are selected, one from the intervention area and one from control 
area. These health facilities should be close to each other in terms of rural/urban 
characteristics and socioeconomic status (and, possibly, disease burden). 
The following data will be collected from the proposed states and LGAs: 
1. Programme-related capital and operating costs, including all the costs identified in Table 26 
and Table 27 . This relates to all four workstreams. Areas of shared resources should also 
be identified so that double counting can be avoided if a combined evaluation is conducted. 
These costs will be collected once for the health facilities (as discussed above). 
2. Facility-based data collection: Outcome data for patients who used outpatient and inpatient 
facilities during a period of one year (i.e. during a one-year period when the programme is 
fully operational – preferably year 2 or year 3 to allow for data analysis and modelling work) 
– this will be used in the evaluation of the CMAM programme. The outcome data for the 
IYCF interventions analysis will come from the household survey conducted as part of the 
impact evaluation. 
3. Facility-based data collection: Patient-related cost data will be collected to capture direct 
and indirect resource use, including opportunity cost (discussed later). These may be 
collected using a questionnaire-based survey or based on focused group interviews 
(recently used for the economic evaluation of CMAM in Bangladesh). As above, these data 
will also be collected in a cross-sectional manner, i.e. patients will be asked once about 
health-related costs. 
4. Household survey data: Outcome data will be collected to be used for the evaluation of 
workstreams 1 and 2. This will be an add-on to the impact evaluation exercise and will be 
collected at baseline and follow-up. 
Timing of data collection 
We propose the following timetable for data collection: 
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1. Programme delivery costs will be collected from intervention and control areas once the 
programme is fully operational, which is likely to be between years 2 and 4. However, to 
allow time for data analysis and economic modelling, we would propose that programme 
delivery costs are collected during year 2 or year 3. 
2. Facility-based outcome and cost data from patients should cover a period of one year for 
all patients admitted to health facilities during the one-year period. Using the same 
argument as above, we propose that this data is collected during year 2 or year 3 of the 
programme. In order to spread the data collection process, it may be feasible to collect 
programme delivery cost data during year 2 and facility-based outcome and cost data 
during year 3. Year 1 will allow preparation time for data collection. 
3. Household survey data: This will be conducted in line with the impact evaluation exercise. 
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Annex B WINNN programme costing methodology 
This annex describes the methodology employed for computing WINNN’s financial costs for Year 
4, which bears similarities to the methodology employed for the previous three years, in order to 
facilitate as much comparison as possible between the implementation costs between the years. 
Methodological departures from previous years, where they occurred, have been mentioned below.  
IPs mapped out all their relevant costs in WINNN Year 4, disaggregated by the four WINNN 
outputs, by economic category, and by the state in which expenditures were incurred. A sample of 
these tracking templates for Year 4 can be seen in Figure 15: below, and is similar to the mapping 
exercises undertaken for previous years—that is, the same categories of cost were analysed 
(using a similar methodology) in Years 1, 2 and 3.34,35 
Figure 15:  Sample of an expenditure tracing template for WINNN IPs 
 
B.1 Apportioning shared personnel and overhead costs 
The second step was to determine the allocation basis for attributing shared costs to various 
WINNN outputs. These are costs which are shared across two or more of the WINNN outputs, 
such as (some) personnel costs, and general overheads. Various apportioning criteria can be used 
for this: for instance, activity-based costing uses the distribution of staff time inputs as a basis for 
apportioning staff wage expenditures or other non-staff shared costs, thus based on the 
assumption that staff time usage provides a close reflection of how those shared costs inputs are 
                                               
34 All conversions from USD to GBP (or vice versa) were done using an exchange rate of £1= $1.55 (Source: IMF 
Representative rates for the period September 2014–August 2015). An exchange rate of £1=$1.59 was used in Year 3, 
of £1= $1.65 in Year 2 and of £1= $1.60 in Year 1.  
35 Additionally, it should be noted that all expenditures cited in this report refer to nominal costs, i.e. costs have not been 
adjusted to take account of inflation.  
© ORIE  90 
effectively allocated to different WINNN outputs. These apportioning criteria work well, say, when 
the total wage bill is known but not its attribution to various sub-activities. Similarly, other non-staff 
inputs (such as floor space) can also be used in cost analyses to apportion shared costs. 
Knowledge of the programme was also applied in specific cases for the purposes of apportioning 
expenditure categories such as medical commodities to specific outputs. For instance, shared 
expenditures on procurement and distribution of RUTF administered through the CMAM 
programme were apportioned fully to the CMAM programme output.  
We employed an activity-based apportioning methodology in our analysis. In Year 1, we did this 
through a staff time-use survey administered to all staff working on WINNN (both full-time and part-
time) within the three WINNN IPs (ACF, SCI and UNICEF). The apportioning percentages obtained 
from the staff time-use survey were then used to attribute common costs to various WINNN 
outputs and states. For the following years, we judged that a simpler, but still accurate, way to 
obtain the same information was to conduct key informant interviews to gather information on the 
relative usage of staff time. This exercise was conducted in the subsequent years for ACF and SCI 
(in the case of UNICEF a different exercise was done36) 
Shared personnel costs 
To provide a simple example of activity-based costing: staff member A in IP organisation X has 
total salaries and allowances of $10,000 and spent, on average, 50% of her time on WINNN. She 
indicated in the key informant interview that of the time she spent on WINNN, 40%, 30%, 30% and 
0% was spent on Outputs 1, 2, 3, and 4 respectively. We then apportioned and attributed staff 
member A’s salary as shown in Table 27:  50% of staff member A’s salary was attributed to 
WINNN, and this amount was further apportioned to various WINNN outputs as per the time-use 
percentages reported by staff member A in the staff time use survey. 
Table 27:  An example of apportioning shared personnel costs 
Staff details Outputs 
Staff 
member 
Salary 
WINNN share 
(50%) 
CMAM 
programme 
(40%) 
IYCF 
interventions 
(30%) 
MNCHW 
events (30%) 
Advocacy 
(0%) 
A 10,000 5,000 2,000 1,500 1,500 0 
Source: Illustrative example 
Aside from the four WINNN outputs, IPs were also given the option of allocating time to a fifth 
category called ‘cross-cutting activities’. Amounts allocated to this category were then apportioned 
to the four outputs as per the time-use percentages.  
This apportioning process was repeated for all staff working on WINNN (whether full- or part-time, 
based in Abuja or in one of the focal states) in all the three IPs. The sum of each individual staff 
salary share in WINNN and its outputs gave us, for each IP, total staff costs attributable to WINNN 
and its four outputs. 
                                               
36 Due to the information available, we used a different apportioning method for Year 2, Year 3 and Year 4 for UNICEF’s 
costing data. For Year 2 and Year 3 we used weights to allocate common costs to WINNN outputs derived from the DFID 
impact logframe. For Year 4 UNICEF common costs were apportioned in their majority to the CMAM programme due to 
the fact that RUTF was the largest share of the total expenses. We will be working with UNICEF to find a suitable method 
of standardising previous years’ costing analyses. 
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Shared overhead costs 
As illustrated in Table 28: , we then obtained the ratio of the total salary sums attributable to each 
WINNN output. These ratios were used for apportioning utilities, fuel, stationary and other shared 
common costs to various WINNN outputs. This implies an implicit weighting by salary—i.e. the 
activities of people with higher salaries count more in the weighting. 
Table 28:  An example of calculating apportioning percentages for shared common 
costs 
Staff details Outputs 
Staff 
member 
Salary WINNN share 
CMAM 
programme 
IYCF 
interventions 
MNCHW 
events 
Advocacy 
A 10,000 5,000 2,000 1,500 1,500 0 
B 20,000 15,000 5,000 10,000 0 0 
C 50,000 20,000 10,000 5,000 0 5,000 
Total 80,000 40,000 17,000 16,500 1,500 5,000 
Ratios   42.5% 41.25% 3.75% 12.5% 
Source: Illustrative example 
Where possible, IPs themselves carried out the allocation of some other shared services, such as 
capital expenditures, training and capacity development, and goods and services for volunteers. 
This process was followed by discussions with ORIE analysts to understand and sense-check the 
bases for these allocations. This process took place from Year 2 onwards, while the allocation in 
Year 1 was done largely by OPM using the weights derived from the staff survey and discussion 
with IP.  
B.2 Annualisation of capital costs 
In previous Preliminary Annual Costing Reports we have always noted that the capital costs of the 
WINNN programme have yet to be annualised. Initial years of a programme often involve lumpy 
capital expenditure for acquiring buildings, vehicles and equipment. These expenditure items are 
then ‘annualised’—i.e. their value is spread across their useful life period. In this analysis, we have 
annualised all capital expenditures across Year 1 and Year 4.  
We have done this by assuming an annual interest rate of 3% and an average lifespan for the 
different capital expenditure categories reported by the IPs as follows: 15 years for ‘vehicles’, 10 
years for ‘medical equipment’, and five years for ‘other equipment’. For any given financial capital 
expenditure reported in every year, we calculate the annualised costs using the assumptions 
regarding interest rate and asset life period described above. Given that the life period for all 
assets considered surpasses our analysis timeframe (four years), we assign the calculated 
annualised cost to the year in which that asset was bought and each subsequent year.  
 
Figure 16:  shows how the financial accounting per capital cost category varies across years with 
the annualisation of capital costs. This figure shows that the annualisation method spreads the 
value of the capital expenditure across the years or the asset life period. More weight is given to 
later years since they include new annualised capital costs and annualised costs pulled from 
previous years. Figure 17:  shows the implications of this analysis for the relative weight of capital 
expenditure on total expenditure. The analysis without annualisation of capital costs shows a trend 
away from capital expenditure, while the analysis with annualisation shows an upward trend in 
respect of the relative share. All our results in Section 3 are calculated using annualisation of 
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capital costs. However, WINNN is not a very capital-intensive programme, and so this does not 
make a substantial difference to the overall findings of previous reports, just the finding about 
trends in capital expenditure. 
Figure 16:  Capital expenditure by category under annualisation and no annualisation 
scenarios, Years 1–4 
 
Figure 17:  Capital expenditure share under annualisation and no annualisation 
scenarios, Years 1–4  
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Annex C Methodology, data and assumptions for the IYCF 
interventions costing 
This annex was prepared at the outset of the implementation of ORIE workstream. It is a 
methodological note that guided all primary data collection and analysis.  
C.1 Health facility staff costs 
 
The approach used for calculating the IYCF interventions staff costs is the same as that used in 
the CMAM programme evaluation. Here we present aspects that are specific to the IYCF 
interventions, including data sources and calculations.  
As for the CMAM programme evaluation, health facility staff costs for providing IYCF interventions 
training will be calculated using the following information: 
Staff cost per session = Σ (Staff time per IYCF session x staff salary)  
Here Σ represents the sum of all clinical staff types.  
The above will be calculated for individual as well as group sessions. For group sessions, staff cost 
per session will be divided by the number of participants in the group: 
                Staff cost per group session  
Number of participants in the group session 
Finally, staff cost per session will be multiplied by the number of IYCF sessions attended by each 
mother. Below we describe each component of this calculation and the related data sources. 
Staff time per IYCF session 
The following data will be collected for the IYCF interventions: 
 identification of all clinical staff members involved in providing IYCF interventions training 
(either based at a health facility or in the community); 
 grade level of clinical staff; 
 time spent per individual and group counselling session; and 
 number of mothers per group counselling session. 
Data sources for staff time 
There are two sources of data for number of sessions and staff time per session: 
WHO norms – WHO has recommended the following duration of IYCF sessions by child’s age: 
 <6 months (six counselling sessions): 
 10 mins antenatal consultation 
 10 mins antenatal consultation 
 20 mins neonatal consultation 
 10 min postnatal consultation at one week 
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 10 min postnatal consultation at five weeks 
 10 min postnatal consultation at five months 
 6–23 months (three counselling sessions): 
 10 mins (6–8 months 
 10 mins (9–11 months)  
 10 mins (12–23 months) 
LGA-level data collection or HFS – The following data will be collected to calculate staff time per 
IYCF session: 
 number of staff members of each type involved in delivering an individual or group session 
 total number of minutes spent per IYCF session by staff category 
 this will be multiplied by the number of IYCF sessions, which will be obtained separately in the 
ORIE endline survey (described below). 
Staff salaries 
As part of the WINNN evaluation, staff salaries will be obtained from higher-level offices, i.e. LGA 
and state-level offices in all WINNN states. This approach has been described in the CMAM 
programme sections above. 
Number of IYCF sessions per mother 
Data on the number of IYCF sessions per mother will be obtained in the ORIE endline survey. 
More specifically, the endline survey includes the following questions (these will be asked 
separately for health facility based and community-based sessions): 
 Have you ever received any specific training on breastfeeding and feeding practices in respect 
of infants and young children at a health facility (or in the community)? 
 When was the first time you received this type of training? 
 How many times did you receive this type of training in the last one month? 
 How many times have you received this type of training in total? 
 The last time you received this type of training, who gave the main health talk? 
 The last time you received this type of training, the setting was? 
one-to-one training; or 
group training 
 If group training, how many other people were in the group? 
 The last time you received this type of training, how long did it last? 
Another source of information for the number of attendees per group session is the f-IYCF group 
session attendance form. Depending on the accuracy of these data sources, we will make a 
decision about which should be used as the primary source – the other will be used in the 
sensitivity analysis. 
Finally, the number of sessions reported in the ORIE endline survey will be compared with WHO 
recommended norms. 
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C.2 Health facility overhead costs 
As described in the discussion of the CMAM programme evaluation, monthly health facility 
overhead costs will be obtained at the level of each health facility. This will then be divided by the 
number of patient visits in a calendar month to arrive at health facility-level overhead cost per 
patient visit. This will then be multiplied by the number of IYCF visits per mother, which will be used 
as a cost input in the decision model. The following formula will be used for this purpose:  
Health facility overhead cost per mother =  
Σ (Overhead resource use cost per visit) x number of IYCF sessions per mother 
Here Σ represents the sum of all overhead resource use types described in the previous section. 
Below we present how data on each component of the above formula will be obtained.  
Health facility overhead cost per IYCF session 
Overhead cost at health facility-level will be collected through a questionnaire survey of LGA-level 
officials (described earlier). Using these costs, annualisation of costs will be carried out (as 
described for CMAM). Costs will then be apportioned to the IYCF interventions using one of the 
following two options: 
apportioned based on IYCF patient visits per month as a proportion of total number of visits at the 
health facility; or 
 apportioned based on IYCF-related activity time per month as a proportion of total activity time 
at the health facility. 
Finally, the following formula will be used to calculate health facility overhead cost per IYCF 
session: 
Overhead cost per IYCF session = Overhead cost x proportion attributable to IYCF interventions 
      Number of IYCF visits per year 
Once overhead cost per IYCF session is established, this will be multiplied by the number of 
sessions per mother. This will then be added to the health facility staff costs (above) to arrive at the 
total health facility cost. 
C.3 CV costs 
The following costs will be included: (1) expenses incurred by CVs when providing CMAM care; 
and (2) opportunity cost of CVs. The approach used for calculating the costs incurred by CVs when 
carrying out IYCF-related activities is the same as CMAM programme evaluation. Here we present 
aspects that are specific to the IYCF interventions. 
CV expenses 
CV expenses are recorded in the HFS (details are provided in the CMAM programme section). 
This information is recorded for a representative sample of CVs to calculate average expenses per 
CV. The following formula will then be used to calculate CV expenses per mother: 
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CV expenses per mother receiving IYCF-related services =  
Average CV expenses per month x Total number of CVs in the LGA 
Number of IYCF interventions beneficiaries in the LGA 
CV opportunity cost 
The following data will be collected to calculate the CV opportunity cost. 
Number of hours spent on IYCF-related activities per week: there are two sources of data for 
this: 
Source 1: HFS – CVs instrument 
Source 2: Operational research – CV interviews 
Number of CVs per LGA 
Source: LGA-level data collection 
Number of individual IYCF interventions beneficiaries per LGA 
Source: IYCF interventions LGA monthly Summary Forms 
In addition, the HFS collected information on whether CVs gave up income to do IYCF-related 
work; estimated/expected income given up; and the time spent on IYCF-related activities (see 
details in CMAM programme section). We will use this information on time spent on IYCF-related 
activities and will multiply it by the expected income (if available) or average daily wage in northern 
Nigeria or the national average wage for Nigeria (age- and gender-specific, if possible). 
C.4 Higher-level costs: WINNN programme 
Higher-level costs of implementing the CMAM programme are incurred by the WINNN programme, 
as well as by the LGA- and state-level governments. First, we discuss the cost incurred by the 
WINNN programme. The costs incurred by the programme can be categorised as personnel costs 
and overhead costs. 
Personnel costs: WINNN programme 
WINNN personnel costs include costs of staff at all levels who are involved in planning, 
implementing, managing or M&E of the programme at any level. This information is available in the 
WINNN ORIE Economic Evaluation Implementing Partner Expenditure Mapping Template. For 
further details, see the CMAM programme sections of the report. 
Personnel costs will be divided by the number of IYCF interventions beneficiaries per year 
(obtained from WINNN monitoring data) to arrive at the cost per IYCF interventions beneficiary of 
WINNN personnel time. 
Overhead costs: WINNN IYCF interventions 
For details of cost categories included in the overhead costs, see the CMAM programme 
evaluation section. All cost categories will be added to obtain the total WINNN IYCF interventions 
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overhead cost per year, which will be divided by the total number of IYCF interventions 
beneficiaries per year to obtain the cost per mother. This information will be based on actual 
expenditure data, which are available in the WINNN ORIE Economic Evaluation Implementing 
Partner Expenditure Mapping Template. Further details are provided in the CMAM programme 
evaluation sections. 
C.5 Higher-level costs: LGA and state level 
Higher-level costs at the level of LGAs and states include personnel costs as well as non-
personnel costs. We use the same approach as is used in the CMAM programme economic 
evaluation (see relevant sections above).  
LGA- and state-level personnel costs 
We will identify LGA- and state-level personnel involved in the WINNN IYCF interventions (e.g. 
monitoring visits), their grades and the number of hours worked on the IYCF interventions per 
week. This information will be collected through interviews conducted with LGA and state-level 
officials (as discussed earlier). 
These data will be combined with the total number of IYCF interventions beneficiaries at LGA- and 
state-level to calculate the number of minutes of LGA- and state-level staff time for each type of 
staff: 
Total number of minutes spent by EACH staff member per IYCF interventions beneficiary =  
Number of hours per week spent on IYCF-related activities. x 60 minutes x (52 weeks/12 months) 
Total number of IYCF interventions beneficiaries per month 
The above calculation will be repeated for each category of LGA and state-level staff. The number 
of minutes per staff category is subsequently multiplied by their respective salaries and summed to 
arrive at the cost per IYCF interventions beneficiary. 
C.6 LGA and state level: specific costs 
Besides the overall cost of managing the WINNN IYCF interventions (captured through personnel 
costs, as described above), we will collect additional data on the following two cost categories, 
which are not captured in LGA and state-level personnel costs above: 
 monitoring and supervision costs; and 
 training costs. 
Further details of what these cost categories include are provided in the CMAM programme 
evaluation section. These costs will be added to the overall costs and divided by the total number 
of IYCF interventions beneficiaries (as described above). 
C.7 Carer costs 
Finally, we capture costs incurred by carers, including out-of-pocket expenses incurred during 
care-seeking, and the opportunity cost of providing care. 
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Carer out-of-pocket expenses 
This includes expenses incurred on food, travel, medicines and other aspects of care-seeking for 
SAM. The following data are collected during the HFS (sampling approach discussed earlier) at 
both OTP and SC health facilities: 
 Main mode of transportation used to get to the facility today 
 Did caregivers spend money on transport today on a one-way trip? 
 Average amount of money spent on a one-way trip to the facility today (of caregivers that spent 
money on transport) 
 Did caregivers spend money on food and drink at the facility today? 
 Average amount of money spent on food and water at the facility today (of caregivers that 
spent money on food and water)  
 Did caregivers spend money on medicines at the facility today? 
 Average amount of money spent on medicines at the facility today (of caregivers that spent 
money on medicines) 
 Did caregivers spend money on any other thing at the facility today? 
Carer opportunity cost 
We also collected data on carer opportunity cost in our HFS. The following information was 
collected at both OTP and SC health facilities: 
 Did caregivers work to generate an income? 
 Did caregivers give up some income to be at the CMAM facility (of caregivers that worked to 
generate income)? 
 Average estimated income caregivers gave up to be at the CMAM facility (of caregivers that 
worked and gave up some income) 
 We will use this information on opportunity cost and multiply it by the average daily wage in 
northern Nigeria, or alternatively by national average wage for Nigeria (age- and gender-
specific, if possible). 
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Annex D Data and assumptions for the CMAM programme 
costing 
This annex was prepared at the outset of the implementation of ORIE workstream. It is a 
methodological note that guided all primary data collection and analysis.  
D.1 Introduction 
Cost data will be collected from a societal perspective, as has been described earlier in the report. 
Using the societal perspective, there are four main groups (organisations and individuals) that incur 
costs which are captured in the economic evaluation: 
 LGA- and state-level government – costs incurred by this group include: 
 health service provision costs (including health services staff costs, overhead costs, 
medicines, instruments and other supplies); and 
 management costs (including management, and M&E). 
 WINNN programme and IPs – costs incurred by this group include: 
 RUTF cost; and 
 personnel and overhead costs. 
 CVs – costs incurred by this group include: 
 out-of-pocket expenditure; and 
 opportunity costs. 
 Parents seeking health care– costs incurred by this group include: 
 out-of-pocket expenditure; and 
 opportunity costs. 
Below we summarise these costs based on the level at which the costs are incurred. They are also 
presented in Figure 18 below. 
CMAM programme-specific costs 
 Higher-level costs: state and LGA: 
 personnel costs  
 overhead costs 
 Higher-level costs: IP: 
 personnel costs  
 overhead costs 
 SAM treatment costs 
 RUTF cost 
 Drug and equipment costs 
 Health facility costs (OTP and SC facilities) 
 Health facility staff costs 
 Health facility overhead costs 
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 CV costs 
 Out-of-pocket costs 
 Opportunity cost 
 Carer costs 
 Out-of-pocket costs 
 Carer opportunity cost 
 
Figure 18:  Cost data for CEA of CMAM programme 
 
The remainder of the annex will discuss each of these cost centres and their data sources and 
assumptions. 
D.2 Health facility staff costs 
Health facility staff cost for treating children with SAM will be calculated using the following 
information: 
OTP/SC facility staff cost for each exit category =  
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Σ (Clinical staff time per SAM visit x staff salary) x number of visits to/nights at OTP/SC facilities 
per child with SAM 
Here Σ represents the sum of all clinical staff types, including doctors, nurses and other clinical 
staff. The same calculation will be conducted for SC staff cost.  
Below we present how data on each component of the above formula will be obtained.  
Staff time per SAM visit 
Calculations 
Data on staff time has been collected for OTP and SC facility staff members, including doctors, 
nurses and other supporting clinical staff. Non-clinical support staff time will be captured under the 
heading ‘overhead costs’. These data include: 
 identification of all clinical staff members involved in providing care for SAM (either based at the 
facility or deployed to the facility for CMAM day);  
 number of hours worked on CMAM programme per week; and 
 grade level of clinical staff. 
This information is then combined with the number of SAM cases at the health facility in a week to 
calculate the number of minutes of clinical staff time for each type of clinical staff (such as doctors 
and nurses): 
Total number of minutes spent by EACH staff type per SAM patient =  
Number of hours per week spent on CMAM prog. x 60 minutes x (52 weeks/12 months) 
Number of SAM cases per month 
The above will be calculated for each staff type separately. For instance, the above calculation 
may show that the total number of minutes spent by all nurses together in a month on treating SAM 
children in an OTP facility is 1,000 minutes. This is then divided by the number of SAM 
appointments in this OTP facility in a month to obtain the number of minutes of nurse’s time per 
SAM appointment in the OTP facility. 
The above calculation is repeated for each category of clinical staff, such as doctors, nurses, and 
other clinical staff. The number of minutes per staff category is subsequently multiplied by their 
respective salaries (discussed below) to calculate the cost of a SAM visit. The same approach is 
used to calculate SC staff costs. 
Data source for staff time 
Data for the above will be obtained from the HFS.  
The HFS includes the following information: 
 categories of clinical staff (such as doctors and nurses) involved in delivering CMAM care at 
OTP and SC facilities; 
 number of staff members in each category; and 
 total number of hours spent on delivering CMAM care in a typical week by staff category. 
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Data on total time spent on SAM is then divided by the total number of SAM cases seen at the 
facility, as described later. 
Staff salaries 
This information was obtained from higher-level offices, i.e. LGA and state-level offices in all 
WINNN states. We collected this information through interviews conducted with officials identified 
in LGA- and state-level offices. The interviews were conducted by a senior health economist based 
in Nigeria who conducted field visits and collected this information using a structured questionnaire 
developed by OPM. The questionnaire asked for the following information: 
 salary at each grade level from grade level 1 to grade level 17 and salary steps from 1 to 15 or 
more within each grade level; and 
 how salaries have changed over the past few years, particularly since 2012 when the WINNN 
programme started. 
All four WINNN states and one LGA per state are included in our survey. 
The salaries considered in our calculations are the consolidated health salary structure plus the 
non-clinical duty allowance for nurses/other health professionals who are not entitled to a call duty 
allowance each month.  
To obtain the hourly salary, the total salary is then divided by 208, which is the number of working 
hours per month. 
Given that for Zamfara the salary information is missing, we considered the average hourly salary 
for Jigawa, Katsina and Kebbi.  
Number of SAM visits per month 
Data on the number of SAM cases per month per health facility was obtained using Monthly 
Electronic Forms. These are monthly tables that record the number of SAM cases under the 
following exit categories: 
 Total SAM patients in a given month: 
 new cases, including relapses; 
 transfers from OTP facility; 
 transfers from SC facility; and 
 returned defaulters. 
 Outcomes for SAM patients: 
 number recovered; 
 number died; 
 number defaulted; 
 number non-recovered; 
 number sent to outpatient; and 
 number sent to inpatient. 
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Number of OTP/SC facility visits per exit category 
After obtaining cost per visit of OTP or SC facility, we multiplied this by the number of OTP facility 
visits or SC facility nights for each exit category. This information was obtained from Patient 
Registration Cards, which were obtained from OTP and SC facilities. A Patient Registration Card 
includes information about the number of visits made by each child with SAM and their eventual 
exit category. To get a representative sample of patients, we used the following sampling 
approach: 
 quarterly sampling in one year to account for seasonal fluctuations; 
 two OTP facilities and one SC facility in each LGA; 
 all three LGAs per state and all four WINNN states in northern Nigeria; and 
 patients sampled in each exit category. 
Based on this, the target sampling size is presented below: 
 eight cards of patients who have RECOVERED from treatment at OTP facilities; 
 eight cards of patients who have DIED during treatment at OTP facilities; 
 eight cards of patients who DEFAULTED from treatment at OTP facilities; 
 eight cards of patients who have NOT RECOVERED from treatment at OTP facilities; 
 eight cards of patients who have been TRANSFERRED to SC from treatment at OTP facilities; 
This is summarised in the table below. 
 
April–June 
2015 
January–
March 2015 
October–
December 
2014 
August–
September 
2014 
Total 
Recovered 2 2 2 2 8 
Died 2 2 2 2 8 
Defaulted 2 2 2 2 8 
Non-recovered 2 2 2 2 8 
Transferred to SC 2 2 2 2 8 
Total 10 10 10 10 40 
4 states x 3 LGAs per state x 2 OTP facilities and 1 SC facility per state = 24 OTP facilities + 12 
SC facilities. 
Total OTP facility cards: 8 cards per category x 5 categories (recovered, non-recovered, defaulted, 
died and referred to SC) = 40 cards per OTP facility x 24 OTP facilities = 960 cards.  
Total SC cards: 8 cards per exit category (two categories: lived or died) = 16 cards per SC. This is 
multiplied by 12 SCs = 192 cards.  
However, it should be noted that for some exit categories we did not achieve the proposed sample 
size because not enough events took place per health facility. For instance, there were fewer 
observed deaths than the proposed numbers. 
D.3 Health facility overhead costs 
Monthly health facility overhead costs will be summarised at the level of OTP and SC health 
facilities. This will then be divided by the number of patient visits in a calendar month to arrive at 
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the health facility-level overhead cost per patient visit. This will then be multiplied by the number of 
visits per SAM child based on the exit category, which will be directly used as the cost input in the 
decision model. The following formula will be used for this purpose:  
OTP/SC facility overhead cost for each exit category =  
Σ (Overhead resource use cost per visit) x number of OTP/SC facility visits per SAM child 
Here Σ represents the sum of all overhead resource use types, which includes the following: 
 non-clinical staff time; 
 building costs, including depreciation, maintenance and new building costs; 
 vehicles, including depreciation, maintenance and new vehicle costs; 
 medical equipment, including depreciation, maintenance and new equipment costs; 
 non-medical equipment, including depreciation, maintenance and new equipment costs; 
 utilities, including electricity, gas, water, internet, telephone and other costs; 
 fuel cost for vehicles; and 
 any other overhead costs not covered above. 
The same calculation will be conducted for both OTP and SC facility overhead costs. 
Below we present how data on each component of the above formula will be obtained. 
Health facility overhead cost per SAM visit 
Data on health facility-level overhead resource use will be collected for the cost categories 
mentioned above. These data are collected through: 
 total OTP facility overhead cost: LGA-level questionnaire (Part 3 of the questionnaire); and 
 total SC facility overhead costs: state-level questionnaire (Part 3 of the questionnaire). 
These questionnaires were implemented in a survey of LGA and state-level officials identified in 
LGA and state-level offices (as discussed above under the category ‘Staff salaries’). However, our 
initial assessment of the data collected through this survey suggests that the quality of the data 
may not be optimal. Several expenditure items appear to be based on gross approximations, which 
may be incorrect. Moreover, it is not possible to check these data against official documents 
because these documents were not made available by state and LGA offices. We will have a better 
understanding of the data quality during summer 2016, when we start analysing these data. 
Once total overhead costs have been established at OTP facility and SC facility level, the following 
calculations were conducted: 
 Annualisation of costs (Larson and Wambua, 2011; Formson and Forsythe, 2010): 
Annualisation in this context refers to apportioning depreciation of capital goods to a period of 
time during the lifecycle. This is particularly relevant to capital costs, including buildings, 
vehicles and equipment, to account for depreciation cost. We expect that cost data for certain 
categories, such as equipment, may not be disaggregated at the level of items (for instance, 
furniture).  
 Hence, we propose to use the following pragmatic approach:  
 buildings: 30 years as base case, and 20 and 50 years in sensitivity analysis; 
 vehicles: 15 years as base case and 10 years in sensitivity analysis; 
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 medical equipment: 10 years as base case and five years in sensitivity analysis; and 
 other equipment: five years as base case and seven years in sensitivity analysis. 
 Apportioning to CMAM programme: We will consider the following two options to apportion 
overhead costs to CMAM programme 
 apportioning, based on CMAM programme patient visits per month as a proportion of total 
number of visits at the health facility; and 
 apportioning, based on CMAM programme activity time per month as a proportion of total 
activity time at the health facility. 
Finally, the following formula will be used to calculate health facility overhead cost per SAM visit: 
Overhead cost per SAM visit = Annualised overhead cost x proportion attributable to CMAM 
programme 
      Number of SAM visits per year 
Once overhead per SAM visit is established, this will be multiplied by the number of visits per SAM 
patient in each exit category to calculate overhead cost per patient. This will then be added to the 
staff costs (above) to arrive at the total health facility cost (for OTP and SC facilities) for each exit 
category. 
D.4 SAM treatment costs: RUTF, therapeutic milk and medication 
The following items will be costed in the CEA: 
 RUTF; 
 therapeutic milk: F75; 
 therapeutic milk: F100; and 
 medications prescribed at OTP or SC facilities, including: 
 antibiotics 
 anti-malarial 
 Vitamin A 
 folic acid 
 albendazole/ mebendazole 
 deworming 
 analgesics 
 any other drugs 
There are two components of the abovementioned costs: 
 unit cost of RUTF pack, therapeutic milk and medication 
 unit cost of procurement 
 unit cost of storage and transportation 
 quantity of RUTF packs, therapeutic milk and medication per child in each exit category. 
Below we present the calculations and data sources for each of these components. 
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Cost of procurement, storage and transportation 
In the CMAM programme, procurement of RUTF and therapeutic milk (F75 and F100) is done by 
WINNN IPs, while storage and transportation of these items is done by WINNN and state and LGA 
governments at different stages. For medications, some of these are procured, stored and 
transported by WINNN programme, while for others this is done by state and LGA governments.  
Below we describe the sources of data for these items.  
Cost data are provided by UNICEF for every year (from Year 1 to Year 5). The following 
information has been collected: 
 item-level total expenditure on RUTF, therapeutic food and medications (i.e. those that UNICEF 
is responsible for); and 
 item-level total quantity of the above. (Expenditure and quantity are not disaggregated by 
state).  
Since the data are not split by procurement, storage and transportation, we calculate these 
separate costs as follows: 
Cost of procurement of one item = total expenditure on the item 
Cost of distribution and storage of one item = (total expenditure on the item) x (total 
quantity of the item) / (total quantity of all the items) 
Data on drugs which are procured (and stored and distributed) by the government are collected 
through the higher-level data collection. This is captured in Part 2 (‘CMAM programme supply 
chain costs’ module) of the LGA-level and state-level data collection. The data collection 
questionnaire asks the following questions: 
 Does the LGA or State pay for storage and/or transportation of RUTF and CMAM programme 
routine medicines and supplies? 
 If yes, how much was paid in total for these activities? 
 How much quantity was stored/transported? 
In particular, we find that the state encountered some costs for the storage and transportation only 
of RUTF. 
Hence, the total cost of each commodity will be: 
Total cost of RUTF/therapeutic food/medicines = 
Cost of procurement (provided by IP) + cost of storage and transportation (provided by IP and 
state-/LGA-level office) 
To arrive at unit cost, we will use the following formula: 
Unit cost of RUTF/therapeutic food/medicines =  
   Total cost of RUTF/therapeutic food/medicines  
Quantity of RUTF/therapeutic food/medicines 
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Quantity of RUTF, therapeutic milk and medication per patient 
Unit cost of RUTF/therapeutic food are multiplied by the quantity of these products per patient in 
each exit category at the level of OTP and SC facilities. The source of data is the following: 
 OTP and SC facility Patient Registration Cards: This is our preferred source and is 
described above. Patient Registration Cards provide detailed information on quantities of RUTF 
and therapeutic food given to each patient.  
We note that it is not possible to use health facility caseload and stock records for this as these 
medicines will also be used for other patients. 
Quantity of other medication per patient 
The unit costs of routine medicines are multiplied by the quantity of these products per patient at 
the level of OTP and SC facilities. The source of data is the following: 
 Normative approach based on recommended/common practice: This approach was used 
in Puett et al. [2013], who assumed that each patient gets Cotrimoxazole and folic acid during 
admission. In order to apply this approach, we would need to confirm the drug regimen for 
treatment at OTP facilities (what is given routinely on every visit, or just the first or second visit, 
depending on age or diagnosis), In particular, this involves checking: folic acid, zinc, 
immunisation, HIV test, antiretroviral, tuberculosis therapy Cotrimoxazole prophylaxis. 
D.5 CV costs 
CV costs include: (1) expenses incurred by CVs when providing CMAM care; and (2) opportunity 
costs of CV. We collect this information in the HFS, as well as data on the number of CVs attached 
to each health facility. Details of CV cost data are provided below. 
CV expenses 
This includes expenses incurred in relation to food, travel and other costs incurred when providing 
CMAM care. The following data are collected through the HFS (sampling approach discussed 
earlier) of both OTP and SC health facilities: 
 Main mode of transportation used to get to the facility today 
 Did CVs spend money on transport today on a one-way trip? 
 Average amount of money spent on a one-way trip to the facility today (of CVs that spent 
money on transport) 
 Did CVs spend money on food and drink at the facility today? 
 Average amount of money spent on food and water at the facility today (of CVs that spent 
money on food and water) 
 Did CVs spend money on any other thing at the facility today? 
 Did CVs give money to support caregivers? 
 What was this money given for:  
 food 
 water 
 transport 
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 drugs 
 other  
 Average total amount of money given last time (of CVs that have given money to caregivers) 
 Did CVs give anything other than money last time 
 Average total value of items given in kind last time (of CVs that have given anything other than 
money to caregivers) 
 Average total value of items given in kind last time (of CVs that have given anything other than 
money to caregivers) 
This information is recorded for a representative sample of CVs to calculate average expenses per 
CV. The following formula will then be used to calculate CV expenses per mother: 
CV expenses per mother receiving CMAM-related services =  
Average CV expenses per month x Total number of CVs in the LGA 
Number of CMAM programme beneficiaries in the LGA 
CV opportunity costs 
We also collected data on CV opportunity costs in our HFS. The following information was 
collected/questions were asked: 
 Do CVs work to generate an income? 
 Did CVs give up some income to be at the CMAM facility? 
 Average time spent by CV on the following: 
 time spent to arrive at the health facility; 
 average number of hours spent at the health facility on CMAM day; 
 average number of hours spent at the health facility on WINNN programme; and 
 average number of hours spent in the community to do CMAM programme work. 
 Average estimated income CVs gave up to be at the CMAM facility. 
To estimate the hourly wage we apply the following formula: 
Hourly wage = Estimated income given up/(travel time + time spent on CMAM programme work) 
D.6 Higher-level costs: WINNN programme 
Higher-level costs of implementing the CMAM programme are incurred by the WINNN programme 
as well as the LGA- and state-level governments. First, we discuss the cost incurred by the WINNN 
programme. The costs incurred by the programme can be categorised as personnel costs and 
overhead costs. 
Personnel costs: WINNN programme 
WINNN personnel costs include the costs of staff at all levels who are involved in planning, 
implementing, managing or M&E of the programme at any level. This information is available in the 
WINNN ORIE Economic Evaluation Implementing Partner Expenditure Mapping Template.  
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 These data are disaggregated at state level and by financial year. 
 If possible, we will try to distinguish between the start-up costs versus ongoing programme 
costs to estimate the cost of starting the CMAM programme, as well as continuing the 
programme that is already ongoing in selected states and LGAs in northern Nigeria. 
Personnel costs are divided by the number of CMAM programme beneficiaries per year (obtained 
from CMAM programme monitoring data, discussed above) to arrive at cost per patient of WINNN 
personnel time using the following formula: 
Cost/patient of WINNN personnel time = WINNN annual expenditure on CMAM programme 
personnel 
              Number of CMAM programme beneficiaries per year 
Overhead costs: WINNN programme 
The following cost categories were included in the calculation of overhead costs: 
 cost of operations and maintenance expenses; 
 cost of training (including capacity development) expenses; 
 cost of WINNN M&E (including supervision and assessment) expenses; 
 cost of WINNN goods and services for CVs; 
 cost of other WINNN goods and services; 
 cost of WINNN vehicles; 
 cost of WINNN medical equipment; and 
 cost of other equipment. 
The costs are disaggregated by state level and by financial year (as above). Also, if possible, we 
will aim to distinguish between start-up and ongoing programme costs. 
All cost categories above are added to obtain the total WINNN overhead cost per year, which is 
divided by the total number of CMAM programme beneficiaries per year to obtain the cost per 
patient. 
Cost/patient of WINNN overhead costs = WINNN annual overhead expenditure: (a) – (g) 
       Number of CMAM programme beneficiaries per year 
This information is based on actual expenditure data, which are available in the WINNN ORIE 
Economic Evaluation Implementing Partner Expenditure Mapping Template. One concern is that 
we have not received this information from UNICEF yet.  
We discuss each of these categories below: 
Cost of operations and maintenance expenses 
This includes the cost incurred by WINNN IPs in terms of rent, vehicle fuel, vehicle maintenance, 
utilities, communications and other expenses that can be allocated to the CMAM programme. 
Allocation of operations and maintenance costs to CMAM programme staff will be done using staff 
time cost weighting, i.e. a staff member working full-time on CMAM programme work will be 
weighted twice as much as a staff member working half-time.  
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Cost of training (including capacity development) expenses 
This includes the cost incurred by WINNN IPs in terms of training materials, venue hire, per diems 
and travel to deliver training 
In order to allocate training costs to the CMAM programme, our ideal scenario is to distinguish 
between CMAM programme-specific and non-specific training. For instance, training on project 
management is non-CMAM programme-specific while training to organise CMAM days is CMAM 
programme-specific. Non-CMAM programme-specific costs can be partly attributed to the CMAM 
programme using an allocation based on proportion of staff time spent on CMAM programme-
related activities, whereas the full cost of CMAM programme-specific training can be allocated to 
the programme. 
However, information at this level may not be available from IPs. Hence, our back-up option is to 
use staff time-based cost weighting, as described above. 
Cost of WINNN M&E (including supervision and assessment) expenses 
This includes the cost incurred by WINNN IPs in terms of M&E materials, venue hire, per diems 
and travel. This cost item will be based on M&E expenditure made by IPs. 
Cost of WINNN goods and services for CVs 
This includes the cost incurred by WINNN IPs in terms of overhead costs incurred in respect of 
CVs, including per diems and training costs. 
Cost of other WINNN goods and services 
This includes the cost incurred by WINNN IPs in terms of other overhead costs of the WINNN 
programme, including the cost of management meetings and stakeholder sensitisation meetings. 
Cost of WINNN vehicles 
This includes the cost incurred by WINNN IPs in terms of the depreciation cost of new and existing 
vehicles, including 4x4 vehicles, other cars, motorbikes and bicycles. These costs will be 
annualised using the approach discussed earlier in the report. 
Cost of other equipment 
This includes the cost incurred by WINNN IPs in terms of computers, telephones, mobile phones, 
furniture and generators. These costs will be annualised using the approach discussed earlier in 
the report. 
D.7 Higher-level costs: LGA and state level 
Higher-level costs at the level of LGA and states include personnel costs as well as non-personnel 
costs. We use a pragmatic approach for this and collect primary data on expenditures on activities 
and personnel. The details of our approach and data source are presented below. 
LGA- and state-level personnel costs 
Calculation 
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We propose using a similar approach to the one used for costing health facilities personnel time. 
This involves collecting data on the following items: 
 identification of LGA and state-level personnel involved in the WINNN CMAM programme (e.g. 
monitoring visits); 
 grade level of the abovementioned staff members; and 
 number of hours worked on the CMAM programme per week. 
The following staff members were identified as relevant to the CMAM programme: 
 LNO; 
 Director of Health at LGA level; 
 nutrition focal person; 
 CMAM programme focal person; and 
 any other personnel. 
This information is then combined with the total number of CMAM programme beneficiaries to 
calculate the LGA-level personnel cost per SAM patient for treatment at OTP facilities: 
LGA-level personnel cost per SAM patient for treatment at OTP facilities = 
LGA-level monthly personnel costs / Total number of CMAM programme beneficiaries per month 
Similarly, we calculate: 
State- and LGA-level personnel cost per SAM patient for SC = 
LGA-level monthly personnel costs / Total number of CMAM programme beneficiaries per month 
The OTP and SC facility personnel cost is given by multiplying the hourly salary times the number 
of hours spent on CMAM care, and respectively weighted by the number of WINNN OTP facilities 
or SC facilities within their remit. The hours spent are aggregated on the basis of the staff grade 
level.  
Data source for staff time 
For each of the personnel identified, we asked for the following information at LGA and state level: 
 current grade level; 
 total working hours last month; 
 percentage share allocated to WINNN CMAM programme activities; 
 number of WINNN OTP facilities within their remit; and 
 number of WINNN SC facilities under remit. 
This information was obtained from higher-level offices: i.e. LGA- and state-level offices in all 
WINNN states. We collected this information through interviews conducted with officials identified 
in LGA- and state-level offices. The interviews were conducted by a senior health economist based 
in Nigeria who conducted field visits and collected this information using a structured questionnaire 
developed by OPM. 
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Staff salaries 
This information was obtained from higher-level offices, i.e. LGA- and state-level offices in all 
WINNN states. We collected this information through interviews conducted with officials identified 
in LGA- and state-level offices. The interviews were conducted by a senior health economist based 
in Nigeria, who conducted field visits and collected this information using a structured 
questionnaire developed by OPM. 
The salaries considered in our calculations are the consolidated health salary structure plus the 
non-clinical duty allowance for nurses/other health professionals who are not entitled to a call duty 
allowance each month.  
To obtain the hourly salary, the total salary is then divided by 208, which is the number of working 
hours per month. 
Given that for Zamfara the salary information is missing, we considered the average hourly salary 
for Jigawa, Katsina and Kebbi.  
D.8 LGA and state level: specific activity costs 
Besides the overall role in managing WINNN (captured through personnel costs above), our field 
experience indicated that we should consider two specific activities in which the LGA and state 
offices may have a role and therefore incur costs. 
Monitoring and supervision costs 
In our interviews with LGA- and state-level officials (discussed earlier), in addition to staff time 
costs, we collected data on the following/asked the following questions: 
 Are LGA- or state-level staff members involved in monitoring and supervision of WINNN 
activities? 
 How many monitoring visits took place in the last three months? 
 How has the number of monitoring visits changed since the WINNN programme started? 
 What was the cost of the last monitoring visit, in terms of the following: 
 cost of vehicle hire and fuel 
 cost of communication  
 field allowance(s) for staff and token for driver 
 other costs 
These costs are added to the overall costs and divided by the total number of CMAM programme 
beneficiaries (as mentioned before). The number of visits is divided by three because a period of 
three months is considered. 
Training costs 
As described above, in our interviews with LGA- and state-level officials, we collected data on the 
following/asked the following questions: 
 Does the LGA or state pay for training of WINNN CMAM programme staff members? 
 Does the LGA or state pay for training of health facility staff at OTP and SC facilities? 
 How many training sessions took place in the last three months? 
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 What was the total training cost in the last three months? 
 How many health facility staff were trained in the last three months? 
As before, these costs are added to the overall costs and divided by the total number of CMAM 
programme beneficiaries. In our case the training costs are zero. 
D.9 Carer costs 
Finally, we capture costs incurred by carers, including out-of-pocket expenses incurred during 
care-seeking, and the opportunity cost of providing care. 
Carer out-of-pocket expenses 
This includes expenses incurred in respect of food, travel, medicines and other aspects of care-
seeking for SAM. The following data were collected/questions were posed during the HFS 
(sampling approach discussed earlier) at both OTP and SC health facilities: 
 Main mode of transportation used to get to the facility today 
 Did caregivers spend money on transport today on a one-way trip? 
 Average amount of money spent on a one-way trip to the facility today (of caregivers that 
spent money on transport) 
 Did caregivers spend money on food and drink at the facility today? 
 Average amount of money spent on food and water at the facility today (of caregivers that 
spent money on food and water)  
 Did caregivers spend money on medicines at the facility today? 
 Average amount of money spent on medicines at the facility today (of caregivers that spent 
money on medicines) 
 Did caregivers spend money on any other thing at the facility today? 
Carer opportunity costs 
We also collected data on carer opportunity costs in our HFS. The following information was 
collected at both OTP and SC health facilities: 
 Did caregivers work to generate an income? 
 Did caregivers give up some income to be at the CMAM facility (of caregivers that worked to 
generate income)? 
 Average estimated income caregivers gave up to be at the CMAM facility (of caregivers that 
worked and gave up some income) 
To estimate the hourly wage we apply the following formula: 
Hourly wage = Estimated income given up/ (travel time + time spent on CMAM programme work) 
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Annex E Summary of focused literature reviews 
E.1 IYCF 
Table 29:  Summary of published economic evaluation studies of feeding practices in respect of children under two years of age  
Study Country 
Type of 
analysis 
Perspective Intervention Comparator 
Costing 
approach 
Cost elements Results 
Chola et 
al. (2011) 
Uganda 
Cost 
analysis 
Health 
provider 
Individual 
peer support 
counselling 
intervention 
None 
Activity-
based 
costing and 
an 
ingredient 
approach 
Start-up  
Travel  
Manual adaptation 
and initial training  
 
Overheads 
Communication 
Utilities 
Office rent 
 
Peer support 
Personnel cost 
Bicycles 
Field materials 
 
Peer supervision 
Personnel cost 
Transport cost 
Supervisory meetings 
Office supplies 
Capital costs 
 
Cost per mother 
counselled was 
$139, 
Cost per visit was 
$26 
Cost per week of 
EBF was estimated 
to be $15 at 12 
weeks postpartum 
Nkonki et 
al. (2014) 
South 
Africa 
Cost 
analysis 
Health 
provider 
Individual 
peer support 
counselling 
intervention 
None As above As above 
Cost per mother 
counselled was 
$228 and cost per 
visit was $52. In an 
operational ‘non-
research’ scenario, 
© ORIE   115
  
these were $137 
and $32 per mother 
and per visit, 
respectively 
 
E.2 CMAM programme 
Table 30:  Summary of published economic evaluation studies of severe acute malnutrition in children 
Study Country 
Type of 
analysis 
Perspective Comparator 
Costing 
approach 
Cost elements 
Cost per child 
treated 
Cost per 
DALY 
averted 
Abdul-Latif 
and 
Nonvignon 
(2014) 
Ghana Cost analysis Societal None 
Traditional 
expenditure-
based costing 
Vehicles purchase 
Equipment purchase 
Staff salaries 
Vehicle operation 
Training cost 
Job aids 
Monitoring cost 
Building rent 
RUTF 
$805.36 per child 
detected and treated 
- 
Puett et al. 
(2013) 
Bangladesh 
Cost-
effectiveness 
Societal 
Inpatient 
treatment 
(facility-
based) 
Activity-based 
costing 
Monitoring cost 
Training cost 
Supervision cost 
Growth Monitoring and 
Promotion sessions 
Household visits by 
community health 
workers 
Curative care  
Community treatment 
= $165 per child 
Inpatient treatment = 
$520 per child 
Community 
treatment = 
$26 
Inpatient 
treatment = 
$214 
Purwestri 
et al. 
(2012) 
Indonesia 
Cost analysis 
(with some 
outcomes 
presented 
separately) 
Societal None 
Traditional 
expenditure-
based costing 
Capital costs 
Staff salaries 
Transportation 
Incentives for voluntary 
workers 
Food supplements 
Haemoglobin and health 
assessment 
Daily programme: 
$376.2 per child 
Weekly programme: 
$331.8 per child 
- 
© ORIE   116
  
Tekeste et 
al. (2012) 
Ethiopia 
Cost-
effectiveness 
Societal 
Inpatient 
treatment 
(facility-
based)  
Traditional 
expenditure-
based costing 
All personnel salaries 
Capital depreciation 
Utilities 
Medicines 
RUTF/milk-based 
formula 
Caretakers' food 
Non-food and other 
supplies 
Therapeutic Feeding 
Centre: $262.62 
(institutional) and 
$21.01 (opportunity 
cost) per child treated  
Community-based 
therapeutic care: 
$128.58 (institutional) 
and $5.87 (opportunity 
cost) per child treated 
- 
Wilford et 
al. (2011) 
Malawi 
Cost-
effectiveness 
Health 
services 
Existing 
health 
services 
without a 
CMAM 
programme 
Traditional 
expenditure-
based costing 
Capital costs: cars, 
motorbikes, computers 
Recurrent costs: RUTF, 
admin cost, direct staff 
cost, transport, training 
cost, medical supplies, 
inpatient cost 
CMAM programme 
area = $169.3  
Non-CMAM 
programme area = 
$16.7 
$42 per 
DALY 
averted 
(base case) 
$493 per 
DALY 
averted 
(worst case) 
Bachmann 
(2009) 
Zambia 
Cost-
effectiveness 
Health 
services 
Do nothing 
Traditional 
expenditure-
based costing 
Cost of health centre 
visit 
Cost of RUTF 
Cost of community 
mobilisation 
CTC = $203 per child 
No treatment = $0 
$53 per 
DALY 
averted 
Ashworth 
and 
Khanum 
(1997) 
Bangladesh 
Cost-
effectiveness 
Societal 
i) Inpatient 
care 
ii) Day care 
Traditional 
expenditure-
based costing 
Staff salaries 
Capital depreciation 
Utilities 
Laboratory costs 
X-ray cost 
Medicines/supplies 
Child's food 
Carer's food 
Inpatient = $159 
Day care = $63.8 
Domiciliary = $38.8 
- 
 
